Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3007368	li-igg	mg/l (mg/l)	2988	3465	0.00%
3007368	li-igg	— (—)	634	678	100.00%	Distribution not available
3007368	li-igg	g/l (mg/l)	36	37	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Autoimmune diseases excluding thyroid diseases

1238

1806

3.79

323.31

1.2

48.32

39.34

mg/l

4.05

1022

1521

Autoimmune diseases excluding thyroid diseases, strict definition

1203

1760

3.79

315.18

1.2

48.51

39.58

mg/l

3.86

990

1482

Headache

870

1626

4.34

311.67

1.2

1.1

36.34

44.10

mg/l

2.39

721

1364

MS-disease / Multiple Sclerosis

617

202

37.75

307.65

1.1

1.2

56.01

32.98

mg/l

12.62

502

171

Postprocedural disorders of nervous system

315

235

14.76

307.65

1.2

1.1

32.96

36.34

mg/l

0.44

262

190

Other and unspecified polyneuropathies, also in other diseases

377

379

10.37

307.65

1.2

1.1

46.33

44.33

mg/l

0.27

332

313

Abnormal findings on diagnostic imaging of central nervous system

287

114

29.33

307.65

1.2

41.56

39.52

mg/l

0.17

227

Polyneuropathies and other disorders of the peripheral nervous system

435

446

10.16

307.65

1.2

1.1

49.38

43.83

mg/l

1.02

385

364

Neurological diseases, wide definition

519

104

25.62

307.65

1.2

1.1

40.78

27.75

mg/l

4.99

426

Disturbances of skin sensation

698

910

8.02

307.65

1.2

1.1

40.15

41.12

mg/l

0.10

586

753

Other demyelinating diseases of the central nervous system

377

102

48.82

307.65

1.2

50.45

36.53

mg/l

2.10

301

Demyelinating diseases of the central nervous system

732

249

36.29

307.65

1.1

1.2

53.17

33.64

mg/l

10.23

598

210

Visual disturbances

736

1426

5.29

307.65

1.2

43.82

41.55

mg/l

0.25

633

1183

Neurological diseases

1149

530

11.08

307.65

1.2

1.1

41.55

34.46

mg/l

2.41

949

442

Other symptoms and signs involving the nervous and musculoskeletal systems

869

1093

8.24

307.65

1.2

35.71

42.14

mg/l

3.30

732

922

Autoimmune diseases related-to ILD

1082

2415

3.89

307.65

1.1

1.2

48.50

40.62

mg/l

3.98

882

2038

Disorders of optic nerve and visual pathways

359

288

13.57

307.65

1.2

1.1

45.22

37.31

mg/l

0.86

287

243

Visual disturbances and blindness

765

1515

5.16

307.65

1.2

44.35

41.68

mg/l

0.32

655

1264

Symptoms and signs involving the nervous and musculoskeletal systems

1157

1487

8.04

307.65

1.2

1.1

38.69

45.52

mg/l

2.48

964

1254

Other degenerative diseases of the nervous system

858

141

48.06

307.65

1.1

51.78

33.24

mg/l

7.20

698

118

Symptoms and signs involving the skin and subcutaneous tissue

896

2226

4.01

307.41

1.2

1.1

41.50

42.18

mg/l

0.08

748

1866

Optic neuritis

239

130

21.20

306.74

1.2

41.70

35.26

mg/l

0.87

184

104

Other neurological diseases

834

1542

4.32

295.08

1.2

1.1

42.16

44.37

mg/l

0.30

702

1297

Concussion

372

387

7.92

247.29

1.2

1.1

39.27

32.15

mg/l

0.60

301

324

ILD medications: immunosuppressive drugs

783

1945

3.80

246.06

1.2

1.1

48.31

43.15

mg/l

1.48

636

1628

Intracranial trauma

400

399

7.11

226.50

1.1

39.08

31.83

mg/l

0.69

328

334

Autoimmune diseases

1117

1814

3.16

220.38

1.2

45.58

39.30

mg/l

2.19

931

1526

Encephalitis

154

24.88

212.04

1.4

1.1

55.56

39.24

mg/l

1.61

138

Symptoms and signs involving cognition, perception, emotional state and behaviour

1007

2259

3.07

209.41

1.2

1.1

40.31

43.30

mg/l

0.57

859

1874

Abnormalities of gait and mobility

218

197

11.52

207.75

1.1

48.83

45.68

mg/l

0.22

167

166

Used for control exclusion in common control thyroid runs

1042

1684

3.16

204.55

1.2

1.1

45.11

39.61

mg/l

1.71

860

1421

Other encephalitis

147

25.26

203.41

1.4

1.1

57.18

40.02

mg/l

1.64

131

General symptoms and signs

1062

1742

3.08

200.39

1.2

1.1

39.21

44.64

mg/l

1.79

896

1461

Diplopia

249

288

8.99

198.35

1.2

1.1

58.96

41.00

mg/l

0.98

207

235

ILD medications

1135

2185

2.84

192.45

1.2

1.1

42.96

42.46

mg/l

0.09

958

1817

Other symptoms and signs involving cognitive functions and awareness

460

898

4.73

192.09

1.2

1.1

43.30

44.14

mg/l

0.06

384

745

Subjective visual disturbances

366

680

5.52

186.70

1.2

1.1

38.80

40.95

mg/l

0.19

324

560

Inflammatory diseases of the central nervous system

214

235

9.63

178.06

1.4

1.1

63.63

41.99

mg/l

4.22

189

191

Spirochaetal infections, other/unspecified

192

209

9.67

160.72

1.1

1.2

61.04

40.67

mg/l

2.64

184

174

Malaise and fatigue

489

997

4.00

158.63

1.2

1.1

36.97

44.31

mg/l

2.77

399

835

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

596

1602

3.37

155.66

1.2

42.07

44.58

mg/l

0.54

499

1345

Use of teriflunomide

37.57

141.13

1.1

54.06

31.19

mg/l

4.15

Episodal and paroxysmal disorders

986

1950

2.59

138.82

1.2

1.1

36.41

44.58

mg/l

4.72

822

1635

Migraine

579

1496

3.18

134.12

1.2

1.1

31.81

42.56

mg/l

6.37

490

1252

Dizziness and giddiness

651

1776

2.93

131.12

1.2

1.1

37.02

43.17

mg/l

2.80

562

1486

Other disorders of optic [2nd] nerve and visual pathways

154

165

9.86

130.61

1.2

1.1

48.22

38.32

mg/l

0.44

129

137

Other soft tissue disorders, not elsewhere classified

892

2047

2.58

129.60

1.2

1.1

38.17

44.90

mg/l

1.64

763

1679

Medical observation and evaluation for suspected diseases and conditions

597

919

3.35

129.33

1.2

1.1

37.07

44.78

mg/l

3.34

536

734

L04AA Selective immunosuppressants

320

742

4.42

125.60

1.1

1.2

52.52

39.77

mg/l

4.12

243

624

Cerebral cysts

147

161

9.65

122.66

1.2

1.1

44.64

40.19

mg/l

0.16

128

129

Dorsalgia

895

1910

2.53

122.15

1.2

37.89

45.22

mg/l

2.93

767

1576

Epilepsy

328

806

4.12

118.26

1.2

1.1

48.48

44.46

mg/l

0.26

287

684

Nerve, nerve root and plexus disorders

909

2326

2.41

117.06

1.2

1.1

41.47

43.58

mg/l

0.49

762

1942

Other headache syndromes

432

1295

3.38

116.64

1.2

1.1

37.69

42.46

mg/l

1.09

354

1092

Diseases of the eye and adnexa

770

1448

2.69

115.29

1.2

1.1

38.81

43.11

mg/l

1.51

645

1210

Benign intracranial hypertension

35.29

115.06

1.2

47.84

31.45

mg/l

0.36

Systemic atrophies primarily affecting the central nervous system

108

13.88

114.44

1.2

1.1

38.12

42.55

mg/l

0.32

Other dorsopathies, not elsewhere classified

885

1919

2.43

110.74

1.2

36.56

45.37

mg/l

4.43

768

1582

Papilloedema, unspecified

16.51

109.08

1.2

1.1

55.38

41.27

mg/l

0.34

Cerebral palsy and other paralytic syndromes

189

315

6.19

108.54

1.3

1.1

50.19

41.22

mg/l

0.38

169

260

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

300

296

5.13

107.40

1.2

1.1

38.73

49.54

mg/l

2.39

245

252

Second line medication for Crohn's disease

558

2061

2.74

104.47

1.2

1.1

45.87

40.35

mg/l

2.00

462

1738

Abnormal involuntary movements

173

279

6.36

102.52

1.2

1.1

37.27

42.10

mg/l

0.75

148

233

Condition for Implicit Sepsis (Organ dysfunction codes)

766

2201

2.42

102.47

1.2

1.1

41.34

42.28

mg/l

0.11

630

1853

Pain in limb

726

1967

2.49

102.44

1.2

1.1

36.38

44.25

mg/l

3.87

612

1609

Condition for Implicit Sepsis (Organ dysfunction codes)

713

2041

2.49

101.69

1.2

1.1

40.27

42.85

mg/l

0.35

589

1718

ILD medications: prednisolone, methylprednisolone, prednisone

875

2131

2.31

100.36

1.2

1.1

38.56

42.70

mg/l

1.28

754

1773

L04AX Other immunosuppressants

539

1998

2.73

100.24

1.2

1.1

45.88

40.38

mg/l

2.03

444

1690

Care involving use of rehabilitation procedures

572

1994

2.66

99.88

1.2

1.1

38.31

41.92

mg/l

1.03

467

1681

Guillain-Barre syndrome

22.18

99.81

1.3

1.1

75.88

43.66

mg/l

1.74

Low back pain

649

1830

2.57

99.38

1.2

1.1

36.56

44.52

mg/l

3.22

555

1504

Implicit Sepsis

672

1967

2.52

99.32

1.2

1.1

40.44

42.53

mg/l

0.25

560

1649

Pain in joint

493

1046

3.03

98.94

1.2

1.1

34.61

46.91

mg/l

6.70

428

852

Other special examinations and investigations of persons without complaint or reported diagnosis

537

919

2.98

96.99

1.2

1.1

36.41

44.78

mg/l

3.54

447

734

Cerebrovascular diseases (FINNGEN)

345

669

3.70

96.65

1.2

45.65

41.99

mg/l

0.47

283

551

Small fibre neuropathy

15.92

95.65

1.2

1.1

44.47

40.70

mg/l

0.21

Pain, not elsewhere classified

278

715

3.94

94.71

1.2

1.1

48.44

43.25

mg/l

0.27

228

599

Anxiety disorders, excluding more controls

706

1913

2.42

93.25

1.1

1.2

35.66

46.37

mg/l

5.65

580

1599

Dorsopathies

859

1935

2.27

92.09

1.2

36.57

45.17

mg/l

4.28

735

1596

Infections, IBD-co-morbidities

101

14.57

91.22

1.2

1.0

68.43

28.51

mg/l

1.04

Cerebrovascular diseases

521

1358

2.72

88.76

1.2

1.1

46.26

45.31

mg/l

0.10

439

1138

Convulsions, not elsewhere classified

250

620

4.04

87.77

1.2

1.1

35.31

43.84

mg/l

2.87

205

516

General examination and investigation of persons without complaint and reported diagnosis

503

919

2.88

86.66

1.2

1.1

44.43

44.78

mg/l

0.03

445

734

Mood disorders, excluding more controls

756

1985

2.29

86.46

1.1

1.2

37.84

46.60

mg/l

3.99

635

1663

Other acute disseminated demyelination

26.62

85.42

1.2

1.1

44.08

28.13

mg/l

2.69

Disorders of ocular muscles, binocular movement, accommodation and refraction

477

1820

2.63

82.39

1.2

40.44

40.09

mg/l

0.03

379

1538

Lower back pain or/and sciatica

852

2652

2.11

82.13

1.2

1.1

37.26

43.95

mg/l

3.39

726

2197

Anxiety disorders

778

2521

2.17

81.14

1.2

35.32

45.07

mg/l

5.72

643

2115

Mood disorders

842

2600

2.11

80.74

1.1

1.2

37.10

45.07

mg/l

4.08

707

2178

Migraine with aura

287

843

3.46

80.50

1.2

1.1

33.08

41.90

mg/l

2.17

243

714

Mood [affective] disorders

840

2601

2.11

80.34

1.1

1.2

37.09

45.07

mg/l

4.08

706

2178

Neurotic, stress-related and somatoform disorders

771

2515

2.16

79.96

1.2

35.37

45.00

mg/l

5.56

638

2110

Implicit Sepsis

572

1791

2.43

79.10

1.2

1.1

40.96

42.97

mg/l

0.21

478

1495

Depression

799

2566

2.12

78.90

1.1

1.2

36.68

45.00

mg/l

4.28

671

2147

Any reimbursement code in KELA

581

1158

2.54

78.26

1.2

42.57

37.73

mg/l

1.43

488

977

Paralytic strabismus

109

144

7.83

77.91

1.2

58.78

42.34

mg/l

0.48

119

Disorders of thyroid, IBD co-morbidities

104

10.24

76.79

1.2

1.1

38.60

26.30

mg/l

1.47

Other antidepressants

788

1902

2.13

73.38

1.2

1.1

38.16

47.40

mg/l

4.19

649

1622

Bell's palsy

149

292

5.22

71.91

1.2

1.1

49.61

40.70

mg/l

0.81

126

240

First line medication for Crohn's disease

882

2382

2.01

71.59

1.2

1.1

40.74

42.78

mg/l

0.37

757

1973

Myalgia

247

712

3.52

71.40

1.2

1.1

33.26

40.97

mg/l

3.14

217

571

Opioids

808

2023

2.09

71.38

1.2

1.1

37.78

43.03

mg/l

2.26

672

1689

STROKE

440

1153

2.62

69.21

1.2

1.1

44.73

42.18

mg/l

0.39

370

951

Soft tissue disorders

819

2074

2.04

68.49

1.2

1.1

36.07

45.03

mg/l

5.74

710

1704

Pain (limb, back, neck, head abdominally)

528

1074

2.48

68.20

1.2

1.1

38.69

47.05

mg/l

3.50

448

873

Fever of other and unknown origin

398

1364

2.62

67.07

1.2

1.1

43.23

44.25

mg/l

0.16

337

1142

Focal epilepsy, strict definition

212

583

3.70

65.86

1.2

1.1

40.11

41.08

mg/l

0.12

184

478

Other and unspecified visual disturbances

129

242

5.46

65.45

1.2

1.1

37.02

38.84

mg/l

0.17

111

195

Alzheimer disease, excluding more controls

12.26

65.33

1.1

1.0

39.89

41.06

mg/l

0.06

Other intervertebral disc disorders

599

1624

2.23

65.20

1.1

39.48

45.01

mg/l

1.51

517

1339

Focal epilepsy

225

648

3.53

65.17

1.2

39.95

40.86

mg/l

0.12

193

536

Examination and observation for other reasons

417

913

2.66

64.80

1.2

1.1

37.00

44.79

mg/l

2.41

379

729

Focal epilepsy, mode (most common among epilepsy diagnosis)

204

553

3.75

64.74

1.2

1.1

40.56

40.84

mg/l

0.03

175

454

Recurrent or chronic depression

362

923

2.78

64.66

1.2

1.1

38.39

46.13

mg/l

2.05

303

792

Anxiety (asthma-related co-morbidities)

560

1958

2.23

64.36

1.2

34.32

43.41

mg/l

4.40

465

1635

Spirochaetal infections, other/unspecified

274

900

3.08

64.05

1.1

1.2

53.43

39.77

mg/l

2.48

261

737

Lyme disease

271

892

3.08

63.13

1.1

1.2

53.66

39.89

mg/l

2.47

258

732

Other spirochaetal diseases

275

913

3.05

63.10

1.1

1.2

53.43

39.83

mg/l

2.48

262

750

Migraine without aura

238

727

3.33

62.90

1.2

1.1

29.97

42.27

mg/l

5.29

196

614

Other spirochaetal diseases

273

905

3.06

62.81

1.1

1.2

53.61

39.86

mg/l

2.50

260

743

Speech disturbances, not elsewhere classified

111

188

6.05

62.77

1.1

39.82

44.20

mg/l

0.35

149

Neuromuscular dysfunction of bladder

120

219

5.62

62.77

1.2

1.1

64.47

43.66

mg/l

0.57

175

Oral corticosteroids

807

2465

1.95

61.85

1.2

1.1

37.73

44.70

mg/l

3.18

676

2049

Ischaemic Stroke, excluding all haemorrhages

342

925

2.77

61.73

1.2

1.1

45.80

46.78

mg/l

0.09

286

773

Any mental disorder

792

2004

1.99

61.16

1.1

1.2

37.64

46.42

mg/l

4.23

674

1676

Persons encountering health services for specific procedures and health care

832

2612

1.92

60.89

1.2

1.1

42.76

42.28

mg/l

0.05

681

2193

Systemic connective tissue disorders

286

990

2.92

60.88

1.2

1.1

42.30

41.81

mg/l

0.05

240

832

Stroke, excluding SAH

366

1018

2.64

60.07

1.2

1.1

46.43

45.97

mg/l

0.04

306

848

Sarcoidosis

152

352

4.41

60.01

1.2

1.1

42.44

40.33

mg/l

0.24

126

290

Certain disorders involving the immune mechanism

198

557

3.61

59.57

1.3

1.1

41.10

41.02

mg/l

0.01

167

465

Sciatica+with lumbago

382

1415

2.50

59.24

1.2

1.1

39.51

45.24

mg/l

1.19

323

1166

Inflammatory bowel disease treatment related agents

866

2587

1.88

58.75

1.2

1.1

38.39

44.27

mg/l

2.49

731

2152

Extrapyramidal and movement disorders

275

951

2.92

58.63

1.2

1.1

37.48

42.13

mg/l

0.96

225

799

Persons encountering health services for examination and investigation

451

919

2.47

58.28

1.2

1.1

39.89

44.78

mg/l

1.28

386

734

All anxiety disorders

567

2132

2.12

57.65

1.2

34.21

42.52

mg/l

4.00

470

1792

Strabismus

274

957

2.90

57.21

1.2

1.1

44.60

40.38

mg/l

0.28

217

799

Stroke, including SAH

378

1098

2.51

56.09

1.2

1.1

46.78

45.52

mg/l

0.13

317

918

Depression or dysthymia

466

1104

2.34

55.33

1.2

1.1

40.82

49.70

mg/l

2.02

390

949

Implicit viral Sepsis

224

716

3.16

54.84

1.3

1.1

38.73

42.46

mg/l

0.69

191

598

Other disorders of eye and adnexa

169

454

3.80

54.54

1.2

1.1

44.74

36.75

mg/l

1.23

150

377

Tramadol

576

1692

2.10

54.54

1.2

1.1

39.36

42.96

mg/l

0.92

490

1414

Use of glatiramer acetate

11.92

54.43

1.1

50.94

29.33

mg/l

3.29

Depression medications

302

524

2.92

53.00

1.2

1.1

35.87

41.43

mg/l

1.21

242

432

Lumbar disc prolapse

445

1530

2.24

52.15

1.1

39.31

45.29

mg/l

1.37

375

1263

Diagnoses used for exclusion with ILD

203

640

3.21

50.96

1.2

52.62

41.74

mg/l

0.49

165

536

Codeine

701

1987

1.93

50.75

1.2

1.1

38.25

43.05

mg/l

1.86

582

1658

Dysphagia

188

572

3.32

50.02

1.2

1.1

61.26

43.43

mg/l

0.86

164

472

Other disorders of lacrimal gland

282

1081

2.64

49.49

1.2

1.1

36.24

42.70

mg/l

1.73

235

885

Spondylopathies

492

1373

2.15

49.10

1.2

1.1

42.39

45.80

mg/l

0.61

409

1134

Parkinson's disease, excluding more controls

10.65

49.04

1.3

1.1

42.95

41.20

mg/l

0.07

Other anxiety disorders

439

1766

2.17

48.63

1.2

35.26

42.13

mg/l

2.31

367

1483

Symptoms and signs involving speech and voice

257

949

2.74

48.58

1.1

34.38

41.60

mg/l

2.05

220

785

Certain infectious and parasitic diseases

720

1913

1.89

48.57

1.2

1.1

42.53

40.19

mg/l

0.49

616

1570

Psychiatric diseases

680

1796

1.90

46.70

1.1

1.2

37.87

46.68

mg/l

3.74

565

1511

Any gastric operation

617

1582

1.97

46.38

1.2

1.1

38.07

42.45

mg/l

1.30

514

1329

GASTRO-related operations

617

1582

1.97

46.38

1.2

1.1

38.07

42.45

mg/l

1.30

514

1329

Diseases of the musculoskeletal system and connective tissue

438

981

2.25

46.37

1.2

1.1

35.72

46.30

mg/l

3.70

371

791

Parkinson's disease, strict definition, excluding more controls

10.87

46.34

1.3

1.1

43.82

43.19

mg/l

0.02

Other/unspecified dorsalgia

272

1051

2.59

46.04

1.2

1.1

33.27

43.18

mg/l

5.80

232

865

Hemiplegia

113

6.65

45.24

1.3

1.2

32.75

37.34

mg/l

0.52

Migraine with aura and triptan purchases

193

640

3.07

44.69

1.1

32.04

39.65

mg/l

1.69

166

528

Ocular pain

111

255

4.46

44.47

1.2

46.01

37.12

mg/l

0.96

205

Viral infections of the central nervous system

108

246

4.50

43.76

1.4

1.1

52.09

41.07

mg/l

1.22

201

Syncope and collapse

270

906

2.57

43.75

1.2

1.1

36.46

45.18

mg/l

2.68

224

758

Viral Sepsis

159

475

3.39

43.66

1.3

1.1

39.69

43.04

mg/l

0.42

134

388

Implicit viral Sepsis

158

474

3.37

43.10

1.3

1.1

39.72

43.01

mg/l

0.41

133

387

Disorders of lacrimal system

311

1328

2.36

43.07

1.2

1.1

36.86

42.35

mg/l

1.49

260

1098

Other extrapyramidal and movement disorders in other diseases

182

596

3.09

42.96

1.2

36.55

41.08

mg/l

0.70

151

503

Other general symptoms and signs

109

6.53

42.57

1.2

1.1

27.15

36.31

mg/l

1.99

Symptoms and signs involving the circulatory and respiratory systems

755

2129

1.78

42.44

1.2

1.1

36.84

45.28

mg/l

2.76

628

1794

Cardiovascular diseases

571

1594

1.94

41.97

1.2

34.54

41.39

mg/l

3.06

499

1312

Parasetamol

579

1532

1.92

41.18

1.2

1.1

37.92

44.92

mg/l

2.20

489

1276

Codeine or tramadol medication

797

2551

1.72

40.14

1.2

38.28

44.15

mg/l

2.47

661

2128

Other diseases of spinal cord

8.59

40.06

1.2

1.1

42.43

33.78

mg/l

0.42

Radiculopathy

118

306

3.90

40.05

1.2

1.1

38.11

44.10

mg/l

0.62

250

Somatoform disorder

163

523

3.16

39.94

1.2

1.1

28.10

41.36

mg/l

8.12

131

435

Viral infections of the central nervous system

100

231

4.44

39.85

1.4

1.1

53.15

41.00

mg/l

1.27

187

Cervicalgia

158

498

3.21

39.81

1.1

38.82

42.32

mg/l

0.38

129

407

Spondylosis

310

1101

2.31

39.54

1.1

40.43

46.87

mg/l

1.15

249

900

Other specific joint derangements/joint disorders

585

2050

1.85

39.50

1.2

1.1

34.96

43.23

mg/l

4.18

503

1698

Visual field defects

173

5.01

39.43

1.2

1.1

46.92

39.76

mg/l

0.58

144

Other systemic involvement of connective tissue (FG)

191

665

2.86

39.37

1.2

34.88

40.09

mg/l

1.40

161

542

Abnormalities of breathing

652

2114

1.80

39.15

1.2

1.1

33.80

45.25

mg/l

10.80

529

1780

Paraplegia, diplegia of upper limbs

10.27

38.60

1.2

1.1

101.06

40.94

mg/l

0.70

Fibromyalgia

104

255

4.16

38.26

1.2

1.1

30.54

38.92

mg/l

2.36

205

Migraine without aura and triptan purchases

190

685

2.82

37.88

1.1

30.57

39.62

mg/l

2.94

156

574

Cervicobrachial syndrome

170

578

2.97

37.62

1.3

1.1

35.88

42.64

mg/l

1.00

156

472

Pain in throat and chest

602

2007

1.81

37.11

1.2

1.1

38.37

45.86

mg/l

1.65

498

1691

Non-invasive ventilation

190

609

2.81

37.08

1.1

1.2

53.12

42.71

mg/l

0.40

149

497

Cardiovascular diseases (excluding rheumatic etc)

568

1778

1.85

36.97

1.2

36.51

41.75

mg/l

1.79

488

1473

ILD differential diagnosis

553

1480

1.88

36.73

1.2

1.1

39.09

43.59

mg/l

1.56

464

1226

COPD differential diagnosis

553

1481

1.88

36.66

1.2

1.1

39.09

43.60

mg/l

1.56

464

1227

Excluding asthma or asthma-COPD overlap

550

1484

1.86

35.67

1.2

1.1

38.52

43.75

mg/l

2.02

461

1229

Viral encephalitis, not elsewhere classified/unspecified

10.02

35.32

1.5

1.1

65.18

46.11

mg/l

0.77

Sequelae of cerebrovascular disease

187

588

2.76

35.14

1.1

51.26

44.44

mg/l

0.58

163

493

Hypothyroidism, strict autoimmune

421

1400

1.99

35.14

1.2

1.1

37.49

38.36

mg/l

0.11

352

1176

Other systemic involvement of connective tissue

197

752

2.64

35.06

1.2

35.88

40.21

mg/l

1.07

167

633

Disorders of vestibular function (Vertigo)

291

1306

2.21

34.63

1.2

1.1

39.87

42.76

mg/l

0.53

245

1081

Chorioretinal inflammation

7.72

34.58

1.2

1.1

47.64

34.67

mg/l

0.84

Status epilepticus

7.84

34.54

1.3

1.1

39.40

44.78

mg/l

0.25

Cervical disc disorders

217

874

2.50

34.52

1.1

37.93

46.20

mg/l

1.07

183

719

Symptoms and signs involving the urinary system

471

1918

1.88

34.48

1.3

1.1

46.96

42.64

mg/l

0.42

396

1614

Oedema, not elsewhere classified

185

681

2.70

34.29

1.2

1.1

39.52

43.87

mg/l

0.56

161

566

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

13.89

34.26

1.2

1.0

52.32

29.88

mg/l

1.32

Symptoms and signs involving the digestive system and abdomen

666

1932

1.73

34.17

1.2

1.1

40.24

45.06

mg/l

0.99

566

1607

Organic, including symptomatic, mental disorders

250

746

2.40

33.77

1.2

1.1

39.81

47.27

mg/l

2.11

202

632

Anaemias

193

461

2.76

33.54

1.2

1.1

40.45

41.31

mg/l

0.08

155

377

Hard cardiovascular diseases

512

1668

1.84

33.24

1.2

1.1

40.16

45.17

mg/l

1.09

430

1395

Other pulmonary diagnosis

540

1484

1.83

33.14

1.2

1.1

38.49

43.75

mg/l

2.04

452

1229

Diseases of the myoneural junction and muscle

105

288

3.70

33.02

1.2

1.1

49.56

44.30

mg/l

0.31

236

Other reaction to severe stress, and adjustment disorders

317

1530

2.09

32.85

1.1

1.2

34.72

40.63

mg/l

2.24

257

1281

Asthma, excluding more controls

508

1437

1.85

32.65

1.2

1.1

36.78

43.62

mg/l

2.24

424

1187

Antihypertensive medication - note that there are other indications

543

1600

1.81

32.50

1.2

1.1

34.08

43.41

mg/l

3.65

456

1325

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

234

999

2.35

32.49

1.2

38.36

42.30

mg/l

0.70

197

834

Asthma

513

1468

1.84

32.38

1.2

1.1

36.76

43.66

mg/l

2.30

426

1214

Provisional assignment of new diseases of uncertain etiology

377

1952

1.94

31.85

1.2

42.72

41.08

mg/l

0.11

323

1631

Triptan medication for migraine, single purchase ok

584

2297

1.73

31.84

1.2

35.36

43.07

mg/l

3.12

494

1918

Migraine, single triptan purchase ok & required. ICD-code if available is included

584

2297

1.73

31.84

1.2

35.36

43.07

mg/l

3.12

494

1918

Other and unspecified nerve root and plexus disorders, also in other diseases

157

562

2.82

31.74

1.1

41.95

41.05

mg/l

0.07

123

469

ILD medications: azathioprine

131

424

3.13

31.72

1.3

1.1

51.92

37.68

mg/l

2.04

109

360

Polyuria

152

535

2.87

31.68

1.2

1.1

42.33

44.12

mg/l

0.23

127

443

Codes for special purposes

377

1957

1.94

31.62

1.2

42.72

41.08

mg/l

0.11

323

1636

Hypothyroidism (congenital or acquired)

222

498

2.54

31.60

1.2

1.1

37.71

40.86

mg/l

0.43

186

409

SLE (Finngen)

7.67

31.10

1.3

1.1

57.87

40.53

mg/l

0.72

Third [oculomotor] nerve palsy

9.96

30.86

1.1

49.95

43.45

mg/l

0.18

Symptoms and signs concerning food and fluid intake

194

4.22

30.67

1.2

1.1

39.91

43.27

mg/l

0.18

158

Meningitis

139

4.95

30.54

1.3

1.1

81.05

41.68

mg/l

3.62

109

Trigeminal neuralgia

128

5.11

30.39

1.2

39.09

37.49

mg/l

0.08

108

Sixth [abducent] nerve palsy

6.93

30.29

1.2

1.1

43.13

41.11

mg/l

0.09

Asthma (mode)

499

1480

1.81

30.28

1.2

1.1

36.70

43.59

mg/l

2.23

413

1226

Hypothyroidism and >3 levothyroxin purchases

218

496

2.50

30.25

1.2

1.1

36.07

40.88

mg/l

0.80

181

407

Hypothyroidism, levothyroxine purchases

218

496

2.50

30.25

1.2

1.1

36.07

40.88

mg/l

0.80

181

407

Other disorders of binocular movement

6.93

30.00

1.2

36.17

40.66

mg/l

0.23

Implicit bacterial Sepsis

234

886

2.29

29.95

1.2

1.1

51.69

43.91

mg/l

0.38

191

744

Other necrotizing vasculopathies (FG)

104

5.59

29.94

1.2

1.1

35.96

41.07

mg/l

0.46

Follow-up examination after treatment for conditions other than malignant neoplasms

259

765

2.25

29.92

1.1

42.16

44.03

mg/l

0.08

222

612

Other disorders of urethra and urinary system

457

1826

1.81

29.74

1.2

1.1

41.72

mg/l

0.00

376

1519

Enlarged lymph nodes

116

365

3.21

29.45

1.2

1.1

40.94

43.58

mg/l

0.28

306

Diseases of inner ear

317

1544

2.00

29.05

1.2

1.1

39.40

43.32

mg/l

0.88

268

1289

Factors influencing health status and contact with health services

180

329

2.76

29.01

1.2

1.1

44.07

46.29

mg/l

0.19

152

272

Diseases of the ear and mastoid process

790

2525

1.58

28.29

1.2

38.24

44.22

mg/l

2.43

672

2094

Primary_lymphoid and hematopoietic malignant neoplasms

147

542

2.74

28.12

1.3

1.1

55.22

41.84

mg/l

1.84

120

453

Disorders of refraction and accommodation

223

994

2.26

28.10

1.2

1.1

32.61

39.77

mg/l

2.81

173

835

Dissociative [conversion] disorders

134

4.85

27.95

1.1

1.2

26.64

36.10

mg/l

2.38

103

Nausea and vomiting

183

740

2.44

27.63

1.2

44.75

41.78

mg/l

0.13

147

607

Pain in thoracic spine

116

381

3.08

27.44

1.1

34.50

42.80

mg/l

1.09

308

Abdominal and pelvic pain

633

1932

1.65

27.40

1.2

1.1

40.65

45.06

mg/l

0.62

547

1607

Malignant neoplasm of brain, including Hilmo

117

5.07

27.31

1.1

1.2

94.15

37.36

mg/l

1.13

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

109

5.21

27.31

1.3

1.1

36.28

41.90

mg/l

0.57

Selective serotonin reuptake inhibitors

606

1909

1.66

27.18

1.2

1.1

36.64

47.29

mg/l

5.25

504

1629

Other joint disorders

644

2084

1.64

27.18

1.2

35.97

43.47

mg/l

3.83

556

1728

Liquid cancers, helper endpoint

219

852

2.26

27.06

1.2

1.1

53.47

41.65

mg/l

2.29

177

721

Implicit bacterial Sepsis

207

805

2.29

26.66

1.2

1.1

53.83

44.28

mg/l

0.42

170

671

Other disorders of nervous system

139

4.62

26.65

1.3

1.1

45.43

39.78

mg/l

0.45

114

Neuralgia and neuritis, unspecified

116

5.02

26.57

1.2

67.61

43.08

mg/l

0.32

Benzodiazepine use

651

2812

1.60

26.54

1.2

1.1

36.25

44.23

mg/l

3.42

527

2362

Disorders of eyelid, lacrimal system and orbit

524

2375

1.68

26.51

1.2

1.1

37.64

43.89

mg/l

2.40

442

1991

Disorders of optic nerve, not elsewhere classified

8.63

26.30

1.3

1.1

33.97

45.14

mg/l

0.62

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

619

2654

1.61

26.24

1.2

1.1

44.98

41.97

mg/l

0.35

504

2227

Sleep disorders (combined)

727

2440

1.57

25.87

1.2

1.1

37.61

44.26

mg/l

2.74

586

2072

Spinal stenosis

225

778

2.21

25.67

1.2

1.1

49.65

47.50

mg/l

0.19

189

643

Asthma (only as main-diagnosis)

447

1468

1.77

25.65

1.2

1.1

33.85

43.66

mg/l

5.62

371

1214

Special screening examination for infectious and parasitic diseases

196

619

2.35

25.62

1.1

43.03

43.26

mg/l

0.02

179

499

Asthma (only as main-diagnosis), excluding more controls

444

1437

1.77

25.61

1.2

1.1

33.85

43.62

mg/l

5.50

369

1187

Other strabismus

184

790

2.34

25.42

1.2

1.1

35.84

39.02

mg/l

0.55

149

664

Other meningitis

8.30

25.34

1.3

1.1

62.67

30.08

mg/l

2.29

Degenerative diseases of the nervous system

137

366

2.76

24.98

1.1

42.34

46.07

mg/l

0.29

110

319

Alzheimer’s disease (Late onset), excluding more controls

7.45

24.72

1.1

47.12

36.49

mg/l

0.70

Persons encountering health services in other circumstances, wide

733

2446

1.55

24.52

1.2

1.1

42.44

43.46

mg/l

0.12

618

2039

Azathioprine

131

490

2.70

24.50

1.3

1.1

51.92

41.84

mg/l

1.18

109

412

Lesion of lateral popliteal nerve

113

4.88

24.40

1.2

36.41

43.43

mg/l

0.49

Bacterial Sepsis

234

954

2.11

24.39

1.2

1.1

56.34

43.94

mg/l

0.66

191

801

Other diseases of urinary system

634

2248

1.59

24.32

1.2

1.1

45.28

41.70

mg/l

0.44

529

1895

Any dementia, excluding more controls

141

362

2.69

24.10

1.1

38.10

46.67

mg/l

1.94

112

307

Malignant neoplasm of brain

5.71

24.08

1.0

1.1

89.29

39.22

mg/l

0.76

Oxycodone

197

803

2.23

23.98

1.2

1.1

55.28

44.56

mg/l

0.95

164

676

Transient ischemic attack

237

922

2.09

23.97

1.2

1.1

44.19

44.34

mg/l

0.02

204

767

Other mental disorders due to brain damage and dysfunction and to physical disease

195

3.79

23.94

1.2

1.1

37.17

44.67

mg/l

1.16

164

Other necrotizing vasculopathies

143

4.34

23.93

1.2

1.1

37.69

42.42

mg/l

0.41

125

Bacterial infection, other or unspecified

290

1309

1.93

23.85

1.2

1.1

53.04

42.42

mg/l

0.77

242

1104

Covid-19 confirmed case

230

1113

2.08

23.82

1.2

49.47

40.71

mg/l

0.42

183

931

Dermatitis

383

2182

1.76

23.79

1.2

1.1

40.72

43.19

mg/l

0.36

318

1839

Asthma, unspecified (mode), excluding more controls

321

1287

1.87

23.48

1.2

1.1

36.56

44.06

mg/l

2.15

260

1067

Triptan medication for migraine, min. 3 purchases

453

2056

1.69

23.41

1.2

34.61

40.22

mg/l

1.34

385

1703

Brachial plexus disorders

297

3.18

23.22

1.2

38.18

38.32

mg/l

0.01

254

Asthma, unspecified (mode)

322

1309

1.86

23.06

1.2

1.1

36.55

44.09

mg/l

2.18

261

1086

Other and unspecified dermatitis

328

1815

1.82

22.83

1.2

1.1

42.23

42.19

mg/l

0.00

269

1531

Coxibs

189

425

2.36

22.81

1.1

36.94

48.40

mg/l

2.95

154

356

Heterophoria

255

3.35

22.80

1.2

37.03

36.56

mg/l

0.03

207

Cervicocranial syndrome

245

3.39

22.77

1.2

1.1

48.70

40.54

mg/l

0.35

202

Other sleep disorders

260

3.31

22.74

1.2

1.1

40.65

45.21

mg/l

0.27

214

Abnormal findings on diagnostic imaging of lung

223

1039

2.07

22.64

1.2

1.1

45.53

44.44

mg/l

0.14

195

862

Personality disorders, excluding more controls

199

930

2.16

22.63

1.2

30.71

42.78

mg/l

5.49

165

776

Finngen Rheumatological endpoints

654

2409

1.55

22.54

1.2

1.1

39.30

42.37

mg/l

0.74

554

1997

Dyspnoea

536

2488

1.60

22.15

1.2

1.1

33.43

44.24

mg/l

8.79

449

2082

Certain infectious and parasitic diseases

470

1401

1.69

22.13

1.2

1.1

41.75

40.33

mg/l

0.25

394

1152

Non-Hodgkin lymphoma, all, including Hilmo

266

3.23

21.91

1.2

1.1

67.85

39.30

mg/l

2.94

221

Abnormalities of heart beat

225

1092

2.03

21.87

1.2

1.1

33.17

45.04

mg/l

5.47

182

919

Persons encountering health services for other counselling and medical advice, not elsewhere classified

684

2446

1.52

21.73

1.2

1.1

41.92

43.46

mg/l

0.18

596

2039

Cough

249

1209

1.96

21.72

1.1

30.18

46.00

mg/l

10.85

209

1021

Bacterial infection, other or unspecified

309

1434

1.83

21.49

1.2

1.1

52.65

41.79

mg/l

0.86

258

1210

Acute upper respiratory infections

637

2564

1.53

21.45

1.2

37.74

43.58

mg/l

2.82

521

2151

Cramp and spasm

130

4.33

21.44

1.1

1.2

39.91

38.92

mg/l

0.06

104

Visual impairment including blindness (binocular or monocular)

134

4.24

21.42

1.3

1.1

47.92

37.97

mg/l

0.72

109

Other facial nerve disorders

6.42

21.09

1.1

33.20

41.03

mg/l

0.51

Dementia, including avohilmo

179

549

2.25

21.08

1.1

37.30

46.02

mg/l

2.68

144

466

Other symptoms and signs involving the urinary system

245

3.26

20.72

1.4

1.1

38.19

45.05

mg/l

0.76

194

Dementia

164

492

2.30

20.38

1.1

35.97

45.23

mg/l

3.13

130

423

Arthropathies

630

2089

1.53

20.26

1.2

37.37

43.38

mg/l

2.42

534

1733

Retention of urine

168

620

2.24

20.26

1.3

1.1

56.19

44.75

mg/l

0.42

142

512

Any dementia

144

413

2.43

20.23

1.1

37.61

46.06

mg/l

1.91

114

355

Systemic lupus erythematosus

4.96

20.22

1.3

1.2

57.87

35.28

mg/l

1.23

Malignant neoplasm of eye, brain and central nervous system

4.74

20.14

1.0

1.2

87.09

38.35

mg/l

0.76

Exclusions for E4_PCOS_BROAD

142

607

2.36

20.10

1.2

1.1

41.40

39.38

mg/l

0.16

108

506

Irritable bowel syndrome

202

997

2.04

19.96

1.2

1.1

35.21

41.12

mg/l

1.38

169

819

Nonorganic sleeping disorders, excluding more controls

143

616

2.34

19.90

1.2

30.59

42.85

mg/l

6.08

118

515

121

484

2.53

19.86

1.2

42.79

37.72

mg/l

0.53

400

Shoulder lesions

413

1500

1.67

19.84

1.2

1.1

39.25

45.91

mg/l

1.61

363

1236

Other functional intestinal disorders

270

1361

1.85

19.79

1.2

1.1

42.08

41.81

mg/l

0.03

214

1123

Sleep apnoea

541

2254

1.56

19.75

1.2

1.1

40.89

44.87

mg/l

1.00

427

1916

Acute upper respiratory infections of multiple and unspecified sites

491

2311

1.58

19.49

1.1

1.2

42.97

42.41

mg/l

0.04

403

1942

Vocal cord dysfunction

311

2.82

19.38

1.2

40.37

42.85

mg/l

0.21

252

Intracranial injury

354

1988

1.69

19.16

1.1

1.2

40.09

42.76

mg/l

0.17

283

1683

Dermatitis and eczema

682

2883

1.47

18.81

1.2

1.1

39.01

43.62

mg/l

1.37

564

2413

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

317

1786

1.73

18.80

1.2

1.1

40.80

44.32

mg/l

0.59

262

1477

Gastrointestinal diseases

434

1326

1.65

18.77

1.1

35.81

43.57

mg/l

2.88

363

1097

Lesion of ulnar nerve

350

2.74

18.41

1.2

1.1

41.07

41.60

mg/l

0.03

287

Other shoulder lesions

238

3.15

18.32

1.2

1.1

48.39

42.36

mg/l

0.24

192

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

4.90

18.29

1.3

1.1

51.83

37.42

mg/l

1.13

Speech and linguistic disorders, excluding more controls

252

3.03

18.25

1.2

1.1

46.95

43.76

mg/l

0.16

201

Other disorders of fluid, electrolyte and acid-base balance

158

698

2.17

18.24

1.2

1.1

45.92

40.93

mg/l

0.70

128

586

Cystitis

509

1954

1.55

18.08

1.2

1.1

45.28

41.21

mg/l

0.39

415

1631

Bronchitis

654

2824

1.46

17.65

1.2

38.32

42.85

mg/l

1.75

530

2369

Gastro-oesophageal reflux disease

390

2087

1.62

17.60

1.1

1.2

36.72

44.37

mg/l

2.28

329

1752

Other diseases of upper respiratory tract

643

2285

1.47

17.20

1.1

1.2

40.55

44.41

mg/l

0.90

553

1881

Diseases of oesophagus, stomach and duodenum

639

2619

1.46

17.14

1.1

1.2

37.22

43.73

mg/l

2.57

539

2182

SLE, ICD10

4.57

17.13

1.3

1.1

51.41

36.33

mg/l

0.71

SLE, strict definition

4.57

17.13

1.3

1.1

51.41

36.33

mg/l

0.71

Cluster headache, strict

4.68

16.86

1.2

1.1

30.42

43.18

mg/l

1.38

Chronic sinusitis

264

1513

1.75

16.45

1.2

37.79

43.14

mg/l

1.00

220

1257

Viral infections characterized by skin and mucous membrane lesions

526

3027

1.49

16.45

1.2

1.1

45.66

41.92

mg/l

0.63

451

2514

Delirium, not induced by alcohol and other psychoactive substances

186

3.30

16.43

1.2

1.1

47.94

47.17

mg/l

0.03

155

Cluster headache, wide

4.57

16.39

1.2

1.1

30.42

42.63

mg/l

1.32

Atypical facial pain

117

4.00

16.31

1.2

1.1

29.98

37.54

mg/l

0.78

100

Dentofacial anomalies [including malocclusion]

477

2529

1.52

16.26

1.1

1.2

37.85

41.73

mg/l

0.80

388

2116

Acute sinusitis

352

2019

1.62

16.20

1.2

34.16

41.99

mg/l

4.33

286

1696

Implicit fungal Sepsis

142

3.64

15.90

1.4

1.1

38.94

44.96

mg/l

0.38

119

Respiratory insufficiency

106

4.08

15.79

1.0

1.1

98.18

47.03

mg/l

0.47

Hypertensive diseases (excluding secondary)

351

1247

1.64

15.66

1.2

39.75

41.82

mg/l

0.33

295

1040

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

234

1317

1.79

15.65

1.2

38.36

38.87

mg/l

0.07

197

1106

Diarrhoea and gastroenteritis of presumed infectious origin

609

2790

1.44

15.53

1.2

1.1

39.99

42.57

mg/l

0.65

510

2326

Diseases of the respiratory system

389

1217

1.61

15.44

1.1

40.10

43.11

mg/l

0.63

327

1008

Benign paroxysmal vertigo

152

745

2.05

15.44

1.2

44.18

41.96

mg/l

0.22

129

627

Functional dyspepsia

168

854

1.98

15.42

1.2

1.1

38.45

42.17

mg/l

0.35

142

716

Restless leg syndrome

360

2.55

15.39

1.2

38.22

40.26

mg/l

0.15

303

Metabolic disorders

539

2232

1.48

15.33

1.2

1.1

41.81

43.48

mg/l

0.33

458

1860

Benign neoplasm of meninges

227

2.98

15.24

1.2

1.1

56.68

38.91

mg/l

1.18

190

Disorders of other endocrine glands

271

1574

1.70

15.22

1.1

1.2

37.55

40.16

mg/l

0.42

214

1326

Complications of medical and surgical care

411

2466

1.54

15.12

1.2

40.42

42.52

mg/l

0.16

345

2078

Sleep apnoea, including avohilmo

565

2406

1.46

15.09

1.2

1.1

40.28

44.36

mg/l

1.09

448

2052

Rheumatism, unspecified

289

2.72

15.03

1.3

1.1

31.94

40.68

mg/l

1.34

238

Use of amantadine

6.71

15.02

1.0

1.1

46.33

41.93

mg/l

0.14

Other and unspecified types of non-Hodgkin lymphoma, hilmo

4.63

14.97

1.2

1.1

71.11

39.16

mg/l

1.61

Constipation

477

2208

1.50

14.94

1.1

45.31

42.28

mg/l

0.43

373

1868

Benign neoplasm: Cerebral meninges

204

3.07

14.85

1.2

1.1

55.89

38.18

mg/l

1.06

173

Other diseases of intestines

666

2685

1.41

14.85

1.2

1.1

38.09

43.11

mg/l

1.78

563

2240

Obesity related asthma

207

1142

1.82

14.80

1.1

35.24

41.79

mg/l

2.10

170

952

Non-follicular lymphoma

189

3.15

14.78

1.3

1.1

69.21

40.56

mg/l

1.91

153

Other symptoms and signs involving the digestive system and abdomen

404

2.42

14.70

1.1

38.51

40.49

mg/l

0.17

333

Use of pramipexole

116

524

2.23

14.57

1.2

1.1

40.34

42.01

mg/l

0.12

444

Other disorders of bladder

244

2.85

14.54

1.3

1.1

42.70

47.88

mg/l

0.56

200

Fasciculation

11.00

14.43

1.1

27.55

41.14

mg/l

0.42

Voice disturbances

154

778

1.99

14.43

1.2

1.1

30.85

42.24

mg/l

5.01

133

646

Viral infections characterized by skin and mucous membrane lesions

255

1504

1.70

14.42

1.3

1.1

43.92

40.11

mg/l

0.72

221

1268

Abnormal findings on diagnostic imaging of other body structures

307

2.63

14.41

1.2

40.51

40.90

mg/l

0.03

257

COPD/asthma/ILD related infections

616

2160

1.43

14.34

1.2

38.11

42.70

mg/l

1.47

511

1814

COPD/asthma related infections

616

2160

1.43

14.34

1.2

38.11

42.70

mg/l

1.47

511

1814

Sleep disorders

550

2764

1.44

14.26

1.2

35.78

43.88

mg/l

2.83

448

2326

Asthma-related infections

342

2131

1.58

14.25

1.2

1.1

37.31

42.57

mg/l

1.01

281

1786

Asthma, hospital admission 2, infections

342

2131

1.58

14.25

1.2

1.1

37.31

42.57

mg/l

1.01

281

1786

Hypo-osmolality and hyponatraemia

336

2.53

14.22

1.2

50.39

40.46

mg/l

1.05

277

Viral meningitis

116

3.79

14.12

1.4

1.1

49.06

40.22

mg/l

0.55

Asthma (diagnoses ohter than nonallergic)

515

2954

1.45

14.07

1.2

1.1

35.28

43.63

mg/l

4.05

427

2468

657

2416

1.41

14.07

1.1

1.2

37.32

43.69

mg/l

3.35

535

2037

Fall on same level

705

2780

1.39

14.03

1.2

41.93

42.20

mg/l

0.04

592

2322

Injuries to the head

663

2925

1.40

14.01

1.2

43.50

42.26

mg/l

0.13

543

2452

Temporomandibular joint disorders, including avohilmo

320

1987

1.60

14.00

1.1

1.2

34.50

38.85

mg/l

0.84

263

1653

Other medical care

217

1105

1.77

13.98

1.1

57.87

42.14

mg/l

0.79

174

923

Chronic diseases of tonsils and adenoids

496

2137

1.47

13.97

1.2

37.53

44.13

mg/l

2.04

433

1758

Osteopathies and chondropathies

301

1740

1.62

13.86

1.1

1.2

38.54

42.20

mg/l

0.81

241

1467

Dental pulpitis, including avohilmo

594

2726

1.42

13.83

1.1

1.2

36.74

43.84

mg/l

2.96

486

2290

Enthesopathies of lower limb, excluding foot

124

588

2.12

13.81

1.2

1.1

43.30

41.71

mg/l

0.08

106

477

Other external causes of accidental injury

503

1710

1.48

13.80

1.2

42.64

mg/l

0.00

410

1435

Genitourinary diseases

373

1192

1.57

13.68

1.2

1.1

38.92

44.96

mg/l

1.77

312

997

Intestinal infectious diseases

561

2999

1.42

13.68

1.2

43.90

42.41

mg/l

0.13

466

2506

Behavioural syndromes associated with physiological disturbances and physical factors

563

2810

1.42

13.66

1.2

36.58

43.75

mg/l

2.20

455

2363

Panic disorder

124

592

2.11

13.62

1.2

31.23

40.95

mg/l

3.20

106

495

Other symptoms and signs involving the circulatory and respiratory systems

178

3.13

13.59

1.2

1.1

72.96

48.31

mg/l

0.30

139

Unspecified dementia

101

3.76

13.48

1.0

1.1

34.47

46.08

mg/l

1.65

Systemic lupus erythematosus, unspecified

4.35

13.44

1.2

1.1

54.11

31.24

mg/l

1.08

Endocrine, nutritional and metabolic diseases

539

1892

1.45

13.34

1.1

1.2

40.91

41.77

mg/l

0.13

445

1588

Accidents

499

1710

1.47

13.19

1.2

42.70

42.64

mg/l

0.01

407

1435

Falls/tendency to fall

671

2427

1.39

13.16

1.2

40.76

42.18

mg/l

0.28

559

2036

Fourth [trochlear] nerve palsy

5.57

13.13

1.2

1.1

117.47

42.22

mg/l

0.40

Disorders of sclera, cornea, iris and ciliary body

319

2040

1.57

13.12

1.2

42.68

42.61

mg/l

0.01

265

1735

Rotator cuff syndrome

288

1274

1.63

13.06

1.1

38.76

46.45

mg/l

2.20

257

1046

Neoplasms

537

1984

1.44

13.03

1.2

40.76

39.78

mg/l

0.11

451

1651

Metatarsalgia

226

2.81

12.98

1.2

1.1

43.58

42.20

mg/l

0.09

183

Asthma, including avohilmo

698

2870

1.37

12.91

1.2

1.1

36.04

44.03

mg/l

3.80

578

2404

Other enthesopathy of foot (+metatarsalgia)

245

2.72

12.75

1.2

1.1

42.63

42.79

mg/l

0.01

199

Hydrocephalus

139

3.34

12.72

1.1

80.80

36.36

mg/l

1.32

110

Other respiratory disorders and diseases

425

2.27

12.71

1.1

1.2

70.99

44.59

mg/l

0.53

350

Other diseases of the respiratory system

425

2.27

12.71

1.1

1.2

70.99

44.59

mg/l

0.53

350

Disorders of muscles

240

2.73

12.69

1.2

1.1

68.29

43.31

mg/l

0.38

193

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

263

2.65

12.68

1.2

35.97

41.01

mg/l

0.47

223

Non-selective monoamine reuptake inhibitors

175

927

1.83

12.66

1.1

33.44

44.54

mg/l

3.95

143

798

Chronic lower respiratory diseases

724

2844

1.36

12.65

1.2

1.1

41.53

43.02

mg/l

0.17

606

2374

Exposure to unspecified factor

586

3033

1.39

12.63

1.1

1.2

43.94

42.32

mg/l

0.15

469

2551

Diffuse large B-cell lymphoma, helper endpoint

4.11

12.59

1.3

1.1

90.29

33.37

mg/l

2.55

Diffuse large B-cell lymphoma, including Hilmo

4.11

12.59

1.3

1.1

90.29

33.37

mg/l

2.55

Diffuse large B-cell lymphoma

4.11

12.59

1.3

1.1

90.29

33.37

mg/l

2.55

Other diseases of blood and blood-forming organs, wide

124

611

2.04

12.53

1.2

65.76

41.16

mg/l

0.65

517

Intestinal infectious diseases

665

2775

1.37

12.53

1.2

44.92

42.56

mg/l

0.26

566

2316

Dislocation, sprain and strain of joints and ligaments at neck level

124

612

2.04

12.51

1.2

1.1

32.43

38.56

mg/l

1.19

108

513

277

1721

1.60

12.47

1.2

34.84

40.33

mg/l

1.61

232

1431

Use of hypnotics and sedatives

613

2540

1.39

12.45

1.2

1.1

38.42

43.69

mg/l

1.68

513

2128

Injuries to the neck

163

884

1.86

12.44

1.2

1.1

45.91

40.83

mg/l

0.16

143

739

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

509

2158

1.43

12.41

1.2

49.12

42.70

mg/l

0.68

424

1814

509

2158

1.43

12.41

1.2

49.12

42.70

mg/l

0.68

424

1814

Cluster headache, strict, including avohilmo

162

3.14

12.40

1.3

1.2

29.47

41.58

mg/l

2.30

129

Dystonia

138

3.31

12.19

1.2

29.31

37.98

mg/l

1.38

115

Persons encountering health services in other circumstances

243

1475

1.65

12.19

1.2

1.1

50.67

41.58

mg/l

0.42

178

1229

Hypertension, essential

456

1778

1.46

12.01

1.2

40.75

43.83

mg/l

0.56

383

1495

N06DA Anticholinesterases

106

388

2.16

11.95

1.1

34.85

46.80

mg/l

3.45

331

Use of anticholinesterases

106

388

2.16

11.95

1.1

34.85

46.80

mg/l

3.45

331

Use of fingolimod

10.18

11.93

1.1

54.75

31.94

mg/l

1.35

Hypermetropia

210

2.79

11.78

1.2

28.20

38.99

mg/l

1.60

170

All influenza

146

778

1.89

11.77

1.2

1.1

36.91

41.44

mg/l

1.00

130

651

Somnolence, stupor and coma

3.98

11.75

1.3

1.1

50.10

38.39

mg/l

0.46

Transport accidents

286

1568

1.57

11.74

1.1

47.70

42.07

mg/l

0.32

248

1314

Dental caries

154

802

1.86

11.73

1.1

1.2

44.41

48.47

mg/l

0.43

128

664

Other heart diseases

304

1271

1.57

11.67

1.2

36.79

42.17

mg/l

1.30

249

1055

Ptosis of eyelid

228

2.70

11.67

1.3

1.1

36.07

42.52

mg/l

0.89

183

Unspecific neurodegenerative disorder

132

455

1.99

11.62

1.1

37.26

46.13

mg/l

2.05

105

387

Insomnia

529

2768

1.40

11.59

1.2

35.72

43.54

mg/l

2.58

430

2323

Cluster headache, wide,, including avohilmo

169

3.00

11.55

1.3

1.2

29.47

41.91

mg/l

2.40

134

Adrenocortical insufficiency

3.85

11.50

1.3

1.1

60.20

36.00

mg/l

0.65

Cardiac arrhythmias

379

1661

1.49

11.44

1.1

37.63

40.53

mg/l

0.57

309

1390

Zoster [herpes zoster]

432

2.19

11.43

1.4

1.1

43.73

41.90

mg/l

0.17

360

Chronic laryngitis and laryngotracheitis

344

2.34

11.41

1.1

38.81

41.91

mg/l

0.21

284

Osteoporosis

108

488

2.08

11.38

1.1

1.2

47.55

39.94

mg/l

0.74

413

Disorders of adult personality and behaviour

214

1289

1.67

11.37

1.2

30.84

39.88

mg/l

4.71

177

1078

Influenza and pneumonia

622

2915

1.36

11.36

1.2

1.1

46.58

41.57

mg/l

0.64

525

2427

Unknown and unspecified causes of morbidity

145

3.13

11.25

1.5

1.1

30.34

44.01

mg/l

2.26

122

Caries of dentine

137

706

1.90

11.23

1.1

42.86

48.77

mg/l

0.66

118

586

Undefined dementia

118

3.30

11.23

1.0

1.1

34.47

43.74

mg/l

1.24

Alzheimer’s disease (Early onset)

4.61

11.19

1.0

1.1

37.94

42.25

mg/l

0.20

Bipolar affective disorders

133

702

1.91

11.10

1.1

1.2

33.57

41.00

mg/l

1.68

113

578

Other bacterial diseases

497

2387

1.40

11.09

1.2

1.1

53.60

41.34

mg/l

1.69

410

2004

Hypermobility syndrome

201

2.78

11.05

1.1

27.70

33.16

mg/l

1.05

163

Undetermined asthma

307

2.39

10.94

1.2

1.1

42.48

43.53

mg/l

0.05

254

Trochanteric bursitis

289

2.44

10.93

1.2

1.1

38.29

41.93

mg/l

0.20

238

Irregular menses

330

1739

1.50

10.90

1.2

33.27

38.54

mg/l

1.78

275

1440

Deforming dorsopathies

142

770

1.85

10.88

1.2

1.1

37.30

41.48

mg/l

0.70

114

620

Undetermined asthma, excluding more controls

308

2.38

10.86

1.2

1.1

42.48

43.35

mg/l

0.04

255

Injuries to the wrist and hand

584

2983

1.36

10.83

1.2

42.55

42.62

mg/l

0.01

487

2493

Sicca syndrome [Sjögren]

203

2.74

10.82

1.4

1.1

33.19

36.62

mg/l

0.41

174

Hypothyreosis and Thyroxine purchase for inclusion criteria

522

2477

1.39

10.81

1.2

1.1

38.33

41.93

mg/l

0.85

437

2062

Benign neoplasms

598

2425

1.36

10.81

1.2

1.1

37.64

42.90

mg/l

2.03

515

2000

Diarrhoea and gastroenteritis of presumed infectious origin

417

2637

1.43

10.78

1.2

38.29

42.00

mg/l

1.16

343

2199

Mixed connective tissue disease

176

2.88

10.76

1.2

41.37

38.75

mg/l

0.18

144

Hypothyroidism, other/unspecified

507

2403

1.39

10.75

1.2

1.1

37.99

42.04

mg/l

0.99

428

2001

Diseases of the skin and subcutaneous tissue

590

2170

1.37

10.69

1.2

1.1

40.56

42.61

mg/l

0.45

489

1832

Implicit fungal Sepsis

3.89

10.69

1.4

1.1

37.89

41.80

mg/l

0.16

Infections with a predominantly sexual mode of transmission

298

1832

1.52

10.66

1.2

35.76

39.91

mg/l

0.97

246

1530

Fungal Sepsis

3.78

10.61

1.4

1.1

37.82

45.20

mg/l

0.34

Abnormal findings on examination of blood, without diagnosis

215

1209

1.64

10.56

1.1

43.17

45.26

mg/l

0.24

177

1021

Pain and other conditions associated with female genital organs and menstrual cycle

163

853

1.77

10.54

1.1

31.34

38.08

mg/l

1.87

135

702

Disorders of synovium and tendon

277

1579

1.54

10.45

1.2

1.1

37.34

44.69

mg/l

2.02

233

1302

Covid-19 suspected case

156

883

1.78

10.43

1.1

47.37

39.20

mg/l

0.29

144

727

Other and unspecified myopathies

179

2.82

10.42

1.2

1.1

56.78

43.34

mg/l

0.45

151

Other and unspecified mononeuropathies of upper limb

4.23

10.39

1.1

33.94

43.84

mg/l

0.78

Other disorders of ear

480

2259

1.39

10.35

1.2

37.95

44.34

mg/l

2.12

411

1887

Other and unspecified mononeuropathies, also in other diseases

4.60

10.27

1.3

1.1

27.09

42.14

mg/l

1.37

Other specified/unspecified systemic involvement of connective tissue

143

3.04

10.24

1.2

1.1

36.83

39.43

mg/l

0.19

119

Personality disorders

199

1212

1.65

10.19

1.2

30.71

39.79

mg/l

3.95

165

1020

Other abnormal immunological findings in serum

4.55

10.07

1.1

33.62

39.84

mg/l

0.31

Disorders of psychological development

108

508

1.99

10.07

1.2

1.1

40.27

37.85

mg/l

0.17

416

Continuous positive airway pressure

379

2.10

10.03

1.2

64.95

44.61

mg/l

0.49

316

Exposure to other specified factors

443

2926

1.39

10.02

1.2

43.77

42.35

mg/l

0.10

366

2448

Hypopituitarism

235

2.54

10.01

1.2

1.1

37.35

42.99

mg/l

0.32

188

Other viral diseases

260

1681

1.54

9.99

1.2

1.1

39.44

39.57

mg/l

0.02

217

1405

Post-traumatic stress disorder

341

2.25

9.90

1.2

25.55

39.54

mg/l

4.94

280

Disorders of choroid and retina

373

1842

1.44

9.89

1.2

1.1

46.42

44.30

mg/l

0.33

298

1557

Hyperkinetic disorders, excluding more controls

457

2.05

9.88

1.2

37.38

40.70

mg/l

0.33

370

Vitamin deficiency, wide

115

3.26

9.87

1.1

1.2

32.38

35.03

mg/l

0.23

Vitamin deficiency

115

3.26

9.87

1.1

1.2

32.37

35.03

mg/l

0.23

Disorders of lens

292

1201

1.52

9.85

1.2

1.1

45.25

46.98

mg/l

0.18

239

1010

Other enthesopathies

152

869

1.76

9.83

1.2

1.1

45.86

42.97

mg/l

0.24

131

713

Other and unspecified drugs and medicaments

250

2.47

9.76

1.2

36.62

40.63

mg/l

0.32

208

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

308

2062

1.48

9.74

1.1

1.2

40.87

42.19

mg/l

0.07

258

1744

Zoster [herpes zoster]

227

1420

1.58

9.72

1.3

1.1

48.92

42.06

mg/l

0.64

190

1184

Retinal detachments and breaks

146

828

1.77

9.71

1.2

1.1

45.59

42.83

mg/l

0.32

118

708

Specific personality disorders

173

1030

1.69

9.70

1.2

30.20

39.84

mg/l

4.29

141

861

Internal derangement of knee

207

1283

1.61

9.68

1.1

1.2

37.74

43.19

mg/l

1.17

174

1069

Faecal incontinence

181

2.73

9.65

1.1

38.24

39.31

mg/l

0.06

154

Any death

257

1192

1.55

9.63

1.2

1.1

60.15

44.83

mg/l

1.40

217

1000

Inflammatory diseases of female pelvic organs

371

1907

1.43

9.60

1.1

1.2

33.28

39.25

mg/l

1.72

314

1575

External causes of morbidity and mortality

401

1406

1.43

9.60

1.1

39.58

43.86

mg/l

0.88

325

1178

Generalized anxiety disorder

121

654

1.86

9.47

1.2

29.59

41.60

mg/l

5.71

108

546

Emotional disorders starting during childhood or adolecense, excluding more controls

151

2.88

9.47

1.1

29.36

39.80

mg/l

1.18

118

Disorders of the thyroid gland

528

2548

1.35

9.46

1.2

1.1

39.32

42.26

mg/l

0.61

448

2127

Abnormal weight loss

224

2.52

9.43

1.2

1.1

41.33

41.91

mg/l

0.02

183

Specific development disorders of speech and language

221

2.52

9.43

1.3

1.1

51.76

37.91

mg/l

0.78

173

Asthma, hospital admissions , main diagnosis only

465

3004

1.37

9.42

1.2

1.1

33.66

43.70

mg/l

6.18

389

2506

Explicit Sepsis

191

1094

1.63

9.41

1.2

1.1

66.03

42.42

mg/l

1.20

153

916

Hypothyroidism, drug reimbursement

284

2.15

9.41

1.2

1.1

32.78

38.96

mg/l

0.86

234

Speech and linguistic disorders

359

2.16

9.37

1.2

1.1

46.95

36.25

mg/l

0.78

295

Nonorganic sleeping disorders

143

816

1.76

9.36

1.2

30.59

39.49

mg/l

4.02

118

681

Soft tissue disorders related to use, overuse and pressure

124

679

1.83

9.29

1.2

1.1

40.48

43.94

mg/l

0.29

107

546

Other bacterial diseases

549

2604

1.34

9.26

1.2

1.1

53.32

41.28

mg/l

1.81

455

2187

Dementia in other diseases classified elsewhere

3.85

9.24

1.2

1.0

33.90

41.91

mg/l

0.62

Other arthritis (FG)

164

977

1.69

9.18

1.1

1.2

54.23

40.13

mg/l

0.54

136

798

Other specified/unspecified arthritis

147

851

1.74

9.14

1.1

1.2

54.16

41.50

mg/l

0.41

122

698

Other hearing loss

105

536

1.92

9.11

1.1

1.2

34.92

45.05

mg/l

2.23

455

Complications of surgical and medical care, not elsewhere classified

536

2749

1.34

9.06

1.2

1.1

39.33

43.22

mg/l

0.44

443

2298

Astigmatism

182

2.66

9.01

1.2

31.25

35.83

mg/l

0.40

143

Paroxysmal tachycardia

125

575

1.83

9.00

1.1

1.2

36.23

41.92

mg/l

0.80

471

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

207

1303

1.58

8.87

1.1

1.2

32.23

38.88

mg/l

2.68

160

1090

Asthma-related pneumonia or sepsis

168

1018

1.65

8.75

1.2

1.1

40.71

42.37

mg/l

0.12

135

852

Asthma, hospital admissions 3, pneumonia

168

1018

1.65

8.75

1.2

1.1

40.71

42.37

mg/l

0.12

135

852

Alzheimer disease

309

2.07

8.75

1.1

38.84

45.71

mg/l

0.89

265

Other viral diseases

198

1250

1.59

8.72

1.2

1.1

40.33

39.38

mg/l

0.11

166

1038

Septicaemia

178

1025

1.63

8.69

1.2

1.1

66.16

41.55

mg/l

1.19

145

865

Other diseases of stomach and duodenum

130

2.95

8.66

1.2

1.1

46.70

45.68

mg/l

0.03

110

Other diseases of pleura

174

933

1.64

8.63

1.1

65.24

43.91

mg/l

0.73

141

789

Acetic acid derivatives and related substances

142

414

1.79

8.63

1.2

1.1

38.68

48.19

mg/l

1.87

117

346

Asthma-related pneumonia

167

1015

1.65

8.61

1.2

1.1

40.71

42.39

mg/l

0.13

135

850

Injuries to the knee and lower leg

670

2880

1.29

8.61

1.2

42.42

42.59

mg/l

0.03

563

2405

Injuries to the ankle and foot

432

2825

1.36

8.57

1.2

40.75

41.78

mg/l

0.15

350

2372

Hypertensive diseases

452

1870

1.37

8.54

1.2

41.70

43.31

mg/l

0.24

382

1569

Acute bronchitis

204

1280

1.57

8.54

1.1

1.2

45.21

41.16

mg/l

0.15

164

1076

Iridocyclitis

128

729

1.76

8.48

1.2

38.35

41.10

mg/l

0.46

103

612

Carpal tunnel syndrome

278

1672

1.47

8.47

1.2

1.1

41.44

43.99

mg/l

0.41

239

1404

Intermittent heterotropia

212

2.48

8.45

1.1

38.72

34.95

mg/l

0.22

169

Substance abuse, excluding more controls

266

1535

1.48

8.41

1.2

37.15

47.31

mg/l

3.70

225

1286

Hypertension

450

1868

1.36

8.33

1.2

41.76

43.34

mg/l

0.23

381

1567

Other complications of surgical and medical care, not elsewhere classified

277

2.26

8.22

1.3

1.2

39.47

40.69

mg/l

0.10

232

Polyarteritis nodosa and related conditions

7.72

8.22

1.1

64.52

29.36

mg/l

0.72

Other skin changes

429

1.99

8.21

1.2

1.1

33.69

42.89

mg/l

1.75

358

Pneumonia, organism unspecified

487

2565

1.33

8.14

1.2

1.1

47.59

41.11

mg/l

0.69

402

2143

Herpesviral [herpes simplex] infections

350

2.10

8.13

1.3

1.1

52.34

39.24

mg/l

1.35

293

Myopia

487

1.92

8.10

1.2

1.1

36.26

38.48

mg/l

0.31

411

Chronic rhinitis, nasopharyngitis and pharyngitis

178

1120

1.60

8.08

1.3

1.1

33.66

41.05

mg/l

2.84

154

928

Injuries to the thorax

211

1379

1.53

8.08

1.2

1.1

53.70

42.30

mg/l

0.53

173

1171

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

174

966

1.61

8.07

1.2

44.72

37.96

mg/l

0.29

131

811

Use of levodopa decarboxylase inhibitor

248

2.31

8.04

1.3

1.1

53.08

45.42

mg/l

0.23

206

Convergent concomitant strabismus

194

2.50

7.99

1.2

34.28

37.34

mg/l

0.26

157

Fitting and adjustment of other devices

129

673

1.73

7.99

1.2

53.49

43.17

mg/l

0.30

116

565

Memory loss

159

2.66

7.96

1.2

1.1

32.95

46.72

mg/l

2.29

133

Poisoning by drugs, medicaments and biological substances

161

994

1.63

7.94

1.2

1.1

37.66

39.46

mg/l

0.22

133

834

Paracetamol or NSAID medication

100

259

1.95

7.91

1.2

1.1

43.91

46.62

mg/l

0.17

223

Alzheimer disease, including avohilmo

368

1.90

7.86

1.1

38.96

46.27

mg/l

1.11

316

Weight loss

257

2.27

7.86

1.2

1.1

40.76

41.05

mg/l

0.01

209

Polymyalgia rheumatica

214

2.40

7.81

1.1

39.89

45.32

mg/l

0.49

185

Anterior Iridocyclitis

116

659

1.77

7.79

1.2

1.1

39.64

40.54

mg/l

0.11

554

Infections with a predominantly sexual mode of transmission

222

1481

1.50

7.74

1.2

36.02

38.49

mg/l

0.41

188

1236

Other disorders of adrenal gland

128

2.85

7.71

1.3

1.1

60.20

35.64

mg/l

0.72

103

Persistent mood disorders

105

581

1.82

7.71

1.2

38.65

41.88

mg/l

0.37

487

Other specified/unspecified soft tissue disorders

3.36

7.66

1.1

31.33

42.88

mg/l

1.06

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

183

1175

1.56

7.65

1.2

39.20

40.16

mg/l

0.10

147

984

Alzheimer’s disease, strict definition

253

2.15

7.64

1.1

41.79

45.75

mg/l

0.34

215

Benign neoplasm of other and unspecified endocrine glands

352

2.06

7.63

1.1

37.90

40.11

mg/l

0.25

289

Disturbances of smell and taste

3.33

7.53

1.2

1.1

45.52

37.59

mg/l

0.18

Senile cataract

238

979

1.49

7.46

1.2

1.1

45.77

47.22

mg/l

0.15

200

829

Vertigo of central origin

6.10

7.43

1.1

45.59

34.92

mg/l

0.40

Retinal vascular occlusion

213

2.36

7.43

1.2

1.1

52.43

41.94

mg/l

0.67

177

Retinal vascular disorders

213

2.36

7.42

1.2

1.1

52.43

41.94

mg/l

0.67

177

Use of donepezil

239

2.25

7.41

1.1

36.23

45.12

mg/l

1.49

200

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

278

1953

1.43

7.41

1.1

1.2

40.81

42.32

mg/l

0.07

233

1643

Pain associated with micturition

323

2.09

7.39

1.2

1.1

70.89

39.92

mg/l

0.43

257

Benign neoplasm: Pituitary gland, craniopharyngeal duct

143

2.69

7.33

1.2

35.28

40.42

mg/l

0.54

112

Vestibular neuronitis

221

2.33

7.31

1.2

1.1

32.64

42.69

mg/l

1.77

179

Spondyloarthritis

476

1.88

7.29

1.1

33.56

37.67

mg/l

0.52

398

Tinnitus

116

673

1.73

7.27

1.2

34.93

42.01

mg/l

0.99

103

566

Poisoning by medicine

148

918

1.62

7.21

1.2

1.1

38.45

39.34

mg/l

0.09

121

768

Injury, poisoning and certain other consequences of external causes

323

1152

1.41

7.21

1.1

39.47

44.80

mg/l

1.01

265

967

Presence of other functional implants

220

1022

1.50

7.17

1.2

1.1

42.49

48.20

mg/l

0.83

155

878

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

536

2835

1.29

7.16

1.2

1.1

48.51

42.03

mg/l

0.75

449

2366

Diseases of male genital organs

252

865

1.47

7.15

1.2

1.1

44.07

53.07

mg/l

1.47

210

733

Propionic acid derivatives

150

455

1.66

7.13

1.2

1.1

39.57

47.21

mg/l

1.15

122

385

Non-allergic asthma (mode)

454

1.88

7.12

1.2

1.1

39.51

44.31

mg/l

0.22

375

Other nutritional deficiencies

380

2665

1.35

7.12

1.1

1.2

42.95

41.83

mg/l

0.15

322

2223

Disorders of mineral metabolism

206

2.35

7.04

1.2

1.1

39.36

36.41

mg/l

0.25

163

Malnutrition

4.26

7.04

1.1

49.59

39.17

mg/l

0.24

Diabetic neuropathy

205

2.34

7.02

1.2

1.1

48.02

45.55

mg/l

0.12

173

Congenital malformations of the nervous system

3.36

7.01

1.0

1.2

61.98

33.67

mg/l

0.78

Tonsillectomy and adenotomy

400

2083

1.34

6.99

1.1

1.2

39.61

mg/l

0.00

341

1740

Non-allergic asthma (mode), excluding more controls

458

1.87

6.94

1.2

1.1

39.51

44.15

mg/l

0.21

378

Early lumbar disc prolapse, operated

345

2.01

6.93

1.1

39.26

41.82

mg/l

0.26

270

Other and unspecified effects of external causes

174

1132

1.54

6.92

1.2

32.58

40.34

mg/l

2.56

140

941

3.49

6.87

1.2

1.1

37.05

40.36

mg/l

0.17

Other specified/unspecified dorsopathies

3.47

6.85

1.1

48.83

41.60

mg/l

0.25

Other acute lower respiratory infections

267

1802

1.42

6.85

1.2

45.21

41.41

mg/l

0.19

218

1514

Other septicaemia

152

923

1.59

6.83

1.2

1.1

63.55

41.15

mg/l

0.90

125

781

Injuries to the abdomen, lower back, lumbar spine and pelvis

193

1273

1.50

6.82

1.1

1.2

43.63

41.03

mg/l

0.26

163

1072

Acute and subacute iridocyclitis

106

612

1.74

6.80

1.2

1.1

39.39

40.74

mg/l

0.17

514

Heartburn

287

2.10

6.79

1.1

30.60

42.27

mg/l

2.61

238

Other and unspecified mood [affective] disorders

261

2.16

6.78

1.2

35.59

39.64

mg/l

0.37

210

Other disorders of bone

118

703

1.69

6.76

1.1

31.96

40.31

mg/l

2.74

592

Mycoses

137

848

1.62

6.75

1.2

1.1

39.67

40.95

mg/l

0.11

115

710

All pneumoniae

554

2907

1.28

6.73

1.2

1.1

48.25

41.67

mg/l

0.80

464

2420

Anti-inflammatory and antirheumatic products, non-steroids

148

455

1.64

6.72

1.1

41.08

47.21

mg/l

0.76

120

385

Other/unspecified soft tissue disorders related to use, overuse and pressure

3.43

6.72

1.1

33.08

41.88

mg/l

0.63

Phobic anxiety disorders

533

1.79

6.70

1.2

35.61

41.21

mg/l

0.55

446

Complications of procedures, not elsewhere classified

416

2616

1.32

6.70

1.2

38.56

43.40

mg/l

0.44

345

2194

Myocarditis

121

2.75

6.70

1.5

1.2

37.56

40.87

mg/l

0.23

Inflammatory disease of uterus

100

571

1.76

6.69

1.1

1.2

31.56

35.73

mg/l

0.44

477

Emotionally unstable personality disorder

564

1.77

6.68

1.2

1.1

30.98

37.79

mg/l

2.00

464

Hypokalaemia

269

2.13

6.68

1.3

1.1

44.43

37.94

mg/l

0.55

215

Other arrhythmias

343

1910

1.36

6.65

1.1

1.2

36.97

42.25

mg/l

1.23

277

1624

Diseases of pulp and periapical tissues, including avohilmo

584

2382

1.27

6.64

1.2

38.24

44.32

mg/l

2.23

484

1994

Disorders of skin appendages

280

2015

1.39

6.58

1.2

1.1

41.75

40.16

mg/l

0.16

231

1693

All kidney diseases

536

2875

1.28

6.57

1.2

44.49

41.71

mg/l

0.28

449

2385

Alzheimer’s disease (Atypical or mixed), excluding more controls

6.17

6.55

1.1

1.0

33.36

35.84

mg/l

0.14

Social phobias

339

1.99

6.54

1.2

31.30

41.04

mg/l

1.87

280

Psychotic depression

123

2.70

6.50

1.2

1.1

29.96

48.82

mg/l

3.10

108

Pneumonias (Asthma/COPD co-morbidities)

547

2894

1.27

6.48

1.2

1.1

48.40

41.77

mg/l

0.79

457

2411

Other predominantly sexually transmitted diseases, not elsewhere classified

156

1009

1.55

6.42

1.1

1.2

39.60

38.01

mg/l

0.18

131

835

Fracture of rib(s), sternum and thoracic spine

128

790

1.63

6.40

1.1

62.50

43.05

mg/l

0.56

104

660

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

251

1115

1.42

6.32

1.2

38.17

41.50

mg/l

0.58

216

926

Aneurysms, operations, SAH

364

1.93

6.31

1.1

44.89

42.79

mg/l

0.12

303

Thyroiditis, ILD-related definition

303

2.03

6.27

1.3

1.1

34.78

33.99

mg/l

0.05

255

Hypothyroidism, strict autoimmune, 3 medication purchases required

444

2313

1.30

6.26

1.2

1.1

38.32

40.99

mg/l

0.53

369

1929

Urticaria and erythema

212

1468

1.45

6.25

1.2

40.12

39.23

mg/l

0.10

164

1233

Benign neoplasm of colon, rectum, anus and anal canal

241

1478

1.42

6.24

1.2

1.1

48.98

45.42

mg/l

0.35

218

1223

Schizophrenia or delusion, excluding more controls

150

958

1.55

6.23

1.1

1.2

36.07

44.26

mg/l

2.58

124

801

Scleritis and episcleritis

181

2.34

6.16

1.1

1.2

47.28

38.81

mg/l

0.19

152

Other problems related to primary support group, including family circumstances

483

1.79

6.15

1.2

1.1

32.51

36.90

mg/l

0.69

405

Coagulation defects, purpura and other haemorrhagic conditions

107

639

1.68

6.12

1.2

1.1

45.68

40.09

mg/l

0.54

532

Pulmonary heart disease

115

700

1.65

6.09

1.2

46.56

40.82

mg/l

0.46

584

Spondylolisthesis/Spondylolysis

397

1.87

6.08

1.1

37.25

42.75

mg/l

0.75

322

Other heart diseases, wide

534

2585

1.27

6.05

1.2

37.17

42.97

mg/l

2.03

437

2177

Pulmonary embolism

115

702

1.64

6.03

1.2

1.1

46.56

40.81

mg/l

0.46

586

Reimbursement for rheumatic diseases

281

2050

1.37

5.99

1.2

1.1

41.66

41.23

mg/l

0.05

234

1722

Oxicams

103

338

1.74

5.98

1.2

1.1

33.51

48.75

mg/l

4.94

279

Deviated nasal septum

152

993

1.53

5.96

1.2

1.1

45.54

47.24

mg/l

0.13

134

824

Chronic iridocyclitis

141

2.51

5.95

1.2

1.1

40.41

39.80

mg/l

0.04

112

Cerebral aneurysm, nonruptured

203

2.23

5.94

1.1

41.88

40.77

mg/l

0.05

172

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

242

1728

1.40

5.89

1.2

43.54

40.35

mg/l

0.39

197

1460

Disorders of lipoprotein metabolism and other lipidaemias

359

1677

1.33

5.89

1.1

42.94

44.64

mg/l

0.28

308

1401

Mycoses

457

3118

1.28

5.88

1.2

39.08

43.29

mg/l

1.24

378

2605

Other disorders of white blood cells

136

2.52

5.87

1.2

37.08

40.44

mg/l

0.19

111

Candidiasis

158

1047

1.51

5.85

1.2

1.1

37.31

39.31

mg/l

0.22

129

879

Benign neoplasm: Colon

197

1300

1.45

5.85

1.1

1.2

49.78

46.51

mg/l

0.27

181

1079

Superficial injury of abdomen, lower back and pelvis

512

1.75

5.85

1.2

1.1

49.26

40.63

mg/l

0.58

421

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

167

2.35

5.81

1.1

48.01

41.56

mg/l

0.46

143

Other CVD (FINNGEN)

186

2.14

5.78

1.3

1.2

38.59

45.16

mg/l

0.57

146

Ménière disease

212

2.18

5.78

1.1

34.80

40.74

mg/l

0.56

178

Disorders of conjunctiva

460

2905

1.27

5.74

1.1

1.2

37.61

41.80

mg/l

1.41

389

2425

Allergic asthma (mode)

135

849

1.56

5.74

1.2

1.1

35.30

41.14

mg/l

1.09

116

709

Behavioural disorders, excluding more controls

3.38

5.72

1.3

1.1

123.03

51.07

mg/l

0.35

Asthma/COPD (KELA code 203)

520

2840

1.26

5.72

1.2

1.1

40.64

43.06

mg/l

0.22

434

2370

Urticaria

179

1223

1.47

5.71

1.2

41.31

39.13

mg/l

0.24

137

1020

Suicide or other Intentional self-harm

151

997

1.52

5.71

1.2

39.21

40.09

mg/l

0.09

125

837

Allergic asthma (mode), excluding more controls

135

851

1.56

5.68

1.2

1.1

35.30

41.21

mg/l

1.11

116

709

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

111

684

1.63

5.67

1.2

34.77

36.32

mg/l

0.13

572

Congenital malformations, deformations and chromosomal abnormalities

354

2581

1.31

5.60

1.1

1.2

37.35

41.22

mg/l

0.84

303

2157

Persons with potential health hazards related to communicable diseases

254

1839

1.37

5.57

1.2

47.88

39.57

mg/l

0.37

173

1557

Menorrhagia

204

783

1.45

5.56

1.1

38.66

40.58

mg/l

0.15

170

651

Venous thromboembolism

215

1474

1.41

5.56

1.2

1.1

44.05

45.06

mg/l

0.09

189

1226

Sensorineural hearing loss

304

1538

1.34

5.53

1.1

1.2

41.85

45.59

mg/l

0.58

255

1287

Decubitus ulcer and pressure area

2.75

5.53

1.2

1.1

139.85

43.06

mg/l

0.51

Injuries to the shoulder and upper arm

405

2541

1.29

5.51

1.1

1.2

40.68

44.00

mg/l

0.68

343

2134

Other coagulation defects

230

2.10

5.49

1.2

1.1

41.30

37.47

mg/l

0.29

190

Presbyopia

178

2.27

5.49

1.1

1.2

34.09

39.67

mg/l

0.58

154

Congenital malformations, deformations and chromosomal abnormalities

380

2713

1.29

5.48

1.1

1.2

38.06

41.79

mg/l

0.77

324

2266

Polycystic ovarian syndrome, consortium definition

410

1886

1.29

5.46

1.2

34.21

39.04

mg/l

1.77

344

1561

Unspecified/other endometriosis

428

1.79

5.42

1.1

24.98

37.22

mg/l

5.60

364

Other specified/unspecified inflammatory spondylopathies

130

2.48

5.37

1.2

26.33

45.15

mg/l

3.69

105

Other disorders of eyelid

155

992

1.49

5.35

1.2

1.1

37.60

44.43

mg/l

1.26

132

821

Impingement syndrome of shoulder

549

1.68

5.33

1.2

1.1

44.99

45.04

mg/l

0.00

448

Pulmonary heart disease, diseases of pulmonary circulation

119

757

1.58

5.32

1.2

1.1

45.85

41.81

mg/l

0.30

102

635

Excessive, frequent and irregular menstruation

242

954

1.39

5.32

1.1

31.34

39.87

mg/l

3.29

201

785

Persons encountering health services for specific procedures, not carried out

254

2.02

5.28

1.3

1.1

41.43

39.39

mg/l

0.07

199

Volume depletion

181

2.22

5.27

1.2

1.1

48.94

37.67

mg/l

0.46

139

Pure hypercholesterolaemia

301

1474

1.33

5.23

1.1

46.69

44.71

mg/l

0.26

263

1228

Infections of the skin and subcutaneous tissue

310

2335

1.32

5.21

1.2

1.1

44.78

42.49

mg/l

0.36

258

1969

Parkinson's disease, strict definition

255

2.01

5.21

1.3

1.1

43.82

46.55

mg/l

0.12

213

Episcleritis

157

2.32

5.20

1.1

1.2

46.35

38.98

mg/l

0.13

129

Parkinson's disease

283

1.95

5.18

1.3

1.1

42.95

46.13

mg/l

0.16

238

Parkinson's disease, including avohilmo

298

1.92

5.13

1.2

1.1

42.49

45.68

mg/l

0.16

248

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

146

982

1.49

5.10

1.2

40.09

40.80

mg/l

0.08

123

833

Oter anti-inflammatory and antirheumatic agents, non-steroids

269

1.75

5.09

1.2

1.1

39.36

50.91

mg/l

1.67

218

Ganglion

103

641

1.61

5.09

1.2

1.1

33.71

41.31

mg/l

1.68

520

Dislocation, sprain and strain of joints and ligaments of knee

342

2435

1.30

5.08

1.2

1.1

41.97

43.23

mg/l

0.15

288

2038

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

253

1180

1.37

5.08

1.1

1.2

32.81

35.93

mg/l

0.71

218

964

Diaphragmatic hernia

141

942

1.50

5.08

1.1

37.55

44.26

mg/l

0.79

122

784

Osteoporosis with pathological fracture (FG)

2.67

5.07

1.2

1.1

46.63

34.94

mg/l

0.34

Glaucoma suspect

134

886

1.52

5.07

1.2

1.1

40.19

42.42

mg/l

0.27

108

741

Ovarian cyst

219

903

1.40

5.07

1.2

1.1

32.39

40.42

mg/l

1.92

184

743

Procreative management

208

1243

1.40

5.05

1.2

1.1

40.95

42.51

mg/l

0.13

183

1031

Polyarthropathies

338

1694

1.31

5.04

1.1

1.2

50.41

43.67

mg/l

0.50

285

1404

Other disorders of skin and subcutaneous tissue

306

2071

1.31

5.03

1.2

50.87

41.65

mg/l

0.64

251

1744

Caries of enamel

496

2884

1.24

5.02

1.1

1.2

42.47

42.45

mg/l

0.00

430

2400

Fibroblastic disorders

468

1.71

5.01

1.1

40.25

45.16

mg/l

0.44

388

Other disorders of the genitourinary system

273

1.95

5.00

1.0

1.2

33.65

37.64

mg/l

0.48

233

DVT of lower extremities and pulmonary embolism

159

1087

1.46

5.00

1.2

1.1

43.49

42.34

mg/l

0.10

138

909

Keratitis

181

1274

1.42

4.99

1.2

42.64

41.25

mg/l

0.13

153

1081

Unspecified fall

232

1677

1.37

4.99

1.1

1.2

40.60

41.38

mg/l

0.09

179

1414

Abnormal results of function studies

219

2.07

4.97

1.2

1.1

32.24

44.94

mg/l

1.68

180

Other predominantly sexually transmitted diseases, not elsewhere classified

122

795

1.54

4.97

1.1

1.2

39.59

37.36

mg/l

0.22

106

659

Disorders of vitreous body and globe

193

1319

1.41

4.97

1.1

41.62

43.55

mg/l

0.27

171

1104

Adhesive capsulitis of shoulder

338

1.84

4.93

1.1

1.2

34.49

44.06

mg/l

1.68

274

Other obstetric conditions, not elsewhere classified

256

1205

1.36

4.92

1.1

1.2

32.80

35.95

mg/l

0.73

220

985

Disorders of vitreous body

188

1289

1.41

4.92

1.1

42.09

43.73

mg/l

0.22

168

1078

Appendectomy

360

2693

1.28

4.89

1.2

33.51

42.91

mg/l

6.12

306

2246

Obsessive-compulsive disorder

269

1.95

4.87

1.2

1.1

31.69

42.31

mg/l

1.83

218

Adverse effects, not elsewhere classified

116

751

1.55

4.87

1.2

1.1

32.51

38.66

mg/l

1.27

628

Early onset COPD, excluding more controls

390

1.77

4.87

1.3

1.1

70.78

46.28

mg/l

0.35

337

Other noninfective gastroenteritis and colitis

124

815

1.53

4.84

1.2

1.1

38.30

40.43

mg/l

0.17

102

675

Conductive and sensorineural hearing loss

327

1697

1.30

4.83

1.1

40.53

45.72

mg/l

1.00

274

1420

Arthropathies in other diseases classified elsewhere

2.85

4.83

1.3

1.2

55.67

41.27

mg/l

0.46

Supplementary factors related to causes of morbidity and mortality classified elsewhere

162

1126

1.44

4.81

1.2

1.1

34.37

41.10

mg/l

2.31

141

938

Noninfective enteritis and colitis

240

1784

1.35

4.74

1.1

1.2

40.52

40.73

mg/l

0.02

193

1505

Calculus of kidney and ureter

126

836

1.51

4.73

1.1

37.36

42.27

mg/l

1.04

108

700

Disturbance of activity and attention

580

1.61

4.71

1.2

1.1

37.14

36.96

mg/l

0.01

480

Dementia in Alzheimer disease

153

2.16

4.70

1.1

36.28

47.67

mg/l

1.30

127

Spondylopathies (FG)

470

1.69

4.69

1.2

31.14

40.47

mg/l

3.20

384

Problems related to lifestyle

367

1.78

4.65

1.2

32.80

40.69

mg/l

1.48

305

Haemorrhage from respiratory passages

128

769

1.50

4.64

1.1

40.03

47.73

mg/l

1.54

104

654

Acute pharyngitis

101

637

1.58

4.60

1.2

1.1

39.37

39.81

mg/l

0.04

536

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

512

2720

1.23

4.59

1.2

1.1

38.44

42.53

mg/l

1.45

411

2286

Conjunctivitis

419

2806

1.25

4.58

1.1

1.2

36.03

41.56

mg/l

2.17

359

2342

Methotrexate

362

1.78

4.55

1.2

1.1

37.80

41.55

mg/l

0.32

306

Other and unspecified vascular occlusions

160

2.20

4.55

1.2

1.1

40.82

40.35

mg/l

0.03

136

Other and unspecified disorders of vitreous body

151

1033

1.44

4.54

1.1

40.01

43.79

mg/l

0.59

134

867

Vasomotor and allergic rhinitis

213

1539

1.36

4.53

1.2

34.18

41.27

mg/l

2.29

181

1273

Vertical strabismus

2.67

4.50

1.2

35.83

41.75

mg/l

0.29

Drug-induced adrenocortical insufficiency

3.32

4.49

1.3

1.1

94.67

39.02

mg/l

—

Other viral diseases, not elsewhere classified

159

1111

1.43

4.48

1.3

1.2

36.41

39.09

mg/l

0.49

138

924

Use of rivastigmine

187

2.09

4.47

1.0

1.1

32.67

44.41

mg/l

1.58

153

Other peripheral vertigo

215

2.01

4.45

1.3

1.1

32.90

42.39

mg/l

0.98

181

All influenza (not pneumonia)

485

1.66

4.44

1.2

1.1

35.16

41.58

mg/l

1.03

397

Sudden idiopathic hearing loss

236

1.96

4.44

1.1

34.28

44.86

mg/l

1.15

197

Other disorders starting during childhood or adolecense, excluding more controls

155

2.18

4.41

1.3

1.2

28.51

40.84

mg/l

1.37

120

Hypotension

300

1.84

4.40

1.3

1.1

42.90

45.54

mg/l

0.16

243

Diseases of the digestive system

187

1350

1.38

4.38

1.2

1.1

39.49

41.73

mg/l

0.23

155

1139

Urolithiasis

130

885

1.47

4.34

1.1

38.65

43.30

mg/l

0.80

111

744

Other CVD

375

1.74

4.33

1.2

41.64

43.51

mg/l

0.13

310

Agranulocytosis

288

1.85

4.31

1.2

1.1

98.00

38.89

mg/l

0.67

243

Rash and other nonspecific skin eruption

239

1.94

4.29

1.2

1.1

41.11

40.76

mg/l

0.01

201

Emotional disorders and disorders of social functioning with onset specific to childhood

249

1.91

4.28

1.1

30.15

37.81

mg/l

0.86

204

Other and unspecified tonsillitis

221

1385

1.34

4.28

1.2

38.87

39.99

mg/l

0.15

182

1158

Other and unspecified erythematous conditions

2.72

4.26

1.1

25.06

41.40

mg/l

1.63

Herpesviral [herpes simplex] infections

138

955

1.45

4.25

1.2

47.12

37.61

mg/l

1.23

119

802

Diseases of tongue

152

2.19

4.24

1.2

1.1

32.01

44.36

mg/l

1.51

124

Diseases of pulp and periapical tissues and dental caries

319

1270

1.29

4.22

1.1

1.2

40.56

47.00

mg/l

1.27

255

1075

Conjunctivitis (acute, non atopic)

153

1077

1.42

4.21

1.1

1.2

41.85

39.90

mg/l

0.24

134

888

Sequelae of injuries, of poisoning and of other consequences of external causes

122

826

1.48

4.21

1.1

1.2

52.90

41.38

mg/l

0.30

104

691

Plantar fascial fibromatosis

220

1.96

4.20

1.1

41.81

42.78

mg/l

0.04

180

Superficial injury of head

113

755

1.50

4.15

1.2

1.1

40.99

41.55

mg/l

0.04

101

642

False labour

216

999

1.35

4.15

1.2

29.28

38.14

mg/l

3.65

178

823

Car occupant injured in other and unspecified transport accidents

112

748

1.50

4.14

1.2

1.1

53.86

39.59

mg/l

0.37

101

618

Diseases of liver

148

1043

1.42

4.14

1.2

44.56

41.77

mg/l

0.20

119

884

Glaucoma

194

1227

1.36

4.13

1.2

1.1

44.45

43.97

mg/l

0.05

156

1026

Dermatographic urticaria

236

1.92

4.11

1.0

1.2

29.86

35.95

mg/l

0.83

195

Emotional disorders starting during childhood or adolescence

227

1.94

4.11

1.1

29.36

37.41

mg/l

0.86

185

Lung diseases due to external agents

272

1.84

4.07

1.2

1.1

87.15

45.69

mg/l

0.43

218

Endometriosis

201

866

1.36

4.06

1.1

37.37

40.53

mg/l

0.28

166

718

Chronic gastritis

591

1.56

4.06

1.1

1.2

34.92

43.20

mg/l

1.59

493

Other retinal disorders

241

1427

1.32

4.05

1.1

47.04

44.39

mg/l

0.33

195

1204

Atopic dermatitis

343

2240

1.26

4.02

1.1

1.2

33.91

40.97

mg/l

3.45

285

1879

Tuberculosis, IBD comorbidity

117

2.32

4.01

1.2

1.1

43.29

41.16

mg/l

0.10

Melanocytic naevi of trunk

392

1.69

4.01

1.2

1.1

43.93

39.24

mg/l

0.43

324

Meniscus derangement

243

1245

1.32

3.99

1.1

1.2

39.06

44.62

mg/l

1.31

208

1030

Lung cancer and mesothelioma

245

1.82

3.99

1.0

1.1

57.73

45.23

mg/l

0.92

211

Fenamates

277

1.70

3.97

1.1

37.16

47.26

mg/l

1.53

228

Spinal instabilities

2.84

3.97

1.1

29.83

43.49

mg/l

0.97

Other and unspecified iron deficiency

139

977

1.43

3.95

1.1

43.86

40.30

mg/l

0.37

117

815

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

107

716

1.50

3.94

1.2

1.1

38.85

38.90

mg/l

0.00

600

Other metabolic disorders

432

1.65

3.94

1.2

39.36

35.44

mg/l

0.26

361

Unspecified haematuria

147

863

1.41

3.91

1.3

1.1

57.97

43.33

mg/l

0.55

133

722

Disorders of synovium and tendon in diseases classified elsewhere

3.83

3.90

1.1

1.0

49.34

41.94

mg/l

—

Hyperkinetic disorders

624

1.53

3.89

1.2

1.1

37.38

36.26

mg/l

0.10

508

Secondary and unspecified malignant neoplasm of lymph nodes

185

2.01

3.88

1.1

55.05

37.96

mg/l

0.69

149

Type of accident

145

1032

1.41

3.87

1.2

1.1

33.38

40.96

mg/l

2.76

125

863

Tuberculosis, wide

119

2.28

3.87

1.2

1.1

43.29

41.59

mg/l

0.08

Diseases of middle ear and mastoid

339

2218

1.25

3.87

1.2

40.04

40.72

mg/l

0.10

280

1855

Diseases of appendix

389

2852

1.23

3.85

1.1

1.2

39.75

43.36

mg/l

0.67

325

2387

Appendicitis, broad definition

386

2845

1.23

3.77

1.1

1.2

39.65

43.40

mg/l

0.70

322

2382

Chronic apical periodontitis

590

2834

1.19

3.75

1.2

1.1

36.83

43.91

mg/l

3.75

491

2368

Other and unspecified anaemias

142

964

1.41

3.75

1.1

44.74

42.12

mg/l

0.29

102

819

Asthma and allergy

479

1.59

3.72

1.2

1.1

33.55

40.67

mg/l

1.15

387

Exclusions for E4_PCOS_CONSORTIUM

406

2076

1.23

3.71

1.1

1.2

35.53

39.54

mg/l

1.02

325

1729

Inflammatory diseases of prostate (prostatitis)

281

1.79

3.70

1.1

34.65

51.08

mg/l

4.00

235

Superficial injury of lower leg

130

916

1.42

3.69

1.1

34.22

39.70

mg/l

1.22

111

763

Asthma and allergy, excluding more controls

480

1.59

3.69

1.2

1.1

33.55

40.86

mg/l

1.20

389

Fall on and from stairs and steps

120

834

1.44

3.67

1.2

1.1

40.66

40.16

mg/l

0.05

697

Hyperplasia of prostate

122

475

1.46

3.64

1.2

1.1

48.61

55.38

mg/l

0.60

402

Arthrosis

329

1440

1.26

3.64

1.1

41.53

44.67

mg/l

0.49

283

1193

Degenerative macular diseases

204

1.92

3.61

1.2

1.1

55.98

40.75

mg/l

1.17

173

Injury of muscle and tendon at shoulder and upper arm level

133

946

1.41

3.59

1.1

1.2

43.24

46.12

mg/l

0.28

114

801

Other anaemias

143

978

1.39

3.58

1.1

44.67

42.21

mg/l

0.27

103

831

Other erythematous conditions

2.41

3.57

1.1

25.24

40.14

mg/l

1.80

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

314

1991

1.25

3.56

1.1

1.2

36.06

40.47

mg/l

1.03

257

1668

Behavioural disorders

2.53

3.56

1.3

1.1

123.03

33.73

mg/l

0.46

Contact with and exposure to communicable diseases

205

1556

1.32

3.56

1.2

35.10

38.18

mg/l

0.47

133

1323

Pneumonitis due to solids and liquids

157

2.05

3.55

1.2

1.1

108.33

43.91

mg/l

0.41

129

Obesity and other hyperalimentation

336

2621

1.24

3.55

1.1

1.2

43.11

41.84

mg/l

0.18

290

2179

Flat foot [pes planus] (acquired)

227

1.86

3.54

1.2

39.23

36.95

mg/l

0.11

192

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

345

1.69

3.54

1.1

55.27

39.87

mg/l

0.96

288

Sequelae of injuries of upper limb

293

1.75

3.53

1.1

1.2

35.93

42.19

mg/l

0.63

240

Secondary hypertension

183

1.95

3.50

1.1

1.2

44.19

38.75

mg/l

0.29

147

Dental caries, including avohilmo

343

1412

1.24

3.48

1.1

1.2

40.25

46.44

mg/l

1.34

275

1200

Other cataract

151

830

1.38

3.48

1.3

1.1

47.71

44.17

mg/l

0.29

125

704

Unspecified urinary incontinence

186

1.94

3.47

1.1

46.21

40.71

mg/l

0.18

150

Tongue abnormality

139

2.10

3.43

1.2

1.1

32.72

39.12

mg/l

0.51

114

Malignant melanoma of skin, including Hilmo

303

1.72

3.43

1.1

86.73

38.56

mg/l

0.61

255

Aplastic and other anaemias

155

1062

1.36

3.42

1.1

44.68

42.26

mg/l

0.29

114

896

Conduct disorder

2.47

3.40

1.3

1.1

123.03

37.86

mg/l

0.43

Iron deficiency anaemia

169

1244

1.34

3.38

1.2

43.26

41.13

mg/l

0.23

136

1042

Other and unspecified urticaria

108

749

1.45

3.38

1.2

46.83

38.65

mg/l

0.84

630

Hernia of abdominal wall, postoperative

388

1.63

3.38

1.2

1.1

45.01

42.80

mg/l

0.11

330

Obesity

333

2616

1.23

3.36

1.1

1.2

43.13

41.69

mg/l

0.20

287

2175

Acute appendicitis, no complications

298

2388

1.24

3.35

1.1

1.2

34.54

42.30

mg/l

3.77

248

1998

Malignant melanoma, including Hilmo

374

1.64

3.34

1.1

84.39

40.21

mg/l

0.67

320

Unspecified mental disorder

214

1657

1.29

3.33

1.1

1.2

35.23

41.62

mg/l

1.97

179

1395

Malignant neoplasm of breast, including Hilmo

103

959

0.69

3.32

1.2

41.89

39.19

mg/l

0.13

798

Malignant neoplasm of breast, HER2-negative, including Hilmo

103

959

0.69

3.32

1.2

41.89

39.19

mg/l

0.13

798

Achilles tendinitis

233

1.81

3.28

1.2

1.1

36.07

42.01

mg/l

0.47

189

Other inflammation of eyelid

353

1.65

3.28

1.2

1.1

38.96

41.47

mg/l

0.20

287

Cardiodefibrillation

777

0.59

3.26

1.2

1.1

44.19

46.19

mg/l

0.16

662

Missing teeth due to accident, extraction or parodontitis

225

1656

1.28

3.25

1.2

1.1

41.70

44.87

mg/l

0.42

188

1387

Glomerular diseases

511

1.53

3.24

1.2

45.31

42.77

mg/l

0.19

419

Malignant neoplasm of digestive organs

675

0.61

3.24

1.2

1.1

54.40

43.16

mg/l

0.74

575

Acute appendicitis

361

2782

1.21

3.22

1.1

1.2

40.09

43.50

mg/l

0.58

303

2327

Other bacterial intestinal infections

472

1.55

3.22

1.2

1.1

84.27

43.00

mg/l

0.72

386

Malignant neoplasm of breast, HER2-negative

916

0.69

3.21

1.2

1.1

41.20

38.75

mg/l

0.11

758

Diseases of external ear

150

1114

1.35

3.16

1.1

38.53

41.12

mg/l

0.46

132

934

Melanocytic naevi

146

1080

1.36

3.16

1.2

38.99

40.21

mg/l

0.15

125

901

Diseases of oral cavity, salivary glands and jaws

266

1083

1.26

3.16

1.1

1.2

40.18

47.68

mg/l

1.45

225

891

Other diseases of liver

531

1.51

3.14

1.2

46.20

41.27

mg/l

0.20

443

Malignant neoplasm of breast

100

932

0.70

3.13

1.2

1.1

42.11

39.24

mg/l

0.14

773

Ischemic heart diseases

349

1717

1.22

3.13

1.1

1.2

35.81

45.87

mg/l

4.33

292

1438

Sequelae of external causes of morbidity and mortality

104

728

1.43

3.13

1.2

58.27

40.89

mg/l

0.35

609

Pruritus

297

1.69

3.11

1.2

1.1

47.49

39.93

mg/l

0.32

247

Malignant melanoma

297

1.69

3.11

1.2

1.1

46.74

39.05

mg/l

0.50

251

Divergent concomitant strabismus

231

1.78

3.08

1.2

38.23

39.55

mg/l

0.08

190

Streptococcal septicaemia

195

1.85

3.06

1.3

1.1

126.87

44.75

mg/l

0.70

161

Alzheimer’s disease (Late onset)

218

1.74

3.04

1.1

45.92

46.24

mg/l

0.02

183

Other diseases of arteries and capillaries

210

1.82

3.03

1.2

1.1

37.56

40.89

mg/l

0.19

173

Pneumonia derived septicemia

2.32

3.01

1.1

209.54

41.63

mg/l

0.74

Purpura and other haemorrhagic conditions

393

1.58

3.01

1.2

1.1

48.14

43.36

mg/l

0.27

318

Misadventures to patients during surgical and medical care

393

1.58

3.01

1.3

1.1

33.13

41.09

mg/l

1.35

328

Acute lymphadenitis

211

1.81

3.00

1.3

1.2

36.66

38.24

mg/l

0.13

170

Hyperlipidaemia, other/unspecified

126

846

1.37

2.97

1.1

47.47

46.70

mg/l

0.06

100

708

Other pleural conditions

183

1.86

2.95

1.1

34.24

46.03

mg/l

1.47

149

Orchitis and epididymitis

212

1.80

2.95

1.1

1.2

48.23

53.92

mg/l

0.27

177

Open wound of wrist and hand

223

1726

1.26

2.95

1.1

1.2

38.21

43.98

mg/l

1.63

183

1455

Other female pelvic inflammatory diseases

507

1.50

2.94

1.1

30.02

35.50

mg/l

0.86

429

Other/unspecified enthesopathies, not elsewhere classified

169

1.90

2.94

1.1

42.05

43.31

mg/l

0.04

138

Ankylosing spondylitis

227

1.77

2.94

1.2

1.1

31.42

44.80

mg/l

2.98

180

Pneumococcal septicemia

2.34

2.92

1.1

222.65

44.23

mg/l

0.74

Other viral diseases, not elsewhere classified

102

720

1.42

2.91

1.3

1.1

36.15

39.07

mg/l

0.41

594

Explicit bacterial Sepsis

235

1.75

2.91

1.3

1.1

118.08

46.57

mg/l

0.69

193

Drug-induced neutropenia

177

1.87

2.91

1.1

150.30

38.61

mg/l

0.71

149

Thrombocytopenia, unspecified

177

1.87

2.91

1.2

1.1

63.44

41.37

mg/l

1.06

148

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

2.39

2.90

1.1

37.56

34.43

mg/l

0.16

Myeloid leukaemia

2.72

2.89

1.4

1.1

27.14

42.61

mg/l

1.15

Excessive attrition of teeth

295

2417

1.22

2.89

1.2

40.99

41.24

mg/l

0.03

242

2026

Bacterial pneumonia (organism specified)

172

1197

1.30

2.89

1.3

1.1

61.96

41.26

mg/l

0.97

149

1019

Status post-ami

411

0.54

2.88

1.1

41.07

49.00

mg/l

0.60

342

Caries of dentine, including avohilmo

369

1564

1.21

2.88

1.2

41.19

45.22

mg/l

0.77

298

1329

Fall on same level involving ice and snow

256

2068

1.24

2.86

1.1

1.2

46.69

41.19

mg/l

0.69

206

1755

Acute tubulo-interstitial nephritis

278

1951

1.23

2.86

1.2

1.1

49.30

41.66

mg/l

0.47

237

1618

Specific development disorders of scholastic skills

190

1.83

2.86

1.1

36.15

37.80

mg/l

0.08

151

Maltreatment syndromes

208

1.79

2.83

1.3

1.2

30.55

41.22

mg/l

1.25

163

Monoamine oxidase A inhibitors

275

1.68

2.83

1.1

1.2

34.41

43.32

mg/l

1.15

235

Nail disorders

253

1.71

2.81

1.2

41.29

41.25

mg/l

0.00

202

Ehlers-Danlos syndrome

3.64

2.80

1.1

22.60

32.14

mg/l

—

Dermatopolymyositis

3.62

2.79

1.2

63.90

32.84

mg/l

—

Renal tubulo-interstitial diseases

406

2552

1.19

2.79

1.2

1.1

46.29

41.36

mg/l

0.42

343

2125

Postprocedural endocrine and metabolic disorders, not elsewhere classified

393

1.56

2.79

1.3

1.2

32.93

35.36

mg/l

0.31

327

Obesity due to excess calories

248

2004

1.24

2.78

1.1

1.2

44.64

40.12

mg/l

0.69

212

1674

Leisure time condition

604

1.44

2.78

1.3

1.1

32.18

40.88

mg/l

2.52

501

Hypothyroidism, autoimmune, DX-based

8.57

2.77

1.6

1.2

19.26

25.30

mg/l

—

Mouth breathing

174

1347

1.29

2.77

1.1

1.2

39.61

44.54

mg/l

0.75

133

1143

Focal brain injury

3.08

2.77

1.2

1.1

48.00

38.00

mg/l

—

Nutritional anaemias

189

1426

1.28

2.76

1.2

43.67

41.30

mg/l

0.28

154

1197

Nontraumatic intracranial haemmorrhage

362

1.58

2.76

1.1

1.2

56.14

45.71

mg/l

0.67

299

Diseases of salivary glands

145

1099

1.32

2.73

1.2

33.82

41.14

mg/l

1.80

116

917

Vascular dementia (subcortical)

3.25

2.73

1.2

1.0

39.16

50.08

mg/l

0.36

Candidiasis

428

1.52

2.70

1.2

1.1

41.84

39.13

mg/l

0.14

355

Assault

583

1.45

2.70

1.2

1.1

33.69

40.52

mg/l

1.09

485

Other disorders of conjunctiva

318

1.61

2.68

1.1

1.2

49.73

42.39

mg/l

0.55

263

Assault by bodily force

319

1.61

2.66

1.3

1.2

36.15

41.07

mg/l

0.42

260

Complications of internal orthopaedic prosthetic devices, implants and grafts

470

1.49

2.66

1.0

1.2

46.04

43.07

mg/l

0.22

394

Bacterial pneumonia, not elsewhere classified

149

1001

1.31

2.64

1.3

1.1

63.10

41.91

mg/l

0.84

130

849

Rheumatoid arthritis

122

811

1.35

2.64

1.1

1.2

42.88

42.64

mg/l

0.02

102

667

Anogenital herpesviral [herpes simplex] infection

496

1.48

2.63

1.2

27.12

38.06

mg/l

5.00

407

Bleeding

339

2014

1.20

2.63

1.1

1.2

50.28

42.77

mg/l

0.58

287

1685

Glomerulonephritis

266

1.66

2.62

1.2

47.76

43.21

mg/l

0.27

218

Invasive ventilation

184

1.80

2.61

1.3

1.1

49.10

43.38

mg/l

0.29

151

Other superficial mycoses

408

1.53

2.61

1.3

1.1

29.99

40.36

mg/l

3.26

335

Autoimmune hyperthyroidism

127

1.98

2.60

1.4

1.1

44.65

35.64

mg/l

0.52

110

Neovascular glaucoma

2.31

2.58

1.2

1.1

40.18

35.54

mg/l

0.22

Fracture of lower leg, including ankle

243

1957

1.23

2.58

1.2

43.84

43.81

mg/l

0.00

201

1652

Superficial injury of wrist and hand

111

817

1.36

2.56

1.2

1.1

52.93

39.52

mg/l

0.33

684

Other specified acquired deformities of limbs

7.30

2.56

1.0

21.58

39.26

mg/l

—

Dialysis, with operation codes

346

1.57

2.56

1.4

1.2

43.02

46.10

mg/l

0.22

280

Fentanyl

163

1.84

2.55

1.2

1.1

52.60

41.32

mg/l

0.36

133

Other bacterial intestinal infections

682

1.40

2.55

1.2

73.95

41.41

mg/l

0.72

571

Other and unspecified nonorganic psychotic disorders

114

845

1.35

2.53

1.1

34.66

41.51

mg/l

1.33

711

Perforation of tympanic membrane

300

1.61

2.52

1.2

1.1

51.81

42.79

mg/l

0.53

247

Bacterial intestinal infections, IBD co-morbidities

476

1.47

2.52

1.2

1.1

80.33

42.82

mg/l

0.60

391

Chondropathies

534

1.45

2.51

1.1

30.65

39.64

mg/l

3.17

445

DVT of lower extremities

444

1.49

2.51

1.1

1.2

40.51

41.93

mg/l

0.11

369

Fracture at wrist and hand level

168

1313

1.28

2.50

1.2

45.62

42.95

mg/l

0.27

143

1112

Coeliac disease

404

1.52

2.50

1.3

1.1

39.70

39.27

mg/l

0.02

336

KRA_PSY_EATING, excluding more controls

315

1.59

2.50

1.2

33.58

40.70

mg/l

0.33

254

Other disorders of glucose regulation and pancreatic internal secretion

247

1.67

2.49

1.1

1.2

39.12

42.65

mg/l

0.21

200

Dental operations

266

1117

1.22

2.47

1.1

1.2

39.05

47.40

mg/l

1.80

219

943

Acute generalized exanthematous pustulosis

116

2.00

2.46

1.1

1.2

42.16

40.42

mg/l

0.05

Lymphoid leukaemia

116

1.99

2.45

1.2

1.1

51.70

38.80

mg/l

0.50

Superficial injury of hip and thigh

366

1.53

2.44

1.1

37.09

42.21

mg/l

0.52

294

Open wound of head

220

1720

1.23

2.42

1.2

49.02

43.75

mg/l

0.53

174

1458

Noninfectious colitis NAS

440

1.48

2.41

1.2

1.1

44.10

40.41

mg/l

0.18

364

Disorders in reading

2.38

2.40

1.0

1.1

37.70

41.17

mg/l

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

376

1.52

2.39

1.1

44.26

42.30

mg/l

0.11

308

Hypoglycaemia, other or unspecified

197

1.73

2.39

1.1

1.2

36.16

42.52

mg/l

0.41

159

Congenital malformations and deformations of the musculoskeletal system

447

1.47

2.38

1.1

1.2

29.73

38.12

mg/l

0.83

371

Glaucoma secondary to other eye disorders

2.22

2.37

1.2

1.1

40.17

38.80

mg/l

0.06

Bacterial pneumoniae

157

1081

1.28

2.37

1.3

1.1

61.65

41.84

mg/l

0.82

138

918

Disorders of orbit

111

1.99

2.36

1.3

1.2

39.88

39.47

mg/l

0.02

Ovarian dysfunction

370

1.52

2.35

1.1

1.2

33.41

34.28

mg/l

0.10

306

Retinal detachment with retinal break

283

1.59

2.33

1.2

1.1

39.96

44.13

mg/l

0.39

238

Ingrowing nail

169

1.79

2.33

1.3

1.2

47.64

40.60

mg/l

0.27

135

Other disorders of patella

610

1.40

2.32

1.1

1.2

31.08

40.74

mg/l

3.25

496

Pyogenic arthritis

140

1.86

2.31

1.2

55.88

42.64

mg/l

0.43

110

Lateral epicondylitis

323

1.55

2.31

1.2

1.1

55.27

44.47

mg/l

0.43

260

Postzoster neuralgia

3.25

2.31

1.4

1.2

42.33

47.95

mg/l

—

Viral conjunctivitis

126

1.92

2.31

1.2

1.1

33.50

38.56

mg/l

0.40

101

Mixed and other personality disorders

300

1.57

2.30

1.1

1.2

30.02

38.68

mg/l

1.81

244

Endometriosis of pelvic peritoneum

639

1.38

2.29

1.1

27.95

37.75

mg/l

3.43

533

L04AC Interleukin inhibitors

200

1.71

2.28

1.2

41.12

41.61

mg/l

0.02

160

Other and unspecified acne

2.59

2.28

1.8

1.1

32.95

34.96

mg/l

0.07

Exposure to other and unspecified man-made environmental factors

2.78

2.28

1.2

33.00

34.45

mg/l

0.07

Alcohol abuse, main dg, excluding more controls

413

1.48

2.28

1.2

32.81

45.21

mg/l

2.72

344

Haemorrhoids and perianal venous thrombosis

114

858

1.33

2.28

1.1

46.94

43.00

mg/l

0.31

705

Transplanted organ and tissue status

293

1.58

2.27

1.2

1.1

41.21

47.15

mg/l

0.52

240

Generalized epilepsy

134

1.88

2.27

1.1

1.2

31.46

40.38

mg/l

0.68

106

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

254

1.62

2.26

1.1

1.2

41.63

41.37

mg/l

0.02

209

Nephropathy related operations

325

1.54

2.26

1.4

1.1

45.00

46.03

mg/l

0.06

263

Striking against or struck by other objects

170

1352

1.26

2.26

1.2

52.73

42.33

mg/l

0.34

132

1142

Substance abuse

266

2083

1.20

2.26

1.2

37.15

45.09

mg/l

2.73

225

1752

Other bursopathies

262

1.61

2.25

1.1

1.2

53.02

45.65

mg/l

0.26

210

Other diseases of blood and blood-forming organs

156

1.80

2.25

1.0

1.1

58.32

43.06

mg/l

0.50

126

All chronic kidney diseases

205

1359

1.23

2.25

1.1

40.45

42.77

mg/l

0.41

176

1131

Childhood asthma (age<16), excluding more controls

481

1.40

2.25

1.3

1.2

39.01

39.83

mg/l

0.05

384

Secondary uncertain malignant neoplasm

271

1.59

2.22

1.1

54.83

39.17

mg/l

0.73

223

Torticollis

2.71

2.21

1.4

1.1

41.82

43.16

mg/l

0.03

Bacterial, viral and other infectious agents

335

1.53

2.21

1.1

1.2

45.96

41.75

mg/l

0.21

271

Viral warts

110

830

1.33

2.21

1.2

1.1

41.38

39.68

mg/l

0.14

692

Childhood asthma (age<16)

483

1.39

2.21

1.3

1.2

39.01

39.61

mg/l

0.04

386

Dermatophytosis

335

1.53

2.21

1.2

1.1

35.32

45.89

mg/l

1.87

271

Dermatitis due to substances taken internally

150

1.81

2.20

1.2

1.1

40.52

40.77

mg/l

0.01

122

Distal bite

135

1.85

2.18

1.1

1.2

47.41

32.66

mg/l

0.48

108

Abnormal findings on antenatal screening of mother

460

1.44

2.16

1.2

40.04

35.12

mg/l

0.27

377

Other abnormal findings in urine

3.03

2.15

1.2

1.0

41.89

48.88

mg/l

—

Superficial injury of thorax

435

1.45

2.15

1.2

1.1

85.93

41.17

mg/l

0.68

354

Sequelae with surgical and medical care as external cause

535

1.41

2.15

1.1

67.70

41.89

mg/l

0.39

447

Polycystic ovarian syndrome

282

1.57

2.14

1.1

32.89

33.18

mg/l

0.03

229

Heart failure, not strict

281

1601

1.19

2.14

1.2

1.1

40.28

45.29

mg/l

1.06

236

1340

Mental and behavioural disorders due to psychoactive substance use

273

2125

1.19

2.14

1.2

37.12

44.98

mg/l

2.75

229

1787

Other sexually transmitted chlamydial diseases

330

1.52

2.14

1.1

29.58

38.67

mg/l

1.87

258

Gonarthrosis

254

1200

1.21

2.13

1.1

1.2

41.61

44.78

mg/l

0.53

221

984

Chronic kidney disease

616

1.37

2.13

1.1

46.35

44.67

mg/l

0.12

509

Early lumbar disc prolapse operation

486

1.43

2.13

1.1

1.2

39.26

39.10

mg/l

0.01

402

Other keratitis

395

1.47

2.13

1.1

49.18

40.30

mg/l

0.53

327

Symptoms and signs involving emotional state

2.11

2.13

1.1

1.2

37.64

30.52

mg/l

0.40

Gonarthrosis [arthrosis of knee](FG)

295

1443

1.19

2.13

1.1

1.2

42.94

44.04

mg/l

0.14

251

1190

Female infertility, cervical, vaginal, other or unspecified origin

162

835

1.26

2.13

1.2

1.1

34.47

40.09

mg/l

1.03

140

686

Presence of other devices

492

1.42

2.13

1.2

44.52

43.66

mg/l

0.08

426

Other contact dermatitis

243

1.61

2.13

1.1

38.24

42.69

mg/l

0.43

205

Gingivitis and periodontal diseases

502

2268

1.14

2.12

1.2

1.1

38.50

43.67

mg/l

1.41

423

1897

Other diseases of gallbladder

2.06

2.11

1.2

1.1

57.25

36.74

mg/l

0.38

Other diseases of anus and rectum

108

817

1.32

2.11

1.1

40.92

42.64

mg/l

0.12

664

COPD (mode)

459

1.39

2.11

1.2

1.1

67.91

47.55

mg/l

0.34

397

Speech therapy

742

1.34

2.10

1.2

37.83

40.40

mg/l

0.31

624

Fissure and fistula of anal and rectal regions

102

769

1.33

2.08

1.1

45.86

42.51

mg/l

0.27

632

Benign neoplasm: Colon, unspecified

530

1.40

2.08

1.1

57.58

43.04

mg/l

0.68

447

Endometriosis diagnosis and infertility diagnosis occurring together

464

1.43

2.07

1.2

28.34

33.44

mg/l

1.75

386

Hyperosmolality and hypernatraemia

3.53

2.06

1.1

50.00

30.57

mg/l

—

Use of memantine

274

1.51

2.06

1.1

38.82

46.82

mg/l

0.96

234

Use of other anti-dementia drugs

274

1.51

2.06

1.1

38.82

46.82

mg/l

0.96

234

Diseases of arteries, arterioles and capillaries (FINNGEN)

423

1.38

2.04

1.2

42.21

45.37

mg/l

0.28

350

Disease of hard tissues of teeth, NOS

247

1073

1.21

2.04

1.2

38.64

47.90

mg/l

2.11

212

884

Disorders of breast

235

1777

1.20

2.04

1.2

1.1

39.90

39.06

mg/l

0.07

198

1485

Intestinal malabsorption

132

1.83

2.04

1.1

1.2

29.32

42.24

mg/l

1.91

105

Otitis externa

102

773

1.32

2.02

1.1

1.2

35.77

40.23

mg/l

0.78

645

Fracture of lumbar spine and pelvis

507

1.40

2.02

1.1

38.26

42.22

mg/l

0.32

414

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

231

1.61

2.02

1.2

28.60

39.57

mg/l

1.63

184

Statin medication

373

1808

1.16

2.02

1.2

42.66

43.36

mg/l

0.08

328

1502

Medicines for HER+ breast cancer

1004

0.73

2.00

1.3

1.2

46.16

40.45

mg/l

0.23

840

Rosacea

360

1.48

1.99

1.2

1.1

32.17

38.91

mg/l

0.89

305

Allergic rhinitis

176

1414

1.23

1.99

1.2

33.78

39.37

mg/l

1.47

149

1180

Anogenital herpesviral [herpes simplex] infection

272

1.55

1.98

1.3

1.2

26.69

35.74

mg/l

2.64

219

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

288

1.53

1.97

1.2

44.35

39.72

mg/l

0.09

231

Phlebitis and thrombophlebitis (not including DVT)

639

1.35

1.95

1.2

41.08

41.46

mg/l

0.02

536

Crohn disease

478

1.41

1.95

1.1

1.2

35.35

39.70

mg/l

0.53

397

Failure and rejection of transplanted organs and tissues

2.60

1.95

1.2

1.1

49.00

38.15

mg/l

—

Female infertility

174

854

1.24

1.94

1.2

1.1

36.84

39.86

mg/l

0.38

154

700

Other gastritis (incl. Duodenitis)

546

1.38

1.94

1.2

39.97

44.32

mg/l

0.42

457

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

245

1.57

1.93

1.3

1.1

34.19

39.11

mg/l

0.32

193

Acute laryngitis and tracheitis

529

1.38

1.93

1.1

29.51

40.00

mg/l

2.93

438

Heart failure and coronary heart disease

659

0.72

1.93

1.2

38.02

47.58

mg/l

1.53

557

Congenital malformations of the circulatory system

505

1.39

1.93

1.2

29.54

41.43

mg/l

3.32

416

Adenomyosis (Endometriosis of uterus)

413

1.43

1.91

1.2

1.1

41.94

38.24

mg/l

0.11

348

Malignant melanoma of skin

243

1.57

1.89

1.2

1.1

46.74

38.22

mg/l

0.48

204

Female infertility, associated with anovulation

406

1.43

1.89

1.1

35.48

38.18

mg/l

0.22

338

Artrosis, including avohilmo

408

1948

1.15

1.89

1.1

1.2

36.70

45.32

mg/l

3.54

345

1621

Alcohol use disorder, Swedish definition

233

1793

1.19

1.89

1.2

38.83

44.84

mg/l

1.53

190

1503

Hallux rigidus

283

1.52

1.89

1.0

1.2

47.50

39.71

mg/l

0.31

239

Atrial fibrillation and flutter with reimbursement

394

1.36

1.88

1.1

1.2

68.97

44.73

mg/l

0.45

328

Other diseases of oesophagus

204

1.62

1.88

1.1

30.26

47.17

mg/l

4.59

165

Abnormal findings in secretions and smears from cervix uteri vagina vulva

269

1725

1.18

1.88

1.1

1.2

33.11

38.74

mg/l

1.71

223

1441

Secondary polycythaemia

2.33

1.88

1.1

46.25

44.96

mg/l

—

Other noninflammatory disorders of vulva and perineum

316

1.49

1.87

1.1

34.07

35.41

mg/l

0.07

260

Other sexually transmitted chlamydial diseases

516

1.38

1.87

1.2

30.76

38.76

mg/l

1.74

410

Polyarthrosis

392

1.42

1.87

1.1

1.2

32.91

44.02

mg/l

1.92

332

Infectious mononucleosis

407

1.43

1.87

1.2

1.1

50.11

38.10

mg/l

0.73

326

Other specified and unspecified personality disorders

341

1.47

1.86

1.2

25.78

39.58

mg/l

5.33

281

FESS (DNB20)

399

1.43

1.86

1.1

46.03

40.97

mg/l

0.25

335

Other arthrosis

198

1132

1.21

1.85

1.1

1.2

38.38

45.52

mg/l

1.48

169

935

Localized swelling, mass and lump of skin and subcutaneous tissue

113

881

1.28

1.84

1.2

1.1

57.28

41.62

mg/l

0.89

730

Pedestrian injured in transport accident

190

1.64

1.84

1.2

32.18

40.13

mg/l

0.98

155

Collagenous colitis

261

1.54

1.84

1.1

1.2

35.14

39.55

mg/l

0.44

215

Diabetic retinopathy

107

512

1.30

1.84

1.1

51.36

47.37

mg/l

0.36

428

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

283

2356

1.17

1.83

1.1

1.2

32.75

41.32

mg/l

3.84

240

1959

Benign neoplasm: Rectum, anus and anal canal

442

1.41

1.83

1.2

41.67

43.79

mg/l

0.15

372

Ethmoidectomy

409

1.42

1.82

1.1

45.57

40.87

mg/l

0.23

344

Diabetic retinopathy, excluding more controls

382

1.34

1.82

1.1

53.69

48.61

mg/l

0.39

317

Other specified and unspecified disorders of eye and adnexa

1.96

1.80

1.1

1.2

58.18

32.67

mg/l

0.73

Anomalies of dental arch relationship, including avohilmo

107

749

1.29

1.79

1.2

1.1

36.97

37.89

mg/l

0.08

624

Atopic dermatitis, strict definition

174

1401

1.22

1.79

1.2

33.14

38.51

mg/l

1.71

143

1173

Obesity, other/unspecified

175

1440

1.22

1.79

1.1

1.2

41.27

39.20

mg/l

0.31

155

1207

Acute peritonitis

138

1.75

1.79

1.1

148.74

41.00

mg/l

0.51

118

Care involving dialysis

176

1.65

1.79

1.2

49.90

43.85

mg/l

0.27

138

Other (seronegative) rheumatoid arthritis, wide

478

1.38

1.79

1.1

43.53

39.77

mg/l

0.29

403

Inflammatory bowel disease

153

1243

1.23

1.78

1.1

1.2

40.13

40.71

mg/l

0.06

123

1041

Viral and other specified intestinal infections

157

1234

1.23

1.77

1.2

34.29

41.19

mg/l

1.68

128

1026

Iron deficiency

102

1.88

1.77

1.0

1.1

75.78

39.05

mg/l

—

Mixed conductive and sensorineural hearing loss

264

1.52

1.75

1.1

1.2

35.68

43.42

mg/l

1.08

223

Crohn disease (strict definition, all UC cases excluded)

170

1.66

1.74

1.1

1.2

34.29

42.57

mg/l

0.64

137

Congenital malformations and deformations of the musculoskeletal system

362

1.43

1.72

1.1

1.2

28.56

38.74

mg/l

0.87

296

Other disorders of breast

431

1.40

1.72

1.3

1.1

32.81

35.03

mg/l

0.28

362

Other local infections of skin and subcutaneous tissue

290

1.49

1.71

1.2

1.1

38.80

41.26

mg/l

0.24

238

L04AD Calcineurin inhibitors

356

1.44

1.71

1.2

1.1

49.16

41.98

mg/l

0.46

294

Preterm labour and delivery

126

1007

1.25

1.71

1.1

39.01

38.73

mg/l

0.02

101

840

Recurrent aphthous stomatitis , including avohilmo

457

1.38

1.70

1.1

41.23

38.95

mg/l

0.15

382

Mental disorders, not otherwise specified

332

1.45

1.69

1.2

32.02

37.42

mg/l

0.66

270

Other diseases of hard tissues of teeth

247

1083

1.18

1.69

1.1

1.2

38.99

47.68

mg/l

1.79

199

891

Maternal care for other conditions predominantly related to pregnancy

131

1033

1.25

1.69

1.2

38.09

35.57

mg/l

0.25

102

853

Amputation of foot

0.00

1.68

0.0

1.1

—

47.52

—

Atopic dermatitis, strict definition with reimbursement

173

1384

1.21

1.67

1.2

1.1

33.60

39.37

mg/l

1.81

142

1159

Secondary thrombocytopenia

2.61

1.66

1.7

1.1

57.63

39.34

mg/l

—

Rheumatoid arthritis, including avohilmo

140

1137

1.23

1.65

1.1

1.2

41.15

41.50

mg/l

0.03

118

941

Other disorders of veins

158

1292

1.22

1.65

1.1

55.72

41.75

mg/l

0.52

134

1072

Thyroiditis

204

1.57

1.65

1.4

1.2

33.27

35.10

mg/l

0.14

173

Benign neoplasm of other and ill-defined parts of digestive system

426

1.39

1.65

1.2

37.39

41.00

mg/l

0.47

359

Complications predominantly related to the puerperium

141

1147

1.23

1.65

1.1

1.2

33.29

36.73

mg/l

0.51

115

967

Viral pneumonia

376

1.41

1.64

1.1

42.52

42.06

mg/l

0.04

306

Substance use, excluding alcohol

773

1.28

1.64

1.2

1.1

32.68

41.39

mg/l

2.78

657

Toxic effects of substances chiefly nonmedicinal as to source

393

1.40

1.64

1.1

1.2

28.13

40.01

mg/l

3.61

326

Suppurative and unspecified otitis media

213

1596

1.18

1.64

1.2

37.96

39.94

mg/l

0.29

174

1336

GI-bleeding

765

1.28

1.62

1.2

1.1

42.24

42.94

mg/l

0.04

638

Other diseases of the digestive system

774

1.28

1.62

1.2

1.1

42.46

42.57

mg/l

0.01

649

Fracture of foot, except ankle

118

943

1.25

1.62

1.2

38.53

39.09

mg/l

0.05

791

249

1929

1.17

1.62

1.2

1.1

39.15

45.91

mg/l

1.82

206

1617

Female genital prolapse

127

573

1.25

1.62

1.1

32.17

42.29

mg/l

2.48

480

Enterocolitis due to Clostridium difficile

237

1.52

1.62

1.2

1.1

114.94

43.91

mg/l

0.58

194

Tuberculosis

1.84

1.61

1.2

1.1

40.92

41.86

mg/l

0.04

Other disorders of the musculoskeletal system and connective tissue

386

1.40

1.61

1.2

1.1

36.48

41.34

mg/l

0.65

319

Major coronary heart disease event

321

1687

1.15

1.60

1.1

1.2

34.97

46.35

mg/l

5.35

268

1413

Benign neoplasm: Rectum

403

1.39

1.60

1.2

40.57

43.73

mg/l

0.23

337

Seronegative rheumatoid arthritis

254

1.50

1.60

1.1

1.2

41.07

39.33

mg/l

0.10

211

Perineal laceration during delivery

815

0.76

1.60

1.1

1.2

34.90

34.67

mg/l

0.02

666

Recurrent dislocation and subluxation of joint

246

1.51

1.60

1.2

47.74

41.22

mg/l

0.12

196

Vasomotor rhinitis (mode)

206

1.56

1.59

1.2

1.1

30.16

42.96

mg/l

1.49

171

Injury of muscle and tendon at hip and thigh level

287

1.47

1.59

1.0

1.2

50.57

42.13

mg/l

0.45

237

Mental and behavioural disorders due to alcohol, excluding acute intoxication

184

1535

1.19

1.59

1.2

1.1

38.55

44.99

mg/l

1.46

154

1295

Injuries to the hip and thigh

167

1256

1.21

1.58

1.1

39.37

42.31

mg/l

0.46

141

1065

Disorders of continuity of bone

296

1.46

1.57

1.1

1.2

26.64

40.58

mg/l

3.84

254

Noninflammatory disorders of female genital tract

229

975

1.18

1.57

1.1

32.44

39.69

mg/l

2.24

196

802

Crohn disease (strict definition, require KELA, min 2 HDR)

223

1.53

1.57

1.1

1.2

34.66

41.12

mg/l

0.60

179

Alcohol use disorder, ICD-based

170

1418

1.20

1.56

1.2

1.1

38.29

44.62

mg/l

1.29

140

1201

Nonsuppurative otitis media

132

928

1.23

1.55

1.2

41.39

41.48

mg/l

0.01

113

773

Septal defects

211

1.54

1.1

1.2

24.93

36.72

mg/l

2.63

169

Kela-code for severe mental illness

174

1456

1.20

1.54

1.1

1.2

35.83

41.40

mg/l

1.35

144

1224

Respiratory disorders in diseases classified elsewhere

2.45

1.54

1.5

1.1

60.92

36.42

mg/l

—

Medical abortion

316

1495

1.15

1.54

1.1

1.2

38.80

38.05

mg/l

0.10

268

1236

Other disorders starting during childhood or adolescence

230

1.51

1.53

1.3

1.1

28.51

38.68

mg/l

1.05

179

264

2012

1.16

1.53

1.2

38.68

45.41

mg/l

1.92

216

1694

Benign neoplasm: Long bones of lower limb

100

1.81

1.53

1.1

27.44

42.27

mg/l

1.95

Other infestations

0.00

1.53

0.0

1.1

—

41.22

—

Colonic or urogenital fistula

110

879

1.25

1.53

1.1

1.2

45.68

40.75

mg/l

0.50

729

Disorder of lipoprotein metabolism, unspecified

257

1.48

1.52

1.1

51.30

41.48

mg/l

0.57

208

Crohn disease (strict definition, require KELA)

225

1.52

1.51

1.1

1.2

34.66

41.03

mg/l

0.59

181

Scabies

598

1.31

1.51

1.2

1.1

42.75

39.11

mg/l

0.33

496

ILD, hospital admission 2, with pulmonary infections

185

1.57

1.51

1.2

1.1

57.00

44.75

mg/l

0.61

152

Malignant neoplasm of pancreas, including Hilmo

144

0.42

1.51

1.5

1.1

84.10

38.63

mg/l

—

123

Non-small cell lung cancer, including Hilmo

250

1.47

1.50

1.0

1.1

49.41

42.18

mg/l

0.43

213

Viral and other specified intestinal infections

118

930

1.24

1.50

1.1

1.2

33.38

39.86

mg/l

1.45

771

Other inflammatory liver diseases

178

1.58

1.48

1.1

37.14

40.20

mg/l

0.25

146

Cellulitis

723

1.27

1.48

1.1

57.14

40.74

mg/l

1.66

606

Prolonged pregnancy

752

0.75

1.47

1.2

32.41

36.60

mg/l

0.60

626

Necrosis of pulp, including avohilmo

285

2486

1.14

1.46

1.1

1.2

36.61

42.46

mg/l

1.45

227

2087

Disorders of parathyroid gland

439

1.35

1.46

1.1

30.52

39.15

mg/l

2.27

370

Other and unspecified psoriasis

163

1.60

1.46

1.1

1.2

42.56

42.86

mg/l

0.01

131

Nonspecific lymphadenitis

179

1.57

1.45

1.3

1.2

30.96

39.20

mg/l

0.89

148

Allergic conjunctivitis

293

2503

1.14

1.45

1.1

1.2

33.00

41.49

mg/l

3.97

248

2082

Abnormal serum enzyme levels

689

1.27

1.45

1.1

39.77

50.08

mg/l

1.19

576

Other hammer toe(s) (acquired)

324

1.40

1.45

1.1

48.32

43.48

mg/l

0.19

270

Acute renal failure

463

1.34

1.44

1.3

1.2

44.13

45.23

mg/l

0.07

381

Viral warts

344

1.40

1.44

1.1

1.2

35.49

39.42

mg/l

0.24

287

Type 2 diabetes, wide definition

314

1767

1.14

1.42

1.1

47.09

43.59

mg/l

0.55

261

1488

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

421

2413

1.12

1.42

1.2

1.1

43.37

42.92

mg/l

0.03

359

2018

Primary open-angle glaucoma, strict

472

1.33

1.42

1.2

1.1

42.73

43.32

mg/l

0.03

407

Follicular cysts of skin and subcutaneous tissue

587

1.30

1.41

1.1

1.2

38.75

41.49

mg/l

0.20

490

Malignant neoplasm of breast, HER-positive

728

0.77

1.41

1.2

45.51

39.01

mg/l

0.24

606

Bacterial, viral and other infectious agents

312

1.42

1.41

1.1

1.2

48.38

41.71

mg/l

0.33

251

Early syphilis

2.27

1.40

1.1

1.2

40.82

52.41

mg/l

—

Schizophrenia

600

0.72

1.40

1.1

47.20

40.81

mg/l

0.74

505

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

299

1.42

1.40

1.2

30.57

36.70

mg/l

0.54

240

Endometriosis ASRM stages 1,2

729

1.26

1.40

1.1

1.2

27.95

36.55

mg/l

3.25

618

Background retinopathy and retinal vascular changes

2.26

1.40

1.1

57.00

39.15

mg/l

—

Other puerperal infections

406

1.36

1.40

1.1

1.2

36.45

34.15

mg/l

0.17

337

Amenorrhoea

321

1.41

1.40

1.2

1.1

43.99

35.00

mg/l

0.52

266

Myocardial infarction, strict

855

0.80

1.39

1.1

44.67

49.29

mg/l

0.47

726

Other abnormal products of conception

194

1093

1.18

1.38

1.1

1.2

33.33

35.92

mg/l

0.56

163

908

Mental and behavioural disorders due to alcohol

218

1807

1.16

1.38

1.2

1.1

38.27

44.81

mg/l

1.72

183

1515

Endometriosis ASRM stages 3,4

106

856

1.24

1.38

1.1

1.2

37.52

36.88

mg/l

0.04

725

Other specific arthropathies, wide

2.21

1.37

1.1

1.2

53.73

31.59

mg/l

—

Other and specified injuries of hip and thigh

2.21

1.37

1.1

1.0

41.22

42.83

mg/l

—

Atrial fibrillation and flutter

109

569

1.24

1.37

1.2

42.60

43.13

mg/l

0.05

467

Gout

464

1.31

1.36

1.0

1.2

54.37

49.50

mg/l

0.32

389

Hypertrophic disorders of skin

199

1.51

1.35

1.3

1.2

48.14

38.38

mg/l

0.32

164

Ischaemic heart disease, wide definition

273

1479

1.14

1.34

1.2

39.34

46.27

mg/l

1.77

226

1228

Cholecystectomy

286

2174

1.14

1.32

1.1

42.17

42.14

mg/l

0.00

242

1819

Other respiratory diseases principally affecting the interstitium

350

1.37

1.32

1.2

1.1

48.31

43.58

mg/l

0.28

289

Extracorporeal dialysis

144

1.60

1.32

1.2

1.1

54.44

42.97

mg/l

0.47

124

Degeneration of macula and posterior pole

119

776

1.22

1.32

1.2

1.1

48.99

44.49

mg/l

0.49

658

Trigger finger

325

1.39

1.31

1.2

1.1

50.70

44.42

mg/l

0.25

265

Early syphilis

2.38

1.29

1.1

1.2

41.68

54.28

mg/l

—

Stomatitis and related lesions

693

1.26

1.29

1.1

39.65

39.15

mg/l

0.04

583

Colorectal cancer

429

0.68

1.29

1.2

1.1

43.90

41.42

mg/l

0.16

369

Unspecified acute lower respiratory infection

490

1.31

1.29

1.3

1.2

43.24

41.88

mg/l

0.09

404

Other and unspecified local infections of skin and subcutaneous tissue

276

1.42

1.28

1.2

1.1

36.11

41.16

mg/l

0.67

225

Papulosquamous disorders

153

1293

1.18

1.27

1.1

1.2

40.26

41.76

mg/l

0.15

123

1088

Other eating disorders

235

1.45

1.27

1.2

1.1

25.10

36.29

mg/l

2.39

188

Other congenital malformations

336

1.37

1.26

1.1

1.2

27.58

36.91

mg/l

1.67

273

Glucosamine medication

124

819

1.21

1.26

1.1

41.36

45.12

mg/l

0.37

699

Superficial injury of shoulder and upper arm

345

1.37

1.26

1.2

35.44

39.68

mg/l

0.44

286

Diseases of peritoneum

244

1.44

1.25

1.1

108.84

39.96

mg/l

0.47

205

Nasal polyp

519

1.29

1.25

1.1

44.43

43.28

mg/l

0.07

430

Malignant neoplasm of breast, ER-positive, including Hilmo

741

0.79

1.25

1.2

1.1

46.24

39.06

mg/l

0.30

614

L02BG Aromatase inhibitors

778

0.77

1.24

1.2

52.27

40.50

mg/l

0.40

653

Sequelae of infectious and parasitic diseases

203

1.48

1.24

1.2

1.1

47.67

40.83

mg/l

0.29

164

Coronary revascularization (ANGIO or CABG)

295

1598

1.13

1.24

1.1

1.2

35.46

46.53

mg/l

4.43

242

1334

Infective dermatitis

295

1.39

1.24

1.2

1.1

29.98

44.14

mg/l

3.38

241

Dysplasia of cervi uteri

132

797

1.20

1.23

1.1

32.10

39.92

mg/l

1.87

104

660

Excessive vomiting in pregnancy

364

1.35

1.23

1.1

27.90

35.58

mg/l

1.66

300

Percutaneous Coronary Intervention

294

1596

1.13

1.22

1.1

1.2

35.51

46.46

mg/l

4.32

241

1332

Diabetic retinopathy, strict definition

382

1.32

1.21

1.1

50.40

45.36

mg/l

0.33

327

Other benign neoplasms of skin

128

1071

1.20

1.21

1.1

1.2

41.00

41.17

mg/l

0.01

109

893

Dislocation, sprain and strain of joints and ligaments of head

140

1.58

1.20

1.0

1.2

26.07

44.44

mg/l

2.37

110

Foreign body in genitourinary tract

2.33

1.19

1.0

1.1

71.33

33.36

mg/l

—

Evidence of alcohol involvement determined by level of intoxication

2.33

1.19

1.5

1.3

47.15

33.31

mg/l

—

Phakomatoses, not elsewhere classified

2.33

1.19

1.0

1.1

28.57

32.19

mg/l

—

Other fall from one level to another

101

827

1.22

1.19

1.3

1.1

43.38

40.82

mg/l

0.17

691

Retinal breaks without detachment

392

1.33

1.19

1.2

41.89

40.53

mg/l

0.09

337

Hypertrophic scar

181

1.50

1.18

1.3

1.2

50.73

38.51

mg/l

0.38

148

Renal failure

129

956

1.19

1.18

1.2

1.1

43.18

44.34

mg/l

0.11

100

803

Mental and behavioural disorders due to opioids

141

1.57

1.17

1.1

32.38

38.44

mg/l

0.63

113

Schizophrenia or delusion

150

1277

1.18

1.17

1.1

1.2

36.07

42.28

mg/l

1.53

124

1071

Fracture of skull and facial bones

748

1.23

1.17

1.2

1.1

64.65

41.80

mg/l

0.54

641

Otitis media, unspecified

442

1.29

1.17

1.1

27.09

38.20

mg/l

2.80

354

Family history of certain disabilities and chronic diseases leading to disablement

182

1.49

1.16

1.2

28.16

38.04

mg/l

1.00

147

Congenital obstruction of the pelviureteric junction

2.52

1.15

1.0

1.1

38.18

32.99

mg/l

—

Folate deficiency anaemia

2.52

1.15

1.2

1.1

27.74

36.52

mg/l

—

Other maternal disorders predominantly related to pregnancy

293

1635

1.12

1.15

1.2

36.13

38.12

mg/l

0.32

248

1352

Iliotibial band syndrome

2.52

1.15

1.0

20.00

32.19

mg/l

—

Hyperparathyroidism

364

1.33

1.15

1.1

29.58

39.68

mg/l

2.92

305

Sequelae of other external causes

150

1.54

1.14

1.1

1.2

34.29

39.48

mg/l

0.26

121

Cyst of kidney

142

1.55

1.14

1.2

1.1

61.39

45.13

mg/l

0.66

121

Malignant neoplasm of bronchus and lung, including Hilmo

322

1.33

1.14

1.0

1.1

52.99

41.47

mg/l

0.90

275

Schizophrenia, schizotypal and delusional disorders

150

1282

1.17

1.13

1.1

1.2

36.07

42.26

mg/l

1.53

124

1076

Crohn's disease NAS

233

1.42

1.13

1.0

1.2

36.92

40.04

mg/l

0.22

193

Angina pectoris

178

1024

1.16

1.12

1.1

41.41

48.63

mg/l

1.28

151

861

Open wound of ankle and foot

327

1.35

1.12

1.2

29.43

38.86

mg/l

1.42

263

Sequelae of injuries of head

151

1.53

1.11

1.0

1.2

138.53

45.46

mg/l

0.46

121

Primary open-angle glaucoma

562

1.26

1.11

1.2

1.1

46.58

44.00

mg/l

0.14

478

Cholecystitis

310

1.36

1.11

1.3

1.2

41.92

42.06

mg/l

0.01

249

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

389

0.69

1.11

1.1

1.2

48.29

41.66

mg/l

0.34

333

Gastroduodenal ulcer

528

1.27

1.10

1.1

39.56

45.69

mg/l

0.73

443

Biological medication for rheuma

700

1.23

1.10

1.2

1.1

38.08

39.30

mg/l

0.10

596

Erysipelas

269

1828

1.12

1.09

1.2

1.1

56.73

41.78

mg/l

1.01

226

1530

Sulfonylureas

519

0.77

1.08

1.1

54.48

44.36

mg/l

0.86

436

Injury of eye and orbit

531

1.26

1.08

1.2

1.1

37.58

42.32

mg/l

0.60

449

Infections of genitourinary tract in pregnancy

390

1.31

1.08

1.1

34.58

35.87

mg/l

0.09

327

Gastric ulcer

355

1.33

1.08

1.1

41.41

45.71

mg/l

0.32

293

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

1.88

1.07

1.0

1.2

34.45

36.54

mg/l

0.09

ILD, hospital admissions

295

1.36

1.07

1.2

1.1

50.27

43.73

mg/l

0.36

245

Injuries to the elbow and forearm

316

2502

1.11

1.07

1.1

1.2

44.55

42.42

mg/l

0.21

251

2125

Congenital malformations of the musculoskeletal system, not elsewhere classified

1.94

1.06

1.1

1.2

22.60

29.44

mg/l

—

Heart failure and bmi 25plus

523

0.79

1.06

1.1

44.20

46.36

mg/l

0.16

444

Corneal ulcer

658

1.23

1.06

1.2

1.1

36.03

40.21

mg/l

0.50

548

Arthropathy in ulcerative colitis

2.14

1.06

1.3

1.1

46.06

30.61

mg/l

—

Open wound of forearm

296

1.35

1.05

1.1

1.2

41.26

41.95

mg/l

0.03

240

Other interstitial pulmonary diseases

296

1.35

1.05

1.2

1.1

50.27

44.13

mg/l

0.33

247

Inflammatory disorders of breast

262

1.38

1.05

1.1

31.77

35.24

mg/l

0.43

217

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

245

1.39

1.05

1.1

1.2

34.66

40.34

mg/l

0.52

200

Other complications of labour and delivery, not elsewhere classified

645

0.78

1.05

1.2

33.03

35.04

mg/l

0.14

528

Intestinal stricture

777

1.21

1.04

1.2

1.1

39.50

42.06

mg/l

0.29

654

Seminoma of testis

2.29

1.04

1.0

1.2

60.40

51.35

mg/l

—

Interstitial lung disease endpoints

297

1.35

1.03

1.2

1.1

50.27

44.13

mg/l

0.33

247

Interstitial lung disease

297

1.35

1.03

1.2

1.1

50.27

44.13

mg/l

0.33

247

Renal tubulo-interstitial disorders in diseases classified elsewhere

2.29

1.03

1.6

1.1

30.40

35.87

mg/l

—

Mental and behavioural disorders due to sedatives or hypnotics

229

1.40

1.03

1.1

1.2

37.80

41.43

mg/l

0.30

184

Salpingitis and oophoritis

517

1.26

1.03

1.1

1.2

32.43

38.03

mg/l

0.89

426

Gout, FINNGEN

551

1.25

1.03

1.0

1.1

54.37

46.24

mg/l

0.62

459

Crushing injury of wrist and hand

2.07

1.03

1.3

1.1

39.57

51.83

mg/l

—

Seropositive rheumatoid arthritis

631

1.23

1.03

1.1

1.2

43.30

40.64

mg/l

0.21

522

Gestational diabetes (for exclusion)

227

1398

1.13

1.02

1.2

37.49

35.93

mg/l

0.21

195

1162

Emergency coronary revascularization (for ACS)

309

1691

1.11

1.02

1.1

36.06

46.41

mg/l

4.20

253

1415

Other and unspecified glaucoma

122

1.56

1.02

1.1

49.62

40.95

mg/l

0.24

103

Loose body in joint

1.92

1.02

1.3

1.1

43.11

44.29

mg/l

—

Seborrhoeic dermatitis

247

1.38

1.01

1.3

1.2

39.19

45.67

mg/l

0.42

200

Ulcerative colitis

109

918

1.19

1.00

1.2

41.04

41.05

mg/l

0.00

776

Hereditary retinal dystrophy

2.01

1.00

1.1

35.90

28.29

mg/l

—

Open wound of lower leg

457

1.27

1.00

1.2

1.1

41.29

41.65

mg/l

0.02

371

Contact with sharp glass

131

1.53

1.00

1.2

1.1

33.00

44.40

mg/l

0.72

101

Deep bite

369

1.29

1.00

1.2

33.11

39.20

mg/l

0.60

303

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

136

1168

1.17

1.00

1.2

1.1

40.62

40.83

mg/l

0.02

112

986

Polycystic ovarian syndrome, broad definition

592

1.24

0.99

1.1

1.2

35.89

35.66

mg/l

0.02

490

Ankylosing spondylitis, ICD10

291

1.34

0.99

1.2

31.42

42.12

mg/l

2.47

234

725

1.20

0.98

1.1

38.71

44.89

mg/l

0.70

617

2.19

0.98

1.0

1.2

38.20

38.44

mg/l

—

Other bursitis of knee

2.18

0.98

1.2

1.1

48.60

40.35

mg/l

—

Unequal limb length (acquired)

0.00

0.98

0.0

1.2

—

44.51

—

Chronic pancreatitis

309

1.33

0.98

1.2

1.1

48.54

45.38

mg/l

0.13

250

Anisometropia and aniseikonia

1.67

0.98

1.1

28.56

39.88

mg/l

—

Skin changes due to chronic exposure to nonionizing radiation

663

1.21

0.97

1.1

39.94

44.48

mg/l

0.41

566

Malignant neoplasm of cervix uteri

1.96

0.97

1.1

1.0

27.43

25.80

mg/l

—

Acne

503

1.25

0.97

1.4

1.1

58.31

37.63

mg/l

0.84

410

All-cause Heart Failure

120

993

0.85

0.97

1.2

1.1

40.24

45.72

mg/l

0.96

840

Glomerular disorders in diseases classified elsewhere

301

1.33

0.97

1.2

1.1

43.91

43.69

mg/l

0.01

242

Alzheimer’s disease (Atypical or mixed)

107

1.58

0.96

1.1

33.36

45.27

mg/l

0.95

Early onset COPD

558

1.24

0.96

1.3

1.2

70.78

43.86

mg/l

0.40

468

Peripheral arterial reconstruction

283

0.67

0.96

1.1

57.09

46.34

mg/l

0.51

238

Osteonecrosis

141

1.49

0.94

1.1

33.66

43.66

mg/l

1.02

122

Malignant neoplasm, wide definition for exclusion

407

2189

1.09

0.94

1.2

1.1

49.75

40.79

mg/l

1.18

339

1830

Other/unspecified rheumatoid arthritis

268

1.35

0.94

1.1

44.15

41.78

mg/l

0.10

225

Periodontitis

418

2569

1.09

0.94

1.1

1.2

41.77

43.88

mg/l

0.42

350

2158

Unspecified threat to breathing

2.24

0.94

1.7

1.1

25.72

43.49

mg/l

—

Other follicular disorders

277

1.34

0.93

1.3

1.2

45.46

40.57

mg/l

0.28

224

Other condition

480

1.25

0.93

1.2

1.1

34.45

39.97

mg/l

0.79

398

Acne vulgaris

400

1.28

0.93

1.3

1.1

62.40

38.82

mg/l

0.76

322

Myocardial infarction, unclassifiable

324

0.72

0.93

1.0

1.1

43.80

47.38

mg/l

0.27

270

Superficial injury of forearm

356

1.30

0.93

1.2

34.15

39.56

mg/l

0.37

294

Benign neoplasm of eye and adnexa

243

1.36

0.92

1.1

40.63

41.06

mg/l

0.01

203

Malignant neoplasm of respiratory system and intrathoracic organs

310

1.29

0.92

1.0

1.1

63.77

41.94

mg/l

1.67

265

Injury of muscle and tendon at wrist and hand level

436

1.26

0.92

1.2

38.37

42.28

mg/l

0.41

368

Psoriatic and enteropathic arthropathies

330

1.31

0.92

1.1

1.2

38.98

40.61

mg/l

0.11

269

Sulfasalazine

110

937

1.18

0.91

1.1

37.13

42.67

mg/l

1.03

779

Chronic periodontitis, including avohilmo

416

2566

1.09

0.91

1.1

1.2

41.84

43.84

mg/l

0.39

348

2155

Heart failure, strict

123

1008

0.86

0.90

1.2

1.1

40.23

47.61

mg/l

1.22

851

Primary gonarthrosis, bilateral

143

1064

1.15

0.90

1.1

44.79

46.52

mg/l

0.14

123

900

Redundant prepuce, phimosis and paraphimosis

647

1.21

0.90

1.2

47.80

50.20

mg/l

0.14

555

Disorders of gallbladder, biliary tract and pancreas

426

2475

1.09

0.90

1.1

1.2

40.64

43.47

mg/l

0.55

356

2073

Other congenital malformations

509

1.24

0.90

1.1

33.12

37.70

mg/l

0.51

432

Mental and behavioural disorders due to tobacco

253

1.35

0.90

1.1

31.35

42.20

mg/l

1.53

210

Adjustment and management of implanted device

305

1.31

0.90

1.1

42.54

44.58

mg/l

0.12

250

Acute suppurative otitis media

155

1266

1.14

0.90

1.2

40.31

40.37

mg/l

0.01

125

1059

LSIL lesion of the cervix uteri, vagina or vulva

609

1.22

0.90

1.1

1.2

33.61

35.42

mg/l

0.19

510

Alcoholic liver disease

236

1.36

0.89

1.3

1.1

43.79

45.31

mg/l

0.10

197

Allergic contact dermatitis

456

1.25

0.89

1.1

36.68

41.12

mg/l

0.34

383

Endometriosis of ovary

630

1.21

0.89

1.1

35.22

38.46

mg/l

0.39

530

Muscle strain

1.70

0.89

1.2

1.1

36.58

41.81

mg/l

0.31

Ulcer of oesophagus

127

1.50

0.88

1.3

1.1

31.08

48.89

mg/l

2.68

106

Other dialysis

1.65

0.88

1.1

38.43

44.27

mg/l

—

Benign neoplasm: Skin of other and unspecified parts of face

254

1.34

0.88

1.1

40.34

41.38

mg/l

0.07

207

Periapical abscess

190

1690

1.13

0.87

1.1

1.2

38.72

43.64

mg/l

0.84

160

1424

Oligomenorrhoea

144

1.46

0.87

1.2

1.1

39.74

33.37

mg/l

0.60

116

Cellulitis of external ear

2.01

0.87

1.0

1.1

31.35

49.30

mg/l

—

Ulcerative colitis, NAS

485

1.24

0.86

1.2

1.1

40.99

40.90

mg/l

0.00

409

Smoking dependency

255

1.34

0.86

1.1

31.35

42.01

mg/l

1.49

212

Parapsoriasis

1.83

0.86

1.0

1.2

26.50

44.19

mg/l

—

Paralytic ileus and intestinal obstruction

621

1.21

0.86

1.3

1.1

38.15

44.26

mg/l

0.99

510

Other and unspecified injuries of lower leg

264

1.33

0.86

1.1

59.38

39.95

mg/l

0.66

214

Malignant neoplasm of bronchus and lung

269

1.30

0.86

1.0

1.1

56.24

42.36

mg/l

0.93

230

Toxic effect of contact with venomous animals

120

1.51

0.85

1.2

1.1

31.36

40.32

mg/l

0.90

Persons encountering health services in circumstances related to reproduction

285

1744

1.10

0.85

1.2

1.1

39.62

43.21

mg/l

0.63

251

1437

Delivery

143

864

0.87

0.85

1.1

1.2

33.70

38.26

mg/l

0.86

114

722

Hallux valgus (acquired)

114

704

1.17

0.84

1.2

42.37

41.66

mg/l

0.04

585

Erysipelas

184

1448

1.12

0.84

1.2

1.1

61.24

42.57

mg/l

0.83

150

1218

Pollen allergy

106

897

1.17

0.83

1.2

31.24

37.44

mg/l

1.55

742

IBD patients in KELA-register

110

946

1.16

0.83

1.1

1.2

39.21

41.56

mg/l

0.24

797

Peripheral artery disease

716

0.83

1.1

75.57

45.82

mg/l

0.53

611

Alcohol dependence

826

1.18

0.83

1.2

1.1

35.39

46.29

mg/l

2.63

701

Diabetes, insulin treatment (Kela reimbursement)

386

2525

0.92

0.83

1.1

1.2

46.81

43.39

mg/l

0.59

327

2118

Hypertensive Renal Disease

1.74

0.82

1.0

35.25

35.04

mg/l

—

Pregnancy with abortive outcome

316

1506

1.10

0.82

1.2

39.20

37.97

mg/l

0.18

268

1244

Personal history of other diseases and conditions

496

1.23

0.81

1.1

1.2

35.39

36.77

mg/l

0.10

420

Later onset COPD

345

0.76

0.81

1.0

1.1

39.40

47.18

mg/l

0.61

289

Other diseases of intestine

338

1.27

0.80

1.1

1.2

42.87

44.99

mg/l

0.13

275

Galactorrhea

1.83

0.79

1.8

1.1

33.50

25.44

mg/l

—

Other and unspecified intracranial injuries

1.67

0.78

1.0

1.1

24.45

42.34

mg/l

1.79

Insulin, combination of fast acting with intermediate-acting or long-acting

229

1894

1.11

0.78

1.1

1.2

48.82

43.46

mg/l

0.75

186

1605

Macular pucker

277

1.30

0.78

1.1

47.04

41.76

mg/l

0.27

240

Other salmonella infections

1.56

0.78

1.1

35.93

38.39

mg/l

0.18

Myeloproliferative diseases

182

1.38

0.77

1.0

1.1

33.75

42.26

mg/l

0.83

148

5-aminosalicylic acid

768

1.17

0.77

1.1

41.65

42.40

mg/l

0.05

649

Use of disulfiram, acamprosate or naltrexone

287

1.29

0.77

1.2

32.98

45.12

mg/l

2.17

232

Pregnancy, childbirth and the puerperium

100

608

0.86

0.76

1.1

1.2

29.17

35.41

mg/l

1.50

503

Other appendicitis

252

1.31

0.76

1.2

35.63

42.93

mg/l

0.85

208

Suggestive for eosinophilic asthma

235

1.32

0.75

1.2

1.1

47.74

43.94

mg/l

0.12

191

Other congenital malformations of skin

279

1.29

0.75

1.1

1.2

34.43

39.43

mg/l

0.34

225

Antenatal screening

103

670

0.86

0.75

1.1

40.52

37.89

mg/l

0.13

537

Atherosclerosis, excluding cerebral and coronary sclerosis

635

0.83

0.75

1.1

47.87

45.67

mg/l

0.18

546

Gestational [pregnancy-induced] hypertension

139

1225

1.13

0.75

1.2

1.1

34.31

36.72

mg/l

0.31

120

1020

Alopecia areata

1.57

0.75

1.0

1.2

30.94

29.52

mg/l

—

Injury of nerves at lower leg level

2.10

0.75

1.0

22.20

39.54

mg/l

—

Other bursal cyst

2.09

0.74

1.2

31.00

41.66

mg/l

—

severe traumatic brain injury, does not include concussion

526

0.80

0.74

1.2

1.1

87.79

44.51

mg/l

0.42

431

Thyrotoxicosis with diffuse goitre

468

1.22

0.74

1.3

1.1

43.16

39.51

mg/l

0.21

392

Psoriatic arthropathies

262

1.30

0.74

1.1

1.2

37.48

41.86

mg/l

0.28

212

Cardiac murmurs and other cardiac sounds

303

1.27

0.74

1.3

1.1

30.42

44.06

mg/l

1.31

246

Toxic liver disease

1.85

0.73

1.1

33.29

30.24

mg/l

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

210

1.34

0.73

1.4

1.1

35.41

39.50

mg/l

0.25

174

Impetigo

167

1.38

0.73

1.2

30.14

38.29

mg/l

0.80

128

Lumbosacral root disorders, not elsewhere classified

2.01

0.73

1.2

1.1

29.80

30.99

mg/l

—

Malignant neoplasm of pancreas

109

0.55

0.72

1.5

1.1

84.10

37.95

mg/l

—

Pediculosis, acariasis and other infestations

681

1.18

0.72

1.2

1.1

41.86

40.34

mg/l

0.12

569

Other disorders of kidney and ureter

317

1.26

0.71

1.2

1.1

100.14

44.51

mg/l

0.52

261

Hypertrophy of breast in women and men

700

1.17

0.71

1.2

1.1

42.80

40.00

mg/l

0.09

581

Myeloproliferative diseases (CML excluded)

168

1.37

0.71

1.0

1.1

35.44

42.51

mg/l

0.58

139

Other and unspecified injuries of head

168

1.37

0.71

1.2

1.1

33.70

44.30

mg/l

1.14

135

Cholelithiasis, broad definition with cholecystitis

357

2228

1.08

0.71

1.1

1.2

39.76

43.33

mg/l

0.68

296

1876

Arteriovenous malformation of cerebral vessels

1.93

0.71

1.0

20.60

52.24

mg/l

—

ILD, hospital admissions 3, with pneumonia sepsis

160

1.38

0.70

1.2

1.1

55.76

41.32

mg/l

0.57

126

Dermatophytosis

258

2365

1.09

0.70

1.1

40.35

43.48

mg/l

0.64

214

1996

Postmenopausal osteoporosis with pathological fracture

101

1.49

0.70

1.1

56.67

37.01

mg/l

—

Mucosal proctocolitis

463

1.21

0.69

1.1

1.2

40.79

42.04

mg/l

0.07

384

Hypertrophy of breast

619

1.18

0.69

1.2

1.1

42.04

38.26

mg/l

0.11

513

Peritonsillar abscess

823

1.16

0.69

1.1

1.2

43.11

40.60

mg/l

0.12

684

Other endocrine disorders

170

1.36

0.69

1.1

1.2

41.09

34.11

mg/l

0.34

134

Actinic keratosis

641

1.17

0.69

1.1

40.77

44.77

mg/l

0.32

547

Artificial joint operation, meniscal resection

344

2071

1.08

0.69

1.1

1.2

40.27

45.26

mg/l

1.27

288

1733

Insulin, fast-acting

141

1255

1.12

0.68

1.1

1.2

41.09

40.82

mg/l

0.02

111

1060

Disorders of tooth development and eruption

538

1.17

0.68

1.1

57.96

43.60

mg/l

0.28

451

Scoliosis

248

1.29

0.68

1.1

44.70

41.91

mg/l

0.10

204

Helminthiases

1.67

0.68

1.0

1.1

86.86

35.59

mg/l

—

Inflammatory bowel disease, strict (require KELA)

110

965

1.14

0.68

1.1

1.2

39.21

41.04

mg/l

0.18

809

Blepharochalasis

639

1.17

0.68

1.1

40.43

43.59

mg/l

0.23

531

Single delivery by caesarean section

579

0.86

0.67

1.2

35.83

36.97

mg/l

0.09

484

Thyrotoxicosis

807

1.15

0.67

1.2

40.96

38.61

mg/l

0.16

682

Other noninfective disorders of lymphatic vessels and lymph nodes

0.55

0.67

1.0

1.2

29.80

39.34

mg/l

—

Single spontaneous delivery

145

861

0.89

0.67

1.2

36.02

38.32

mg/l

0.33

115

719

COPD-related respiratory insufficiency

205

1.32

0.67

1.1

123.44

48.56

mg/l

0.45

171

Seminoma of testis, including Hilmo

1.80

0.66

1.0

1.2

60.40

46.32

mg/l

—

Puerperal sepsis

385

1.22

0.65

1.1

37.06

36.21

mg/l

0.04

327

Myocardial infarction

114

907

0.88

0.64

1.1

42.63

49.13

mg/l

0.85

767

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

377

1.22

0.63

1.0

1.2

33.85

39.99

mg/l

1.00

318

Other obstructed labour

269

1.27

0.63

1.1

1.2

30.11

35.70

mg/l

0.84

223

1.50

0.63

1.1

1.2

20.14

32.52

mg/l

—

Etanercept

216

1.30

0.63

1.0

1.1

31.74

41.54

mg/l

1.02

177

Certain conditions originating in the perinatal period

343

1.22

0.62

1.1

32.71

35.92

mg/l

0.23

278

Heart failure and antihypertensive medication

414

1.17

0.62

1.3

1.1

39.38

46.43

mg/l

0.55

346

Endocarditis

1.55

0.62

1.3

1.1

38.41

49.04

mg/l

0.34

Family history of malignant neoplasm

397

1.21

0.61

1.1

1.2

45.28

37.39

mg/l

0.42

344

Nontoxic goitre/thyroid nodule

814

0.86

0.61

1.2

1.1

47.03

40.57

mg/l

0.38

679

Ulcerative rectosigmoiditis

280

1.25

0.60

1.1

1.2

48.08

43.20

mg/l

0.19

231

Hernia

405

2548

1.07

0.60

1.2

1.1

40.80

44.35

mg/l

0.59

346

2139

Accessory breast

0.00

0.60

0.0

1.1

—

24.99

—

Carcinoid syndrome

0.00

0.60

0.0

1.2

—

57.47

—

Exposure to excessive natural cold

0.00

0.60

0.0

1.1

—

55.38

—

Burns and corrosions

490

1.19

0.60

1.1

1.2

31.54

41.49

mg/l

2.95

404

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

224

1792

1.09

0.60

1.2

1.1

34.89

38.16

mg/l

0.61

195

1484

Maternal care related to the fetus and amniotic cavity and possible delivery problems

234

1263

1.09

0.60

1.1

1.2

32.67

39.24

mg/l

1.98

196

1045

Thyrotoxicosis with toxic single thyroid nodule

0.00

0.59

0.0

1.0

—

25.81

—

Melanoma of uvea

0.00

0.59

0.0

1.1

—

54.22

—

LSIL lesion of the cervix uteri

528

1.18

0.59

1.1

1.2

33.45

34.77

mg/l

0.12

443

Excessive earwax

189

1686

1.09

0.59

1.1

50.88

43.26

mg/l

0.28

151

1422

Intestinal adhesions without obstruction

192

1.30

0.59

1.4

1.1

40.24

45.00

mg/l

0.28

157

Contraceptive management

209

1344

1.09

0.59

1.2

37.54

42.04

mg/l

0.64

179

1107

Foreign body or object entering through skin

219

1.28

0.58

1.1

1.2

35.90

45.88

mg/l

1.36

179

Mandibular retrognathia

254

1.26

0.58

1.1

1.2

38.40

39.84

mg/l

0.07

213

Venous complications and haemorrhoids in the puerperium

1.72

0.58

1.7

1.2

29.50

26.23

mg/l

—

Insulin, fast-acting or short human

141

1272

1.11

0.57

1.1

1.2

41.09

41.11

mg/l

0.00

111

1071

Aortic aneurysm

455

0.82

0.57

1.1

42.14

45.47

mg/l

0.17

383

Kidney transplant status

158

1.33

0.57

1.2

44.07

42.64

mg/l

0.08

130

Other and unspecified corneal deformities and disorders

1.49

0.57

1.1

64.13

39.66

mg/l

0.37

Arthropathic psoriasis

328

1.22

0.57

1.1

1.2

45.55

40.61

mg/l

0.20

271

Psoriasis

105

933

1.13

0.57

1.1

1.2

40.11

40.55

mg/l

0.03

779

Diverticular disease of intestine

236

1392

1.08

0.56

1.2

1.1

40.35

45.35

mg/l

0.93

209

1158

Gonarthrosis,primary

302

1735

1.07

0.56

1.1

1.2

44.18

45.59

mg/l

0.17

259

1442

Acute epiglottitis

1.63

0.55

1.0

1.1

34.67

39.52

mg/l

—

Postprocedural musculoskeletal disorders, not elsewhere classified

159

1.32

0.55

1.1

36.46

43.58

mg/l

0.49

135

Ulcer of lower limb, not elsewhere classified

293

1.23

0.55

1.1

116.84

46.02

mg/l

0.55

242

ILD, hospital admissions 1, main diag only

266

1.24

0.55

1.2

1.1

46.24

44.62

mg/l

0.08

222

Cholelithiasis

339

2192

1.07

0.54

1.1

1.2

40.11

43.28

mg/l

0.55

281

1844

Pleural effusion

294

1.23

0.54

1.2

1.1

38.89

44.64

mg/l

0.38

240

Polycythaemia vera

1.48

0.53

1.1

41.00

32.47

mg/l

—

Type 1 diabetes

114

1022

1.11

0.53

1.2

43.61

40.23

mg/l

0.30

856

Other and unspecified injuries of abdomen, lower back and pelvis

1.54

0.53

1.2

1.1

27.33

45.26

mg/l

—

Alcohol abuse counselling and surveillance

1.54

0.53

1.2

1.1

39.88

38.44

mg/l

—

Acute pancreatitis

535

1.16

0.52

1.2

33.58

43.11

mg/l

1.66

434

Gout, unspecified

396

1.19

0.52

1.1

51.47

46.59

mg/l

0.27

332

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

377

2407

0.94

0.52

1.1

1.2

46.21

43.13

mg/l

0.51

320

2030

Alcohol-induced chronic pancreatitis

161

1.31

0.51

1.1

38.99

46.10

mg/l

0.72

133

conjunctival haemorrhage

161

1.31

0.51

1.1

41.07

42.73

mg/l

0.07

133

Superficial injury of neck

1.41

0.51

1.4

1.1

36.54

34.11

mg/l

—

Melanocytic naevi of scalp and neck

1.41

0.51

1.1

60.11

40.65

mg/l

—

Pregnancy hypertension

206

1707

1.08

0.51

1.2

1.1

35.34

37.57

mg/l

0.34

179

1417

Embolic stroke

1.41

0.51

1.0

60.36

43.27

mg/l

—

Coxarthrosis [arthrosis of hip](FG)

156

1002

1.10

0.51

1.1

1.2

47.85

43.61

mg/l

0.32

124

835

Malignant neoplasm of skin

136

845

1.10

0.51

1.1

62.33

42.20

mg/l

0.68

115

712

Malignant neoplasm of thyroid gland, including Hilmo

197

1.27

0.51

1.2

1.1

29.18

34.15

mg/l

0.43

165

Delivery, wide proxy

122

718

0.90

0.50

1.2

32.09

38.07

mg/l

1.27

593

Diabetic maculopathy, excluding more controls

324

1.21

0.50

1.1

1.2

51.76

41.75

mg/l

0.57

257

Thyrotoxicosis, other and/or unspecified

640

1.14

0.50

1.2

1.1

38.62

40.10

mg/l

0.11

534

Inflammation of lacrimal passages (acute and unspecified)

1.47

0.50

1.7

1.1

65.67

33.51

mg/l

—

Benign leiomyoma with endometriosis

398

1.18

0.50

1.2

42.26

34.84

mg/l

0.28

348

Allergic urticaria

288

1.22

0.50

1.2

30.60

38.39

mg/l

0.94

233

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

343

1.20

0.50

1.1

41.87

33.54

mg/l

0.31

289

Premature rupture of membranes

106

844

0.90

0.50

1.2

32.24

37.18

mg/l

0.90

706

Benign neoplasm: Liver

1.50

0.50

1.3

1.1

31.50

38.26

mg/l

—

Maternal care for known or suspected malpresentation of fetus

763

0.89

0.49

1.2

35.74

37.42

mg/l

0.17

636

Complications following abortion and ectopic and molar pregnancy

1.43

0.49

1.1

31.66

30.54

mg/l

0.05

Bitten or struck by other mammals

436

1.17

0.49

1.1

38.08

38.09

mg/l

0.00

369

Malignant neoplasm of testis

1.56

0.49

1.0

1.2

55.71

44.10

mg/l

—

Unstable angina pectoris

639

1.12

0.49

1.1

41.92

47.36

mg/l

0.94

546

Heart failure,strict

120

934

0.91

0.48

1.2

1.1

40.53

47.94

mg/l

1.15

784

Varicose veins of other sites

181

1.27

0.48

1.1

1.2

41.89

45.49

mg/l

0.13

151

Any event in cancer register

432

2415

1.05

0.48

1.2

1.1

53.22

40.56

mg/l

1.27

358

2010

Tumor necrosis factor alpha inhibitors

634

1.14

0.47

1.2

1.1

37.76

39.92

mg/l

0.17

535

Lichen planus

299

1.21

0.47

1.1

44.41

39.65

mg/l

0.24

251

Other disorders of prostate

1.49

0.47

1.1

44.00

56.47

mg/l

—

Acute alcohol intoxication

833

1.12

0.47

1.2

32.35

43.05

mg/l

3.60

705

Adalimumab

364

1.18

0.47

1.2

42.32

39.59

mg/l

0.14

299

Schizoid personality disorder

1.46

0.47

1.0

1.1

27.43

35.33

mg/l

—

Congenital malformations of the respiratory system

1.46

0.47

1.1

41.00

33.02

mg/l

—

Leiomyoma of uterus

256

1357

1.07

0.46

1.1

1.2

41.44

39.25

mg/l

0.20

213

1144

Impacted maxillary molar

299

0.80

0.46

1.1

28.76

37.70

mg/l

1.01

240

Dislocation, sprain and strain of joints and ligaments of elbow

227

1.24

0.46

1.1

1.2

54.73

38.76

mg/l

0.40

185

Later onset COPD, excluding more controls

210

1.21

0.46

1.0

1.1

39.40

45.92

mg/l

0.46

179

Diabetic maculopathy

300

1.19

0.46

1.1

51.76

43.25

mg/l

0.46

257

Conduction disorders

630

1.12

0.45

1.1

40.57

44.24

mg/l

0.39

529

Urethritis and urethral syndrome

1.40

0.45

1.1

73.89

35.41

mg/l

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

581

1.13

0.44

1.1

1.2

32.01

41.55

mg/l

2.35

477

All dysplastic lesions of the cervix uteri, vagina or vulva

153

1391

1.08

0.43

1.1

1.2

34.57

37.13

mg/l

0.41

122

1170

Motorcycle rider injured in other and unspecified transport accidents

211

1.23

0.43

1.0

1.2

42.53

46.38

mg/l

0.22

165

Viral pneumonia (unknown virus, not influenza)

211

1.23

0.43

1.1

41.81

42.35

mg/l

0.03

173

Lichen simplex chronicus and prurigo

148

1.29

0.43

1.2

1.1

31.14

41.35

mg/l

0.87

123

Dialysis

104

1.35

0.43

1.1

1.2

60.67

44.66

mg/l

—

Injury of muscle and tendon at lower leg level

461

1.15

0.43

1.2

1.1

45.01

43.71

mg/l

0.08

381

Eustachian salpingitis and obstruction

340

1.18

0.43

1.1

1.2

36.25

37.89

mg/l

0.14

278

Malignant neoplasm, without specification of site, including Hilmo

1.41

0.43

1.2

1.1

50.98

35.91

mg/l

—

Long labour

112

1051

0.91

0.42

1.2

34.65

37.53

mg/l

0.44

870

Malignant neoplasm of stomach, including Hilmo

0.64

0.42

1.2

1.1

77.33

37.46

mg/l

—

Malignant neoplasm

370

2080

1.05

0.42

1.2

1.1

55.41

40.96

mg/l

1.26

308

1740

Postpartum haemorrhage due to anatomy

542

0.87

0.42

1.0

1.2

29.23

35.97

mg/l

1.18

450

Other congenital malformations of female genitalia

1.52

0.41

1.2

30.40

28.99

mg/l

—

Other congenital malformations of upper alimentary tract

0.00

0.41

0.0

1.1

—

42.45

—

Acute posthaemorrhagic anaemia

1.36

0.41

1.1

1.2

44.62

38.90

mg/l

—

Mesothelioma

0.00

0.40

0.0

1.2

—

40.47

—

Other diseases of lip and oral mucosa

149

1380

1.08

0.40

1.1

1.2

34.86

41.55

mg/l

1.29

131

1149

COPD, hospital admissions 1, only main diagnosis

599

0.89

0.40

1.1

73.49

45.59

mg/l

0.37

508

Routine general health check-up of defined subpopulation

1.47

0.40

1.6

1.2

26.80

39.81

mg/l

—

In situ neoplasms

119

1092

1.09

0.40

1.1

1.2

37.97

41.49

mg/l

0.38

917

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

1.37

0.40

1.2

1.1

50.67

37.71

mg/l

0.43

Abscess of anal and rectal regions

278

1.19

0.40

1.2

52.83

45.97

mg/l

0.20

223

Evidence of alcohol involvement determined by blood alcohol level

1.43

0.39

1.2

1.1

39.60

39.32

mg/l

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.43

0.39

1.2

1.1

35.80

44.10

mg/l

—

Peptic ulcer

0.00

0.39

0.0

1.1

—

35.41

—

Acute alcohol intoxication, ICD10

721

1.11

0.39

1.2

32.82

41.92

mg/l

2.34

607

All dysplastic lesions of the vulva

124

1.29

0.38

1.0

1.2

32.75

30.68

mg/l

0.15

103

Other salmonella infections

124

1.29

0.38

1.1

1.2

35.13

39.80

mg/l

0.45

Eating disorder

437

1.14

0.38

1.2

1.1

33.58

35.66

mg/l

0.08

356

Eating disorders

503

1.13

0.38

1.2

1.1

35.32

36.30

mg/l

0.04

410

Acute pancreatitis (for exclusion)

551

1.13

0.38

1.2

33.58

43.10

mg/l

1.65

450

Melanocytic naevi of other and unspecified parts of face

170

0.76

0.38

1.2

39.63

40.99

mg/l

0.05

143

Nonalcoholic fatty liver disease

298

1.18

0.38

1.2

40.22

41.80

mg/l

0.08

248

Diabetic nephropathy

340

1.16

0.38

1.2

48.99

46.78

mg/l

0.11

289

Other/unspecified seropositive rheumatoid arthritis

694

1.11

0.38

1.1

43.57

40.27

mg/l

0.28

594

Thoracic aortic aneurysm

323

0.84

0.38

1.1

1.2

46.56

47.07

mg/l

0.01

274

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

289

1.18

0.38

1.4

1.1

32.08

41.91

mg/l

1.41

233

Spontaneous abortion

214

1357

1.06

0.37

1.1

1.2

37.19

38.22

mg/l

0.12

179

1128

Other viral hepatitis

234

1.20

0.37

1.2

47.26

41.76

mg/l

0.17

190

Maternal care for cervical incompetence

116

1.30

0.37

1.3

1.1

25.00

36.54

mg/l

—

Endometriosis of intestine

1.39

0.37

1.4

1.2

27.02

31.81

mg/l

—

Diabetic nephropathy, excluding more controls

284

1.16

0.36

1.2

1.1

48.99

48.58

mg/l

0.02

239

Diseases of arteries, arterioles and capillaries

201

1395

1.06

0.36

1.2

1.1

51.39

44.11

mg/l

0.29

163

1182

Other menopausal disorders

107

552

1.09

0.36

1.3

1.1

35.63

42.02

mg/l

0.88

464

Effects of foreign body entering through natural orifice

897

1.09

0.36

1.2

1.1

60.51

42.27

mg/l

0.41

750

Seropositive rheumatoid arthritis, wide

706

1.11

0.36

1.1

43.30

40.14

mg/l

0.27

606

Single delivery by forceps and vacuum extractor

513

0.90

0.36

1.2

33.23

36.97

mg/l

0.48

431

Valvular operations

310

0.84

0.36

1.1

36.42

46.05

mg/l

0.94

262

Lactose intolerance

1.34

0.36

1.1

1.2

22.41

29.79

mg/l

1.50

Unspecified maternal hypertension

1.43

0.35

1.0

1.2

34.55

29.54

mg/l

—

Other congenital malformations of peripheral vascular system

1.43

0.35

1.3

1.2

40.17

29.23

mg/l

—

Superficial injury of ankle and foot

479

1.13

0.35

1.1

39.86

37.82

mg/l

0.15

394

Insulin, intermediate and long-acting

191

1746

1.06

0.35

1.1

1.2

47.26

43.61

mg/l

0.44

157

1479

Blood alcohol or alcohol intoxication level

1.37

0.34

1.4

1.2

41.99

40.86

mg/l

—

Benign neoplasm: Liver/bile ducts

1.37

0.34

1.3

1.1

31.50

37.83

mg/l

—

Bursitis of shoulder

1.37

0.34

1.7

1.1

43.67

41.45

mg/l

—

Erosion of teeth , including avohilmo

116

1074

1.08

0.34

1.2

38.07

39.99

mg/l

0.25

902

Anorexia (incl.atypical)

265

1.17

0.33

1.2

1.1

29.52

36.85

mg/l

0.59

218

Family history of other conditions

1.31

0.33

1.2

42.50

32.24

mg/l

—

Malignant neoplasm of bladder

0.67

0.33

1.2

1.1

32.17

41.69

mg/l

—

Acute nasopharyngitis (common cold)

413

1.13

0.32

1.1

43.46

42.52

mg/l

0.06

344

Burns and corrosions of external body surface, specified by site

369

1.14

0.32

1.1

1.2

30.82

41.23

mg/l

2.38

302

Ovarian hyperstimulation (induction)

1.36

0.32

1.0

1.1

31.09

32.54

mg/l

—

Nontoxic multinodular goitre

466

0.88

0.32

1.2

1.1

46.88

38.24

mg/l

0.43

395

Conotruncal defects

1.28

0.32

1.0

1.1

25.90

31.18

mg/l

—

Atrophic disorders of skin

426

1.13

0.32

1.3

1.2

36.41

37.67

mg/l

0.07

361

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

360

1.14

0.32

1.1

1.2

41.87

35.88

mg/l

0.21

301

Haemorrhage in early pregnancy

133

1209

1.07

0.32

1.2

33.36

36.47

mg/l

0.40

115

1008

Clear cell adenocarcinoma of kidney

1.33

0.32

1.5

1.1

60.34

35.75

mg/l

0.89

Iron deficiency anaemia secondary to blood loss (chronic)

379

1.14

0.32

1.2

1.1

37.62

41.01

mg/l

0.28

310

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

107

784

0.93

0.32

1.1

45.68

42.54

mg/l

0.24

664

Biguanides

371

2354

0.96

0.32

1.1

1.2

47.50

42.49

mg/l

1.02

317

1974

Postmenopausal bleeding

384

0.90

0.31

1.2

1.1

42.68

44.34

mg/l

0.07

322

Pilonidal cyst

370

1.14

0.31

1.2

56.20

41.48

mg/l

1.24

302

Acquired haemolytic anaemia

1.35

0.31

1.1

65.00

31.64

mg/l

—

Intrahepatic Cholestasis of Pregnancy (ICP)

314

1.15

0.31

1.1

44.80

32.96

mg/l

0.39

262

Malignant neoplasm of testis, including Hilmo

1.32

0.31

1.0

1.2

55.71

43.45

mg/l

—

Foreign body in ear

1.32

0.31

1.0

1.1

45.86

43.89

mg/l

—

Congenital malformations of the respiratory system

1.32

0.31

1.1

1.2

41.00

32.52

mg/l

—

Insulin, fast-acting (human)

569

0.90

0.31

1.1

35.67

39.82

mg/l

0.63

476

Use of levodopa decarbox-comt-inhibitor

1.30

0.30

2.1

1.1

68.57

45.64

mg/l

—

Benign lipomatous neoplasm

888

1.08

0.30

1.1

1.2

36.55

40.45

mg/l

0.82

749

Cutaneous abscess, furuncle and carbuncle

105

975

1.08

0.30

1.1

43.61

39.73

mg/l

0.45

817

Malignant neoplasm of thyroid gland

175

1.20

0.30

1.2

1.1

25.15

33.57

mg/l

0.93

146

Erythema intertrigo

1.27

0.30

1.7

1.1

31.86

45.98

mg/l

—

Ulcerative colitis (strict definition, require KELA)

639

1.10

0.29

1.1

42.21

40.79

mg/l

0.09

533

Sub-endpoint used in defining T1D endpoints

116

1065

1.07

0.29

1.2

1.1

43.69

40.98

mg/l

0.23

894

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

689

1.09

0.28

1.1

43.65

40.34

mg/l

0.27

590

COPD

110

839

1.07

0.28

1.2

1.1

58.42

46.13

mg/l

0.27

714

Simple and mucopurulent chronic bronchitis

1.32

0.28

1.2

1.1

70.80

34.39

mg/l

—

Insulin medication

229

1838

1.05

0.28

1.1

1.2

48.82

43.40

mg/l

0.76

186

1551

Type 2 diabetes

442

2496

1.03

0.28

1.2

45.39

42.00

mg/l

0.68

377

2102

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

623

1.09

0.27

1.1

42.72

40.41

mg/l

0.15

520

Polycystic kidney disease

1.25

0.27

1.0

1.1

46.15

44.35

mg/l

—

Total colectomy

116

0.77

0.27

1.2

1.1

38.56

41.67

mg/l

—

Total colectomy operation

116

0.77

0.27

1.2

1.1

38.56

41.67

mg/l

—

Lesion of sciatic nerve

1.25

0.27

1.1

56.75

40.75

mg/l

—

Conductive hearing loss, unspecified

233

1.16

0.27

1.2

1.1

25.53

45.73

mg/l

4.18

195

Diabetes mellitus

481

2725

1.03

0.26

1.1

1.2

46.05

42.12

mg/l

0.80

410

2287

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

702

1.08

0.26

1.1

41.30

40.51

mg/l

0.05

586

Carcinoma in situ of other and unspecified digestive organs

0.69

0.26

1.4

1.1

42.00

41.03

mg/l

—

Medical treatment for female infertility

106

1124

0.94

0.26

1.1

1.2

28.82

36.70

mg/l

3.22

931

Postpartum care and examination

511

1.08

0.26

1.1

33.30

36.85

mg/l

0.35

403

All dysplastic lesions of the cervix uteri

136

1274

1.06

0.25

1.1

1.2

33.51

36.70

mg/l

0.52

107

1066

Alcohol abuse, main dg

559

1.09

0.25

1.2

32.81

42.50

mg/l

1.98

462

Acute and transient psychotic disorders

416

1.11

0.24

1.0

1.2

32.48

40.33

mg/l

1.50

345

Major anomalies of jaw size

1.27

0.24

1.3

1.2

36.00

34.72

mg/l

0.05

Idiopathic urticaria

1.17

0.24

1.3

1.2

25.78

41.70

mg/l

—

Contact with heat and hot substances

180

0.83

0.24

1.1

35.90

40.71

mg/l

—

143

Malignant neoplasm of stomach

0.72

0.24

1.2

1.1

77.33

37.25

mg/l

—

HSIL lesion of the cervix uteri, vagina or vulva

929

1.07

0.23

1.1

1.2

33.30

35.93

mg/l

0.40

780

Seborrhoeic keratosis

504

1.09

0.23

1.1

49.83

42.14

mg/l

0.39

426

Presence of cardiac and vascular implants and grafts

730

0.94

0.23

1.1

40.71

48.94

mg/l

1.17

631

Carcinoma in situ of skin of scalp and neck

1.32

0.23

1.0

1.1

26.00

49.26

mg/l

—

AV-block

324

1.11

0.23

1.1

41.80

46.10

mg/l

0.33

269

Aortic valve malfunction, age under 60 years

275

1.13

0.23

1.0

1.2

29.22

43.98

mg/l

2.82

228

Malignant neoplasm of endocrine gland

190

1.16

0.23

1.2

1.1

38.49

33.23

mg/l

0.15

157

Carbimazole or st.post thyroidectomy, condition for graves disease

698

1.08

0.23

1.2

1.1

40.58

39.28

mg/l

0.08

586

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.25

0.22

1.2

1.1

39.00

47.32

mg/l

—

Lactose intolerance, other/unspecified

1.27

0.22

1.1

1.2

22.89

30.00

mg/l

—

Prolapse and hernia of ovary and fallopian tube

1.24

0.22

1.0

1.1

36.00

32.96

mg/l

—

Solid cancers, helper endpoint

336

2048

0.97

0.22

1.2

1.1

55.69

41.20

mg/l

1.10

279

1709

Non-rheumatic valve diseases

143

981

1.05

0.22

1.1

46.38

44.64

mg/l

0.14

113

835

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

622

1.08

0.22

1.1

34.48

41.47

mg/l

1.05

508

Obstructed labour due to maternal pelvic abnormality

439

1.09

0.21

1.2

34.55

38.92

mg/l

0.46

365

Other specified and unspecified disorders of iris and ciliary body

0.00

0.21

0.0

1.0

—

26.36

—

Complications specific to multiple gestation

0.00

0.21

0.0

1.1

—

24.17

—

Left side

0.00

0.21

0.0

1.2

—

39.14

—

Congenital malformations of heart and great arteries

454

1.09

0.21

1.1

1.2

30.00

40.80

mg/l

2.28

371

Postpartum haemorrhage

126

1116

0.95

0.21

1.1

1.2

32.33

37.53

mg/l

1.04

104

920

Contact with other sharp object(s)

258

1.13

0.21

1.1

1.2

34.00

41.54

mg/l

1.14

206

Mental and behavioural disorders due to hallucinogens

0.00

0.21

0.0

1.1

—

37.25

—

Postpartum hemorraghe, all women as controls

126

1302

0.95

0.20

1.1

1.2

32.33

36.34

mg/l

0.78

104

1086

Acute appendicitis, with complications

586

1.08

0.20

1.1

65.10

42.46

mg/l

1.07

485

Mandibular prognathia

1.20

0.19

1.0

1.2

33.53

31.43

mg/l

—

Impacted teeth

101

948

0.95

0.19

1.2

31.32

38.30

mg/l

2.25

783

Other disorders of iris and ciliary body

1.18

0.19

1.5

1.1

34.50

41.47

mg/l

—

Gout, idiopatic and unspecified

510

1.08

0.19

1.1

52.23

46.78

mg/l

0.35

431

Diabetes mellitus in pregnancy

189

1164

1.04

0.19

1.1

1.2

39.95

36.48

mg/l

0.46

162

959

Embedded teeth, including avohilmo

457

0.92

0.18

1.1

30.42

38.08

mg/l

1.46

374

Fracture of forearm

213

1885

1.03

0.18

1.1

1.2

47.85

41.20

mg/l

0.62

167

1588

Pacemaker

585

0.93

0.18

1.1

38.40

44.97

mg/l

0.82

493

Varicose veins

189

1377

1.04

0.17

1.2

1.1

38.34

43.86

mg/l

1.11

157

1145

Diabetes, varying definitions

474

2718

1.02

0.17

1.1

1.2

45.86

42.25

mg/l

0.71

403

2282

Ventral hernia

640

0.94

0.17

1.1

43.99

41.53

mg/l

0.12

539

Inguinal hernia

204

1410

0.97

0.17

1.2

1.1

44.30

45.97

mg/l

0.15

171

1192

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

507

1.07

0.17

1.1

67.09

40.93

mg/l

1.00

438

Chronic viral hepatitis

205

1.12

0.17

1.2

54.51

41.33

mg/l

0.38

162

Maxillary retrognathism

0.73

0.17

1.2

26.00

35.70

mg/l

—

Malignant neoplasm of prostate, including Hilmo

368

1.07

0.17

1.1

50.98

47.15

mg/l

0.25

320

COPD related to multimorbidity

672

1.06

0.16

1.2

1.1

63.37

45.50

mg/l

0.30

574

COPD, hospital admissions 3, with asthma pneumonia sepsis

423

1.07

0.16

1.2

1.1

84.82

46.77

mg/l

0.42

356

Diabetes medication

458

2772

0.98

0.16

1.1

1.2

45.39

42.30

mg/l

0.59

388

2322

Ulcerative colitis (strict definition, all Crohn cases excluded)

525

1.07

0.16

1.1

45.12

41.30

mg/l

0.23

435

Suppurative and necrotic conditions of lower respiratory tract

119

0.84

0.15

1.1

45.10

44.40

mg/l

—

Polyp of the female genital tract

111

666

0.96

0.15

1.1

38.32

40.78

mg/l

0.23

558

Other benign neoplasms of connective and other soft tissue

274

1.10

0.15

1.3

1.1

35.10

41.87

mg/l

0.67

229

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

332

1.09

0.15

1.1

1.2

44.80

35.33

mg/l

0.30

276

Polypectomy (DHB20)

161

0.87

0.15

1.1

63.87

44.82

mg/l

0.42

132

Other chronic obstructive pulmonary disease

102

804

1.05

0.15

1.2

1.1

60.71

45.95

mg/l

0.30

683

Tooth eruption problems

710

0.95

0.15

1.1

1.2

26.00

37.83

mg/l

4.37

586

Seropositive rheumatoid arthritis, strict definition

379

0.92

0.15

1.1

39.70

40.02

mg/l

0.02

318

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

352

1.08

0.14

1.2

44.59

44.12

mg/l

0.03

292

Coxarthrosis, primary, with hip surgery

101

986

0.96

0.14

1.1

42.05

44.63

mg/l

0.29

835

Poor fetal growth

635

1.06

0.14

1.2

32.75

35.17

mg/l

0.20

533

Other and unspecified injuries of wrist and hand

122

1.15

0.13

1.1

1.2

22.21

35.64

mg/l

—

Peripheral artery operations in Hilmo

232

0.90

0.13

1.2

1.1

169.11

46.54

mg/l

0.51

195

Myocardial infarction, without ST-elevation

732

1.05

0.13

1.1

40.52

45.13

mg/l

0.64

627

Persistent delusional disorders

211

0.90

0.13

1.0

1.2

33.04

42.26

mg/l

0.75

173

491

1.06

0.13

1.1

1.2

32.82

34.17

mg/l

0.16

410

Other malignant neoplasms of skin (=non-melanoma skin cancer)

103

734

0.96

0.12

1.1

66.43

43.20

mg/l

0.58

623

Congenital malformations of eye, ear, face and neck

252

0.91

0.12

1.3

1.2

22.69

39.11

mg/l

4.94

205

Coxarthrosis

141

901

1.03

0.12

1.1

1.2

47.12

45.65

mg/l

0.09

112

748

Complications associated with artificial fertilization

1.18

0.12

1.0

1.2

31.09

33.70

mg/l

—

Supervision of normal pregnancy

111

657

0.96

0.12

1.2

1.1

34.22

38.07

mg/l

0.46

526

Fracture of shoulder and upper arm

115

1110

1.03

0.12

1.1

43.89

40.09

mg/l

0.32

936

Type 1 diabetes, wide definition, subgroup 1

873

0.96

0.11

1.1

1.2

42.53

39.95

mg/l

0.18

737

Congenital malformations of the urinary system

172

1.11

0.11

1.0

1.2

44.15

37.81

mg/l

0.45

136

Pedal cyclist injured in transport accident

847

1.04

0.11

1.1

44.22

40.82

mg/l

0.16

714

Psoriatic arthropathies, ICD10

318

1.07

0.11

1.1

1.2

37.48

41.95

mg/l

0.29

263

Type 1 diabetes, wide definition

902

0.96

0.11

1.1

1.2

42.01

39.86

mg/l

0.15

760

Coxarthrosis, primary

150

1236

1.03

0.10

1.1

47.87

44.48

mg/l

0.24

121

1045

Other psoriatic arthropathies

309

1.07

0.10

1.1

1.2

37.48

41.68

mg/l

0.27

255

Other (not insulin) diabetes medications

397

2392

0.98

0.10

1.2

46.36

42.70

mg/l

0.70

341

2010

Squamous cell neoplasms and carcinomas of the skin

115

1.13

0.10

1.1

55.38

42.41

mg/l

0.24

Congenital malformations of the urinary system

183

1.09

0.10

1.0

1.2

51.20

39.60

mg/l

0.62

146

Embedded and impacted teeth

143

1211

0.97

0.10

1.1

1.2

30.81

40.26

mg/l

3.93

119

1008

Labour and delivery complicated by fetal stress [distress]

141

948

0.97

0.10

1.2

31.49

36.54

mg/l

1.19

120

775

Other abnormal uterine and vaginal bleeding

545

1.04

0.10

1.2

1.1

34.39

38.36

mg/l

0.50

456

Sexual dysfunction

1.09

0.09

1.0

1.1

41.42

48.95

mg/l

—

Adhesive middle ear disease

1.09

0.09

1.0

1.2

33.60

37.51

mg/l

—

Maternal care for known or suspected fetal abnormality and damage

740

1.03

0.09

1.2

31.33

36.61

mg/l

0.81

616

Valvular heart disease excluding rheumatic fever

143

1006

1.03

0.09

1.1

46.38

44.32

mg/l

0.17

113

854

Complications of labour and delivery

283

1546

1.02

0.09

1.1

1.2

35.88

38.47

mg/l

0.47

244

1269

Failed induction of labour

309

0.94

0.09

1.1

39.05

36.37

mg/l

0.16

251

Fracture of femur

456

0.95

0.09

1.1

41.46

44.26

mg/l

0.19

380

Combinations of oral blood glucose lowering drugs

736

0.96

0.09

1.1

54.10

45.95

mg/l

0.63

626

Aggressive periodontitis

1.11

0.09

1.2

1.1

54.17

40.60

mg/l

—

malignant neoplasm of male genital organs

393

1.04

0.08

1.1

54.07

46.65

mg/l

0.56

336

Ectopic pregnancy

664

0.96

0.08

1.3

1.2

30.80

37.84

mg/l

1.30

564

Viral haemorrhagic fevers, not elsewhere classified/unspecified

511

0.96

0.08

1.2

1.1

52.14

40.17

mg/l

0.92

418

284

1.06

0.08

1.1

51.04

43.82

mg/l

0.39

245

Dipeptidyl peptidase 4 (DPP-4) inhibitors

147

1203

0.98

0.08

1.1

48.07

45.73

mg/l

0.21

130

1008

Carcinoma in situ of cervix uteri

440

0.95

0.08

1.1

36.04

35.75

mg/l

0.02

372

HSIL lesion of the cervix uteri

884

1.03

0.08

1.1

1.2

33.03

35.90

mg/l

0.41

745

Umbilical hernia

884

1.03

0.08

1.2

1.1

37.90

45.43

mg/l

1.01

745

Other ulcerative colitis

195

1.08

0.08

1.2

34.61

43.43

mg/l

0.58

159

Childhood allergy (age < 16)

696

1.03

0.08

1.2

34.23

39.89

mg/l

0.69

574

Other renal tubulo-interstitial diseases

1.05

0.08

1.0

1.1

46.73

31.00

mg/l

—

Malignant neoplasm of cervix uteri, including Hilmo

1.03

0.08

1.1

27.43

29.90

mg/l

—

Non-ischemic cardiomyopathy

566

0.97

0.08

1.1

1.2

39.49

45.60

mg/l

0.71

471

D07AA Corticosteroids, weak (group I)

627

1.04

0.07

1.1

41.61

38.46

mg/l

0.22

525

Use of biperiden

137

1.10

0.07

1.2

35.62

41.14

mg/l

—

114

Abnormal spermatozoa

235

0.94

0.07

1.0

1.1

61.88

51.90

mg/l

0.27

199

Other chronic obstructive pulmonary disease, including avohilmo

135

1092

1.02

0.07

1.2

1.1

53.35

45.35

mg/l

0.20

106

923

Other acute skin changes due to ultraviolet radiation

0.84

0.07

1.4

1.1

29.29

37.02

mg/l

—

Primary coxarthrosis, bilateral

590

1.03

0.07

1.2

1.1

64.07

43.72

mg/l

0.77

506

Rubella [German measles]

0.87

0.06

1.3

1.1

42.17

49.58

mg/l

—

Pyothorax

0.85

0.06

1.1

49.13

45.80

mg/l

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

226

1.06

0.06

1.0

1.2

27.65

32.17

mg/l

0.36

188

Chronic periodontitis, complicated

172

1733

0.98

0.06

1.1

42.50

44.57

mg/l

0.30

142

1459

Lichen ruber planus, wide definition including periferal and oral lichen planus

589

0.97

0.06

1.1

1.2

41.00

41.05

mg/l

0.00

495

Psoriasis vulgaris

591

1.03

0.06

1.1

1.2

45.10

40.51

mg/l

0.26

494

Pregnancy examination and test

551

1.03

0.06

1.2

1.1

31.68

38.94

mg/l

0.93

434

Hernia of abdominal wall

144

1466

0.98

0.06

1.2

40.63

43.91

mg/l

0.37

121

1240

Maternal care for known or suspected abnormality of pelvic organs

127

881

0.98

0.06

1.2

31.73

38.74

mg/l

1.49

107

735

Cyst of Bartholin Gland

121

0.91

0.06

1.1

1.2

21.00

34.08

mg/l

2.62

Obstructed labour due to malposition and malpresentation of fetus

112

1065

0.98

0.05

1.2

43.73

37.59

mg/l

0.39

100

878

Other or unspecified ileus, impaction or obstruction

425

0.96

0.05

1.1

1.2

41.57

45.93

mg/l

0.34

344

Viral hepatitis

267

1.05

0.05

1.2

47.26

41.25

mg/l

0.19

217

Graves disease, strict definition

356

1.04

0.05

1.4

1.1

41.54

36.20

mg/l

0.25

303

Pre-eclampsia or eclampsia

901

1.02

0.05

1.3

1.1

33.87

36.52

mg/l

0.30

752

Injury of unspecified body region

208

1.06

0.05

1.0

1.2

31.01

42.49

mg/l

1.28

169

Operations 2 for CAVS

470

1.03

0.05

1.1

37.70

45.91

mg/l

1.14

394

Calcific aortic valvular stenosis, diagnosis (helper)

470

1.03

0.05

1.1

37.70

45.91

mg/l

1.14

394

Postpartum hemorraghe, parous women as controls

126

1090

0.98

0.05

1.1

1.2

32.33

35.71

mg/l

0.60

104

904

Type 2 diabetes, strict (exclude DM1)

394

2331

0.99

0.04

1.1

1.2

46.54

42.55

mg/l

0.77

339

1964

Duodenal ulcer

201

0.94

0.04

1.1

36.20

50.96

mg/l

1.60

165

Calcific aortic valvular stenosis

471

1.03

0.04

1.1

37.70

45.82

mg/l

1.12

395

Calcific aortic valvular stenosis, operated

471

1.03

0.04

1.1

37.70

45.82

mg/l

1.12

395

Calcific aortic valvular stenosis, including rheumatic fever

471

1.03

0.04

1.1

37.70

45.91

mg/l

1.14

394

Retained placenta and membranes, without haemorrhage

427

1.03

0.04

1.1

1.2

31.46

38.06

mg/l

1.19

355

Pre-eclampsia or poor fetal growth

148

1456

1.01

0.04

1.2

1.1

33.85

36.34

mg/l

0.35

122

1215

Lichen planus, including avohilmo

493

0.97

0.04

1.1

1.2

42.99

41.31

mg/l

0.09

410

Abrasion of teeth

118

1197

0.99

0.04

1.1

39.52

40.79

mg/l

0.12

1004

Injuries to unspecified part of trunk, limb or body region

301

0.96

0.03

1.0

1.1

31.44

40.79

mg/l

1.24

247

Haemangioma, any site

240

1.04

0.03

1.2

1.1

29.86

41.25

mg/l

1.56

200

Pedal cyclist injured in other and unspecified transport accidents

379

1.03

0.03

1.1

61.88

41.01

mg/l

0.53

312

Coronary atherosclerosis

184

1175

0.99

0.03

1.2

40.94

48.13

mg/l

1.36

144

985

Supervision of high-risk pregnancy

107

635

1.01

0.03

1.2

1.1

38.52

38.32

mg/l

0.01

508

Left ventricular outflow tract obstruction (LVOTO), broad definition

310

1.03

0.03

1.0

1.2

29.71

44.58

mg/l

2.86

253

COPD, hospital admission 2, with asthma infections

547

1.02

0.03

1.2

1.1

78.48

45.89

mg/l

0.41

462

Crowding of teeth, including avohilmo

355

1.02

0.03

1.1

32.88

37.41

mg/l

0.42

284

Malignant neoplasm of prostate

346

1.02

0.02

1.1

50.55

47.04

mg/l

0.21

302

COPD, hospital admissions

100

856

0.99

0.02

1.2

1.1

60.59

45.58

mg/l

0.30

727

Abnormalities of forces of labour

410

1.02

0.02

1.2

52.45

38.75

mg/l

0.30

343

Arthropod-borne viral fevers and viral haemorrhagic fevers

261

1.03

0.02

1.3

1.2

44.27

42.56

mg/l

0.07

214

Type 2 diabetes, definitions combined, including avohilmo

401

2346

1.00

0.02

1.1

1.2

45.96

42.39

mg/l

0.67

345

1976

Basal cell carcinoma, including avohilmo

109

742

1.01

0.02

1.1

65.81

42.96

mg/l

0.60

628

418

0.98

0.02

1.2

1.1

55.08

44.58

mg/l

0.78

356

Foreign body on external eye

520

1.02

0.02

1.2

85.23

44.68

mg/l

0.47

430

Hypertensive Heart Disease

368

0.98

0.02

1.2

42.73

42.47

mg/l

0.02

309

Pre-eclampsia

849

1.01

0.02

1.3

1.1

34.92

36.88

mg/l

0.19

710

Crohn's disease of large intestine

178

0.95

0.02

1.1

1.2

24.47

42.74

mg/l

3.28

145

Major coronary heart disease event excluding revascularizations

168

1110

1.01

0.02

1.1

42.85

48.09

mg/l

0.88

143

936

Hypertensive heart and/or renal disease

396

1.02

0.02

1.2

42.60

42.99

mg/l

0.03

335

Contact with machinery

303

1.02

0.01

1.2

1.1

52.83

48.42

mg/l

0.21

242

Type 2 diabetes, definitions combined

394

2319

1.00

0.01

1.1

1.2

46.43

42.42

mg/l

0.77

338

1957

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

963

1.01

0.01

1.1

1.2

48.47

44.33

mg/l

0.29

801

Glucagon-like peptide-1 (GLP-1) analogues

963

1.01

0.01

1.1

1.2

48.47

44.33

mg/l

0.29

801

Gonarthrosis, primary, with knee surgery

141

1117

1.00

0.00

1.1

40.28

46.80

mg/l

0.91

113

942

Other blood glucose lowering drugs, excl. Insulins

336

0.98

0.00

1.2

1.1

42.97

43.05

mg/l

0.00

278

Basal cell carcinoma

103

711

1.00

0.00

1.1

67.55

42.48

mg/l

0.64

601

COPD, early/later onset

102

856

1.00

0.00

1.2

1.1

60.71

45.60

mg/l

0.31

728

Benign neoplasm of ovary

446

1.01

0.00

1.2

44.61

35.77

mg/l

0.42

383

Benign neoplasm of middle ear and respiratory system

185

1.03

0.00

1.1

47.97

41.90

mg/l

0.16

153

Haemangioma and lymphangioma, any site

261

1.00

0.00

1.2

1.1

29.86

41.46

mg/l

1.58

217

Otosclerosis

171

0.99

0.00

1.2

1.1

31.42

43.39

mg/l

0.97

146

Congenital ovarian cysts

181

0.99

0.00

1.1

28.29

32.90

mg/l

0.27

144

Other Crohn's disease

259

1.00

0.00

1.1

1.2

31.42

41.70

mg/l

1.63

214

Other secondary gonarthrosis

112

0.98

0.00

1.0

1.1

35.50

42.55

mg/l

—

Gout, strict definition

342

0.99

0.00

1.1

55.14

47.56

mg/l

0.31

286

Postpartum haemorrhage due to retained placenta

553

0.99

0.00

1.2

35.88

37.05

mg/l

0.09

463

Postmenopausal atrophic vaginitis

426

1.00

0.00

1.2

1.1

41.69

43.42

mg/l

0.08

352

Maternal care for other known or suspected fetal problems

135

851

1.00

0.00

1.1

1.2

35.89

37.97

mg/l

0.22

107

704

Arthropod-borne viral fevers and viral haemorrhagic fevers

570

1.00

0.00

1.3

1.1

48.99

40.16

mg/l

0.68

468

Congenital malformations of genital organs

412

1.01

0.00

1.1

28.81

36.51

mg/l

1.17

348

Schizoaffective disorder

273

0.99

0.00

1.1

1.2

29.28

41.03

mg/l

2.05

223

Injury of muscle and tendon at forearm level

0.98

0.00

1.0

1.1

27.60

46.45

mg/l

—

Injury of blood vessels of thorax

0.00

0.0

1.2

—

39.67

—

Renal cell carcinoma of kidney

0.91

0.00

1.0

1.1

40.60

37.14

mg/l

—

Benign neoplasm: Skin of scalp and neck

0.86

0.00

1.2

1.1

64.60

39.72

mg/l

—

Folliculitis decalvans

0.00

-0.00

0.0

1.2

—

41.33

—

Cleft lip, lip and palate or palate

1.02

-0.00

1.0

1.2

85.20

34.12

mg/l

—

Photocontact dermatitis [berloque dermatitis]

0.00

-0.00

0.0

1.2

—

40.56

—

Cystic kidney disease

0.93

-0.00

1.0

1.2

65.25

40.07

mg/l

—

Malignant neoplasm of pyriform sinus, including Hilmo

0.00

-0.00

0.0

1.2

—

62.80

—

Haematosalpinx/Haematoma of broad ligament

0.00

-0.00

0.0

1.0

—

19.57

—

Unspecified organic or symptomatic mental disorder

0.00

-0.00

0.0

1.2

—

42.20

—

Induced delusional disorder

0.00

-0.00

0.0

1.2

—

35.00

—

Ankylosis of teeth

0.00

-0.00

0.0

1.3

—

34.50

—

Benign neoplasm: Rectosigmoid junction

0.94

-0.00

1.1

1.2

47.58

39.15

mg/l

—

Other disorders of amniotic fluid and membranes

700

1.00

-0.00

1.1

38.70

36.40

mg/l

0.20

582

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

0.93

-0.00

1.0

1.1

35.80

39.86

mg/l

—

Periodontal disease, other/unspecified

1.01

-0.00

1.7

1.1

36.80

41.00

mg/l

—

Other and unspecified disease of Bartholin gland

0.97

-0.00

1.2

1.1

42.08

28.78

mg/l

—

Eccrine sweat disorders

0.00

-0.00

0.0

1.0

—

40.60

—

Cystic kidney disease

0.89

-0.00

1.0

1.2

48.14

40.77

mg/l

—

Macular cyst

1.00

-0.00

1.0

1.1

47.60

36.70

mg/l

—

Ulcerative enterocolitis

0.90

-0.00

1.1

34.20

40.78

mg/l

—

Brain mixed glioma

0.00

-0.00

0.0

1.2

—

38.40

—

Pterygium

0.89

-0.00

1.2

1.1

45.10

44.10

mg/l

—

Carcinoma in situ of larynx

0.00

-0.00

0.0

1.2

—

49.80

—

Secondary sideroblastic anaemia

0.00

-0.00

0.0

1.0

—

31.80

—

Defect, injury or illness of face

0.00

-0.00

0.0

1.2

—

48.16

—

Other and unspecified hereditary haemolytic anaemias

0.00

-0.00

0.0

1.4

—

24.40

—

Hereditary lymphedema

0.00

-0.00

0.0

1.0

—

42.36

—

Other specified disorders of kidney and ureter

0.96

-0.00

1.3

1.1

279.14

38.37

mg/l

—

Hereditary lymphedema

0.00

-0.00

0.0

1.0

—

39.47

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

IgG [Mass/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS